id	sid	tid	token	lemma	pos
aijmsr-823	1	1	american	american	PROPN
aijmsr-823	1	2	international	international	PROPN
aijmsr-823	1	3	journal	journal	PROPN
aijmsr-823	1	4	of	of	ADP
aijmsr-823	1	5	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	1	6	scientific	scientific	ADJ
aijmsr-823	1	7	research	research	NOUN
aijmsr-823	1	8	vol	vol	NOUN
aijmsr-823	1	9	.	.	PROPN
aijmsr-823	2	1	6	6	NUM
aijmsr-823	2	2	,	,	PUNCT
aijmsr-823	2	3	no	no	INTJ
aijmsr-823	2	4	.	.	NOUN
aijmsr-823	2	5	3	3	NUM
aijmsr-823	2	6	;	;	PUNCT
aijmsr-823	2	7	2020	2020	NUM
aijmsr-823	2	8	issn	issn	VERB
aijmsr-823	2	9	2638	2638	NUM
aijmsr-823	2	10	-	-	SYM
aijmsr-823	2	11	1249	1249	NUM
aijmsr-823	2	12	e	e	NOUN
aijmsr-823	2	13	-	-	PROPN
aijmsr-823	2	14	issn	issn	PROPN
aijmsr-823	2	15	2638	2638	NUM
aijmsr-823	2	16	-	-	SYM
aijmsr-823	2	17	1273	1273	NUM
aijmsr-823	2	18	published	publish	VERB
aijmsr-823	2	19	by	by	ADP
aijmsr-823	2	20	cribfb	cribfb	PROPN
aijmsr-823	2	21	,	,	PUNCT
aijmsr-823	2	22	usa	usa	PROPN
aijmsr-823	2	23	1	1	NUM
aijmsr-823	2	24	comparison	comparison	NOUN
aijmsr-823	2	25	of	of	ADP
aijmsr-823	2	26	in	in	ADP
aijmsr-823	2	27	vitro	vitro	X
aijmsr-823	2	28	activity	activity	NOUN
aijmsr-823	2	29	of	of	ADP
aijmsr-823	2	30	colistin	colistin	NOUN
aijmsr-823	2	31	with	with	ADP
aijmsr-823	2	32	ceftolozane	ceftolozane	NOUN
aijmsr-823	2	33	/	/	SYM
aijmsr-823	2	34	tazobactam	tazobactam	NOUN
aijmsr-823	2	35	against	against	ADP
aijmsr-823	2	36	multi	multi	ADJ
aijmsr-823	2	37	drug	drug	NOUN
aijmsr-823	2	38	resistant	resistant	ADJ
aijmsr-823	2	39	pseudomonas	pseudomona	NOUN
aijmsr-823	2	40	aeruginosa	aeruginosa	NOUN
aijmsr-823	2	41	“	"	PUNCT
aijmsr-823	2	42	a	a	DET
aijmsr-823	2	43	last	last	ADJ
aijmsr-823	2	44	line	line	NOUN
aijmsr-823	2	45	treatment	treatment	NOUN
aijmsr-823	2	46	against	against	ADP
aijmsr-823	2	47	mdr	mdr	PROPN
aijmsr-823	2	48	”	"	PUNCT
aijmsr-823	2	49	k.	k.	PROPN
aijmsr-823	2	50	m.	m.	PROPN
aijmsr-823	2	51	anwarul	anwarul	PROPN
aijmsr-823	2	52	islam	islam	PROPN
aijmsr-823	2	53	associate	associate	PROPN
aijmsr-823	2	54	professor	professor	PROPN
aijmsr-823	2	55	the	the	DET
aijmsr-823	2	56	millennium	millennium	PROPN
aijmsr-823	2	57	university	university	PROPN
aijmsr-823	2	58	,	,	PUNCT
aijmsr-823	2	59	bangladesh	bangladesh	PROPN
aijmsr-823	2	60	muhammad	muhammad	PROPN
aijmsr-823	2	61	aitmaud	aitmaud	PROPN
aijmsr-823	2	62	uddolah	uddolah	PROPN
aijmsr-823	2	63	khan	khan	PROPN
aijmsr-823	2	64	assistant	assistant	PROPN
aijmsr-823	2	65	professor	professor	PROPN
aijmsr-823	2	66	baqai	baqai	PROPN
aijmsr-823	2	67	medical	medical	ADJ
aijmsr-823	2	68	university	university	NOUN
aijmsr-823	2	69	,	,	PUNCT
aijmsr-823	3	1	pakistan	pakistan	PROPN
aijmsr-823	3	2	sarah	sarah	PROPN
aijmsr-823	3	3	azhar	azhar	PROPN
aijmsr-823	4	1	senior	senior	ADJ
aijmsr-823	4	2	lecturer	lecturer	NOUN
aijmsr-823	4	3	baqai	baqai	PROPN
aijmsr-823	4	4	medical	medical	ADJ
aijmsr-823	4	5	university	university	NOUN
aijmsr-823	4	6	,	,	PUNCT
aijmsr-823	4	7	pakistan	pakistan	PROPN
aijmsr-823	4	8	muhammad	muhammad	PROPN
aijmsr-823	4	9	rashid	rashid	PROPN
aijmsr-823	4	10	ahmed	ahmed	PROPN
aijmsr-823	4	11	professor	professor	PROPN
aijmsr-823	4	12	baqai	baqai	PROPN
aijmsr-823	4	13	medical	medical	ADJ
aijmsr-823	4	14	university	university	NOUN
aijmsr-823	4	15	,	,	PUNCT
aijmsr-823	4	16	pakistan	pakistan	PROPN
aijmsr-823	4	17	sumreen	sumreen	PROPN
aijmsr-823	4	18	khurram	khurram	PROPN
aijmsr-823	4	19	lecturer	lecturer	PROPN
aijmsr-823	4	20	baqai	baqai	PROPN
aijmsr-823	4	21	medical	medical	ADJ
aijmsr-823	4	22	university	university	NOUN
aijmsr-823	4	23	,	,	PUNCT
aijmsr-823	4	24	pakistan	pakistan	PROPN
aijmsr-823	4	25	hina	hina	PROPN
aijmsr-823	4	26	masood	masood	PROPN
aijmsr-823	4	27	lecturer	lecturer	PROPN
aijmsr-823	4	28	baqai	baqai	PROPN
aijmsr-823	4	29	medical	medical	ADJ
aijmsr-823	4	30	university	university	NOUN
aijmsr-823	4	31	,	,	PUNCT
aijmsr-823	4	32	pakistan	pakistan	PROPN
aijmsr-823	4	33	lubna	lubna	PROPN
aijmsr-823	4	34	farooq	farooq	PROPN
aijmsr-823	4	35	assistant	assistant	PROPN
aijmsr-823	4	36	professor	professor	PROPN
aijmsr-823	4	37	baqai	baqai	PROPN
aijmsr-823	4	38	medical	medical	ADJ
aijmsr-823	4	39	university	university	NOUN
aijmsr-823	4	40	,	,	PUNCT
aijmsr-823	4	41	pakistan	pakistan	PROPN
aijmsr-823	4	42	abstract	abstract	ADJ
aijmsr-823	4	43	objectives	objective	NOUN
aijmsr-823	4	44	to	to	PART
aijmsr-823	4	45	evaluate	evaluate	VERB
aijmsr-823	4	46	and	and	CCONJ
aijmsr-823	4	47	compare	compare	VERB
aijmsr-823	4	48	in	in	ADP
aijmsr-823	4	49	vitro	vitro	X
aijmsr-823	4	50	activity	activity	NOUN
aijmsr-823	4	51	of	of	ADP
aijmsr-823	4	52	ceftolazane	ceftolazane	NOUN
aijmsr-823	4	53	/	/	SYM
aijmsr-823	4	54	tazobactum	tazobactum	NOUN
aijmsr-823	4	55	and	and	CCONJ
aijmsr-823	4	56	colistin	colistin	VERB
aijmsr-823	4	57	against	against	ADP
aijmsr-823	4	58	multi	multi	ADJ
aijmsr-823	4	59	drug	drug	NOUN
aijmsr-823	4	60	resistant	resistant	ADJ
aijmsr-823	4	61	(	(	PUNCT
aijmsr-823	4	62	mdr	mdr	NOUN
aijmsr-823	4	63	)	)	PUNCT
aijmsr-823	4	64	strains	strain	NOUN
aijmsr-823	4	65	of	of	ADP
aijmsr-823	4	66	pseudomonas	pseudomona	NOUN
aijmsr-823	4	67	aeruginosa	aeruginosa	NOUN
aijmsr-823	4	68	.	.	PUNCT
aijmsr-823	5	1	methodology	methodology	NOUN
aijmsr-823	5	2	after	after	ADP
aijmsr-823	5	3	ethical	ethical	ADJ
aijmsr-823	5	4	approval	approval	NOUN
aijmsr-823	5	5	this	this	PRON
aijmsr-823	5	6	in	in	ADP
aijmsr-823	5	7	vitro	vitro	X
aijmsr-823	5	8	cross	cross	ADJ
aijmsr-823	5	9	-	-	ADJ
aijmsr-823	5	10	sectional	sectional	ADJ
aijmsr-823	5	11	study	study	NOUN
aijmsr-823	5	12	was	be	AUX
aijmsr-823	5	13	conducted	conduct	VERB
aijmsr-823	5	14	from	from	ADP
aijmsr-823	5	15	october	october	PROPN
aijmsr-823	5	16	2017	2017	NUM
aijmsr-823	5	17	to	to	ADP
aijmsr-823	5	18	april	april	PROPN
aijmsr-823	5	19	2018	2018	NUM
aijmsr-823	5	20	.	.	PUNCT
aijmsr-823	6	1	routine	routine	ADJ
aijmsr-823	6	2	samples	sample	NOUN
aijmsr-823	6	3	of	of	ADP
aijmsr-823	6	4	pus	pus	NOUN
aijmsr-823	6	5	,	,	PUNCT
aijmsr-823	6	6	wound	wound	NOUN
aijmsr-823	6	7	swabs	swab	NOUN
aijmsr-823	6	8	,	,	PUNCT
aijmsr-823	6	9	blood	blood	NOUN
aijmsr-823	6	10	,	,	PUNCT
aijmsr-823	6	11	tracheal	tracheal	NOUN
aijmsr-823	6	12	aspirates	aspirate	NOUN
aijmsr-823	6	13	and	and	CCONJ
aijmsr-823	6	14	urine	urine	NOUN
aijmsr-823	6	15	were	be	AUX
aijmsr-823	6	16	collected	collect	VERB
aijmsr-823	6	17	and	and	CCONJ
aijmsr-823	6	18	received	receive	VERB
aijmsr-823	6	19	from	from	ADP
aijmsr-823	6	20	the	the	DET
aijmsr-823	6	21	in	in	ADP
aijmsr-823	6	22	-	-	PUNCT
aijmsr-823	6	23	patient	patient	NOUN
aijmsr-823	6	24	and	and	CCONJ
aijmsr-823	6	25	out	out	ADJ
aijmsr-823	6	26	-	-	PUNCT
aijmsr-823	6	27	patient	patient	NOUN
aijmsr-823	6	28	clinics	clinic	NOUN
aijmsr-823	6	29	.	.	PUNCT
aijmsr-823	7	1	all	all	DET
aijmsr-823	7	2	the	the	DET
aijmsr-823	7	3	samples	sample	NOUN
aijmsr-823	7	4	were	be	AUX
aijmsr-823	7	5	submitted	submit	VERB
aijmsr-823	7	6	for	for	ADP
aijmsr-823	7	7	culture	culture	NOUN
aijmsr-823	7	8	and	and	CCONJ
aijmsr-823	7	9	sensitivity	sensitivity	NOUN
aijmsr-823	7	10	testing	testing	NOUN
aijmsr-823	7	11	at	at	ADP
aijmsr-823	7	12	the	the	DET
aijmsr-823	7	13	microbiology	microbiology	NOUN
aijmsr-823	7	14	laboratory	laboratory	NOUN
aijmsr-823	7	15	of	of	ADP
aijmsr-823	7	16	ziauddin	ziauddin	VERB
aijmsr-823	7	17	university	university	NOUN
aijmsr-823	7	18	hospital	hospital	NOUN
aijmsr-823	7	19	,	,	PUNCT
aijmsr-823	7	20	https://www.cribfb.com/journal/index.php/aijmsr	https://www.cribfb.com/journal/index.php/aijmsr	PROPN
aijmsr-823	7	21	american	american	PROPN
aijmsr-823	7	22	international	international	PROPN
aijmsr-823	7	23	journal	journal	PROPN
aijmsr-823	7	24	of	of	ADP
aijmsr-823	7	25	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	7	26	scientific	scientific	ADJ
aijmsr-823	7	27	research	research	NOUN
aijmsr-823	7	28	vol	vol	NOUN
aijmsr-823	7	29	.	.	PROPN
aijmsr-823	8	1	6	6	NUM
aijmsr-823	8	2	,	,	PUNCT
aijmsr-823	8	3	no	no	INTJ
aijmsr-823	8	4	.	.	NOUN
aijmsr-823	8	5	3	3	NUM
aijmsr-823	8	6	;	;	PUNCT
aijmsr-823	8	7	2020	2020	NUM
aijmsr-823	8	8	2	2	NUM
aijmsr-823	8	9	north	north	NOUN
aijmsr-823	8	10	nazimabad	nazimabad	PROPN
aijmsr-823	8	11	campus	campus	NOUN
aijmsr-823	8	12	.	.	PUNCT
aijmsr-823	9	1	all	all	DET
aijmsr-823	9	2	the	the	DET
aijmsr-823	9	3	samples	sample	NOUN
aijmsr-823	9	4	were	be	AUX
aijmsr-823	9	5	processed	process	VERB
aijmsr-823	9	6	according	accord	VERB
aijmsr-823	9	7	to	to	ADP
aijmsr-823	9	8	the	the	DET
aijmsr-823	9	9	provided	provide	VERB
aijmsr-823	9	10	microbiological	microbiological	ADJ
aijmsr-823	9	11	procedures	procedure	NOUN
aijmsr-823	9	12	,	,	PUNCT
aijmsr-823	9	13	clsi	clsi	ADJ
aijmsr-823	9	14	guidelines	guideline	NOUN
aijmsr-823	9	15	2018	2018	NUM
aijmsr-823	9	16	.	.	PUNCT
aijmsr-823	10	1	results	result	VERB
aijmsr-823	10	2	forty	forty	NUM
aijmsr-823	10	3	sample	sample	NOUN
aijmsr-823	10	4	from	from	ADP
aijmsr-823	10	5	the	the	DET
aijmsr-823	10	6	out	out	ADJ
aijmsr-823	10	7	-	-	PUNCT
aijmsr-823	10	8	patient	patient	NOUN
aijmsr-823	10	9	clinics	clinic	NOUN
aijmsr-823	10	10	represented	represent	VERB
aijmsr-823	10	11	pre	pre	NOUN
aijmsr-823	10	12	-	-	NOUN
aijmsr-823	10	13	dominance	dominance	NOUN
aijmsr-823	10	14	of	of	ADP
aijmsr-823	10	15	multi	multi	ADJ
aijmsr-823	10	16	drug	drug	NOUN
aijmsr-823	10	17	resistant	resistant	ADJ
aijmsr-823	10	18	strains	strain	NOUN
aijmsr-823	10	19	of	of	ADP
aijmsr-823	10	20	pseudomonas	pseudomona	NOUN
aijmsr-823	10	21	aeruginosa	aeruginosa	NOUN
aijmsr-823	10	22	(	(	PUNCT
aijmsr-823	10	23	which	which	PRON
aijmsr-823	10	24	was	be	AUX
aijmsr-823	10	25	found	find	VERB
aijmsr-823	10	26	to	to	PART
aijmsr-823	10	27	be	be	AUX
aijmsr-823	10	28	41.2	41.2	NUM
aijmsr-823	10	29	%	%	NOUN
aijmsr-823	10	30	)	)	PUNCT
aijmsr-823	10	31	.	.	PUNCT
aijmsr-823	11	1	on	on	ADP
aijmsr-823	11	2	culture	culture	NOUN
aijmsr-823	11	3	and	and	CCONJ
aijmsr-823	11	4	sensitivity	sensitivity	NOUN
aijmsr-823	11	5	testing	testing	NOUN
aijmsr-823	11	6	,	,	PUNCT
aijmsr-823	11	7	it	it	PRON
aijmsr-823	11	8	was	be	AUX
aijmsr-823	11	9	observed	observe	VERB
aijmsr-823	11	10	that	that	SCONJ
aijmsr-823	11	11	60	60	NUM
aijmsr-823	11	12	%	%	NOUN
aijmsr-823	11	13	of	of	ADP
aijmsr-823	11	14	the	the	DET
aijmsr-823	11	15	mdr	mdr	PROPN
aijmsr-823	11	16	strains	strain	NOUN
aijmsr-823	11	17	of	of	ADP
aijmsr-823	11	18	p.	p.	NOUN
aijmsr-823	11	19	aeruginosa	aeruginosa	PROPN
aijmsr-823	11	20	were	be	AUX
aijmsr-823	11	21	susceptible	susceptible	ADJ
aijmsr-823	11	22	to	to	ADP
aijmsr-823	11	23	ceftolazane	ceftolazane	NOUN
aijmsr-823	11	24	/	/	SYM
aijmsr-823	11	25	tazobactum	tazobactum	NOUN
aijmsr-823	11	26	which	which	PRON
aijmsr-823	11	27	was	be	AUX
aijmsr-823	11	28	markedly	markedly	ADV
aijmsr-823	11	29	comparable	comparable	ADJ
aijmsr-823	11	30	to	to	ADP
aijmsr-823	11	31	the	the	DET
aijmsr-823	11	32	susceptibility	susceptibility	NOUN
aijmsr-823	11	33	shown	show	VERB
aijmsr-823	11	34	by	by	ADP
aijmsr-823	11	35	colistin	colistin	NOUN
aijmsr-823	11	36	(	(	PUNCT
aijmsr-823	11	37	99%).statistically	99%).statistically	ADV
aijmsr-823	11	38	,	,	PUNCT
aijmsr-823	11	39	p	p	PRON
aijmsr-823	11	40	value	value	NOUN
aijmsr-823	11	41	was	be	AUX
aijmsr-823	11	42	highly	highly	ADV
aijmsr-823	11	43	significant	significant	ADJ
aijmsr-823	11	44	and	and	CCONJ
aijmsr-823	11	45	was	be	AUX
aijmsr-823	11	46	found	find	VERB
aijmsr-823	11	47	to	to	PART
aijmsr-823	11	48	be	be	AUX
aijmsr-823	11	49	0.0001	0.0001	NUM
aijmsr-823	11	50	.	.	PUNCT
aijmsr-823	12	1	conclusion	conclusion	NOUN
aijmsr-823	12	2	colistin	colistin	NOUN
aijmsr-823	12	3	showed	show	VERB
aijmsr-823	12	4	superior	superior	ADJ
aijmsr-823	12	5	activity	activity	NOUN
aijmsr-823	12	6	as	as	SCONJ
aijmsr-823	12	7	compared	compare	VERB
aijmsr-823	12	8	to	to	ADP
aijmsr-823	12	9	ceftolazane	ceftolazane	NOUN
aijmsr-823	12	10	/	/	SYM
aijmsr-823	12	11	tazobactum	tazobactum	NOUN
aijmsr-823	12	12	against	against	ADP
aijmsr-823	12	13	mdr	mdr	PROPN
aijmsr-823	12	14	isolates	isolate	NOUN
aijmsr-823	12	15	of	of	ADP
aijmsr-823	12	16	p.	p.	PROPN
aijmsr-823	12	17	aeruginosa	aeruginosa	PROPN
aijmsr-823	12	18	.	.	PUNCT
aijmsr-823	13	1	thus	thus	ADV
aijmsr-823	13	2	,	,	PUNCT
aijmsr-823	13	3	colistin	colistin	PROPN
aijmsr-823	13	4	has	have	AUX
aijmsr-823	13	5	proven	prove	VERB
aijmsr-823	13	6	to	to	PART
aijmsr-823	13	7	be	be	AUX
aijmsr-823	13	8	a	a	DET
aijmsr-823	13	9	possible	possible	ADJ
aijmsr-823	13	10	and	and	CCONJ
aijmsr-823	13	11	important	important	ADJ
aijmsr-823	13	12	alternative	alternative	NOUN
aijmsr-823	13	13	against	against	ADP
aijmsr-823	13	14	mdr	mdr	PROPN
aijmsr-823	13	15	isolates	isolate	NOUN
aijmsr-823	13	16	of	of	ADP
aijmsr-823	13	17	p.	p.	PROPN
aijmsr-823	13	18	aeruginosa	aeruginosa	PROPN
aijmsr-823	13	19	,	,	PUNCT
aijmsr-823	13	20	but	but	CCONJ
aijmsr-823	13	21	due	due	ADP
aijmsr-823	13	22	to	to	ADP
aijmsr-823	13	23	its	its	PRON
aijmsr-823	13	24	narrow	narrow	ADJ
aijmsr-823	13	25	therapeutic	therapeutic	ADJ
aijmsr-823	13	26	window	window	NOUN
aijmsr-823	13	27	and	and	CCONJ
aijmsr-823	13	28	toxicity	toxicity	NOUN
aijmsr-823	13	29	profile	profile	NOUN
aijmsr-823	13	30	this	this	DET
aijmsr-823	13	31	drug	drug	NOUN
aijmsr-823	13	32	can	can	AUX
aijmsr-823	13	33	be	be	AUX
aijmsr-823	13	34	used	use	VERB
aijmsr-823	13	35	only	only	ADV
aijmsr-823	13	36	when	when	SCONJ
aijmsr-823	13	37	there	there	PRON
aijmsr-823	13	38	is	be	VERB
aijmsr-823	13	39	no	no	DET
aijmsr-823	13	40	working	work	VERB
aijmsr-823	13	41	alternative	alternative	NOUN
aijmsr-823	13	42	,	,	PUNCT
aijmsr-823	13	43	or	or	CCONJ
aijmsr-823	13	44	the	the	DET
aijmsr-823	13	45	infection	infection	NOUN
aijmsr-823	13	46	is	be	AUX
aijmsr-823	13	47	severely	severely	ADV
aijmsr-823	13	48	debilitating	debilitate	VERB
aijmsr-823	13	49	.	.	PUNCT
aijmsr-823	14	1	keywords	keyword	NOUN
aijmsr-823	14	2	:	:	PUNCT
aijmsr-823	14	3	gram	gram	NUM
aijmsr-823	14	4	-	-	PUNCT
aijmsr-823	14	5	negative	negative	ADJ
aijmsr-823	14	6	infection	infection	NOUN
aijmsr-823	14	7	,	,	PUNCT
aijmsr-823	14	8	p.	p.	NOUN
aijmsr-823	14	9	aeruginosa	aeruginosa	PROPN
aijmsr-823	14	10	,	,	PUNCT
aijmsr-823	14	11	resistant	resistant	ADJ
aijmsr-823	14	12	.	.	PUNCT
aijmsr-823	15	1	introduction	introduction	NOUN
aijmsr-823	15	2	antibacterial	antibacterial	ADJ
aijmsr-823	15	3	drug	drug	NOUN
aijmsr-823	15	4	are	be	AUX
aijmsr-823	15	5	the	the	DET
aijmsr-823	15	6	main	main	ADJ
aijmsr-823	15	7	therapeutic	therapeutic	ADJ
aijmsr-823	15	8	agents	agent	NOUN
aijmsr-823	15	9	in	in	ADP
aijmsr-823	15	10	medicine	medicine	NOUN
aijmsr-823	15	11	to	to	PART
aijmsr-823	15	12	treat	treat	VERB
aijmsr-823	15	13	broad	broad	ADJ
aijmsr-823	15	14	spectrum	spectrum	NOUN
aijmsr-823	15	15	diseases	disease	NOUN
aijmsr-823	15	16	caused	cause	VERB
aijmsr-823	15	17	by	by	ADP
aijmsr-823	15	18	bacterial	bacterial	ADJ
aijmsr-823	15	19	infections	infection	NOUN
aijmsr-823	15	20	.	.	PUNCT
aijmsr-823	16	1	in	in	ADP
aijmsr-823	16	2	modern	modern	ADJ
aijmsr-823	16	3	science	science	NOUN
aijmsr-823	16	4	,	,	PUNCT
aijmsr-823	16	5	antibiotic	antibiotic	ADJ
aijmsr-823	16	6	development	development	NOUN
aijmsr-823	16	7	is	be	AUX
aijmsr-823	16	8	one	one	NUM
aijmsr-823	16	9	of	of	ADP
aijmsr-823	16	10	the	the	DET
aijmsr-823	16	11	milestones	milestone	NOUN
aijmsr-823	16	12	.	.	PUNCT
aijmsr-823	17	1	millions	million	NOUN
aijmsr-823	17	2	of	of	ADP
aijmsr-823	17	3	lives	life	NOUN
aijmsr-823	17	4	all	all	ADV
aijmsr-823	17	5	over	over	ADP
aijmsr-823	17	6	the	the	DET
aijmsr-823	17	7	world	world	NOUN
aijmsr-823	17	8	are	be	AUX
aijmsr-823	17	9	saved	save	VERB
aijmsr-823	17	10	daily	daily	ADV
aijmsr-823	17	11	because	because	SCONJ
aijmsr-823	17	12	of	of	ADP
aijmsr-823	17	13	the	the	DET
aijmsr-823	17	14	use	use	NOUN
aijmsr-823	17	15	of	of	ADP
aijmsr-823	17	16	antibiotic	antibiotic	ADJ
aijmsr-823	17	17	agents	agent	NOUN
aijmsr-823	17	18	.	.	PUNCT
aijmsr-823	18	1	but	but	CCONJ
aijmsr-823	18	2	there	there	PRON
aijmsr-823	18	3	is	be	VERB
aijmsr-823	18	4	an	an	DET
aijmsr-823	18	5	important	important	ADJ
aijmsr-823	18	6	threat	threat	NOUN
aijmsr-823	18	7	round	round	ADP
aijmsr-823	18	8	the	the	DET
aijmsr-823	18	9	globe	globe	NOUN
aijmsr-823	18	10	–	–	PUNCT
aijmsr-823	18	11	the	the	DET
aijmsr-823	18	12	emergence	emergence	NOUN
aijmsr-823	18	13	of	of	ADP
aijmsr-823	18	14	resistance	resistance	NOUN
aijmsr-823	18	15	against	against	ADP
aijmsr-823	18	16	antibacterial	antibacterial	ADJ
aijmsr-823	18	17	agents	agent	NOUN
aijmsr-823	18	18	(	(	PUNCT
aijmsr-823	18	19	ventola	ventola	NOUN
aijmsr-823	18	20	,	,	PUNCT
aijmsr-823	18	21	2015	2015	NUM
aijmsr-823	18	22	)	)	PUNCT
aijmsr-823	18	23	.	.	PUNCT
aijmsr-823	19	1	irrational	irrational	ADJ
aijmsr-823	19	2	and	and	CCONJ
aijmsr-823	19	3	over	over	ADP
aijmsr-823	19	4	the	the	DET
aijmsr-823	19	5	counter	counter	NOUN
aijmsr-823	19	6	use	use	NOUN
aijmsr-823	19	7	of	of	ADP
aijmsr-823	19	8	antibiotics	antibiotic	NOUN
aijmsr-823	19	9	result	result	VERB
aijmsr-823	19	10	in	in	ADP
aijmsr-823	19	11	emergence	emergence	NOUN
aijmsr-823	19	12	of	of	ADP
aijmsr-823	19	13	resistant	resistant	ADJ
aijmsr-823	19	14	isolates	isolate	NOUN
aijmsr-823	19	15	of	of	ADP
aijmsr-823	19	16	bacteria	bacteria	NOUN
aijmsr-823	19	17	which	which	PRON
aijmsr-823	19	18	do	do	AUX
aijmsr-823	19	19	not	not	PART
aijmsr-823	19	20	respond	respond	VERB
aijmsr-823	19	21	to	to	ADP
aijmsr-823	19	22	drug	drug	NOUN
aijmsr-823	19	23	therapy	therapy	NOUN
aijmsr-823	19	24	(	(	PUNCT
aijmsr-823	19	25	buke	buke	PROPN
aijmsr-823	19	26	et	et	PROPN
aijmsr-823	19	27	al	al	PROPN
aijmsr-823	19	28	.	.	PROPN
aijmsr-823	19	29	,	,	PUNCT
aijmsr-823	19	30	2005	2005	NUM
aijmsr-823	19	31	)	)	PUNCT
aijmsr-823	19	32	.	.	PUNCT
aijmsr-823	20	1	antibacterial	antibacterial	ADJ
aijmsr-823	20	2	drug	drug	NOUN
aijmsr-823	20	3	resistance	resistance	NOUN
aijmsr-823	20	4	threatens	threaten	VERB
aijmsr-823	20	5	this	this	DET
aijmsr-823	20	6	milestone	milestone	NOUN
aijmsr-823	20	7	and	and	CCONJ
aijmsr-823	20	8	has	have	AUX
aijmsr-823	20	9	become	become	VERB
aijmsr-823	20	10	a	a	DET
aijmsr-823	20	11	significant	significant	ADJ
aijmsr-823	20	12	risk	risk	NOUN
aijmsr-823	20	13	to	to	ADP
aijmsr-823	20	14	health	health	NOUN
aijmsr-823	20	15	of	of	ADP
aijmsr-823	20	16	mankind	mankind	NOUN
aijmsr-823	20	17	.	.	PUNCT
aijmsr-823	21	1	antibacterial	antibacterial	ADJ
aijmsr-823	21	2	resistance	resistance	NOUN
aijmsr-823	21	3	is	be	AUX
aijmsr-823	21	4	now	now	ADV
aijmsr-823	21	5	a	a	DET
aijmsr-823	21	6	major	major	ADJ
aijmsr-823	21	7	clinical	clinical	ADJ
aijmsr-823	21	8	concern	concern	NOUN
aijmsr-823	21	9	round	round	ADP
aijmsr-823	21	10	the	the	DET
aijmsr-823	21	11	globe	globe	NOUN
aijmsr-823	21	12	and	and	CCONJ
aijmsr-823	21	13	is	be	AUX
aijmsr-823	21	14	a	a	DET
aijmsr-823	21	15	major	major	ADJ
aijmsr-823	21	16	public	public	ADJ
aijmsr-823	21	17	health	health	NOUN
aijmsr-823	21	18	problem	problem	NOUN
aijmsr-823	21	19	of	of	ADP
aijmsr-823	21	20	the	the	DET
aijmsr-823	21	21	current	current	ADJ
aijmsr-823	21	22	century	century	NOUN
aijmsr-823	21	23	(	(	PUNCT
aijmsr-823	21	24	levy	levy	NOUN
aijmsr-823	21	25	,	,	PUNCT
aijmsr-823	21	26	2002	2002	NUM
aijmsr-823	21	27	)	)	PUNCT
aijmsr-823	21	28	.	.	PUNCT
aijmsr-823	22	1	p.	p.	NOUN
aijmsr-823	22	2	aeruginosa	aeruginosa	PROPN
aijmsr-823	22	3	is	be	AUX
aijmsr-823	22	4	a	a	DET
aijmsr-823	22	5	very	very	ADV
aijmsr-823	22	6	ubiquitous	ubiquitous	ADJ
aijmsr-823	22	7	microorganism	microorganism	NOUN
aijmsr-823	22	8	,	,	PUNCT
aijmsr-823	22	9	present	present	ADJ
aijmsr-823	22	10	in	in	ADP
aijmsr-823	22	11	many	many	ADJ
aijmsr-823	22	12	natural	natural	ADJ
aijmsr-823	22	13	and	and	CCONJ
aijmsr-823	22	14	artificial	artificial	ADJ
aijmsr-823	22	15	environments	environment	NOUN
aijmsr-823	22	16	(	(	PUNCT
aijmsr-823	22	17	haley	haley	NOUN
aijmsr-823	22	18	,	,	PUNCT
aijmsr-823	22	19	colmer	colmer	NOUN
aijmsr-823	22	20	-	-	PUNCT
aijmsr-823	22	21	hamood	hamood	NOUN
aijmsr-823	22	22	,	,	PUNCT
aijmsr-823	22	23	&	&	CCONJ
aijmsr-823	22	24	hamood	hamood	NOUN
aijmsr-823	22	25	,	,	PUNCT
aijmsr-823	22	26	2012	2012	NUM
aijmsr-823	22	27	)	)	PUNCT
aijmsr-823	22	28	.	.	PUNCT
aijmsr-823	23	1	p.	p.	NOUN
aijmsr-823	23	2	aeruginosa	aeruginosa	PROPN
aijmsr-823	23	3	has	have	VERB
aijmsr-823	23	4	a	a	DET
aijmsr-823	23	5	unique	unique	ADJ
aijmsr-823	23	6	grape	grape	NOUN
aijmsr-823	23	7	like	like	ADP
aijmsr-823	23	8	odour	odour	NOUN
aijmsr-823	23	9	of	of	ADP
aijmsr-823	23	10	aminoacetophenone	aminoacetophenone	NOUN
aijmsr-823	23	11	on	on	ADP
aijmsr-823	23	12	culture	culture	NOUN
aijmsr-823	23	13	media	medium	NOUN
aijmsr-823	23	14	/	/	SYM
aijmsr-823	23	15	agar	agar	NOUN
aijmsr-823	23	16	(	(	PUNCT
aijmsr-823	23	17	cox	cox	PROPN
aijmsr-823	23	18	,	,	PUNCT
aijmsr-823	23	19	&	&	CCONJ
aijmsr-823	23	20	parker	parker	PROPN
aijmsr-823	23	21	,	,	PUNCT
aijmsr-823	23	22	1979	1979	NUM
aijmsr-823	23	23	)	)	PUNCT
aijmsr-823	23	24	.	.	PUNCT
aijmsr-823	24	1	it	it	PRON
aijmsr-823	24	2	colonizes	colonize	VERB
aijmsr-823	24	3	naturally	naturally	ADV
aijmsr-823	24	4	on	on	ADP
aijmsr-823	24	5	skin	skin	NOUN
aijmsr-823	24	6	,	,	PUNCT
aijmsr-823	24	7	in	in	ADP
aijmsr-823	24	8	nasal	nasal	PROPN
aijmsr-823	24	9	mucosa	mucosa	NOUN
aijmsr-823	24	10	,	,	PUNCT
aijmsr-823	24	11	throat	throat	NOUN
aijmsr-823	24	12	and	and	CCONJ
aijmsr-823	24	13	also	also	ADV
aijmsr-823	24	14	in	in	ADP
aijmsr-823	24	15	fecal	fecal	ADJ
aijmsr-823	24	16	samples	sample	NOUN
aijmsr-823	24	17	.	.	PUNCT
aijmsr-823	25	1	p.	p.	NOUN
aijmsr-823	25	2	aeruginosa	aeruginosa	PROPN
aijmsr-823	25	3	is	be	AUX
aijmsr-823	25	4	a	a	DET
aijmsr-823	25	5	nosocomial	nosocomial	ADJ
aijmsr-823	25	6	pathogen	pathogen	NOUN
aijmsr-823	25	7	.	.	PUNCT
aijmsr-823	26	1	it	it	PRON
aijmsr-823	26	2	is	be	AUX
aijmsr-823	26	3	also	also	ADV
aijmsr-823	26	4	an	an	DET
aijmsr-823	26	5	opportunistic	opportunistic	ADJ
aijmsr-823	26	6	organism	organism	NOUN
aijmsr-823	26	7	and	and	CCONJ
aijmsr-823	26	8	causes	cause	VERB
aijmsr-823	26	9	life	life	NOUN
aijmsr-823	26	10	threatening	threaten	VERB
aijmsr-823	26	11	infections	infection	NOUN
aijmsr-823	26	12	in	in	ADP
aijmsr-823	26	13	immune	immune	NOUN
aijmsr-823	26	14	-	-	PUNCT
aijmsr-823	26	15	compromised	compromise	VERB
aijmsr-823	26	16	individuals	individual	NOUN
aijmsr-823	26	17	(	(	PUNCT
aijmsr-823	26	18	kielhofner	kielhofner	NOUN
aijmsr-823	26	19	,	,	PUNCT
aijmsr-823	26	20	atmar	atmar	NOUN
aijmsr-823	26	21	,	,	PUNCT
aijmsr-823	26	22	hamill	hamill	NOUN
aijmsr-823	26	23	,	,	PUNCT
aijmsr-823	26	24	&	&	CCONJ
aijmsr-823	26	25	musher	musher	PROPN
aijmsr-823	26	26	,	,	PUNCT
aijmsr-823	26	27	1992	1992	NUM
aijmsr-823	26	28	)	)	PUNCT
aijmsr-823	26	29	.	.	PUNCT
aijmsr-823	27	1	according	accord	VERB
aijmsr-823	27	2	to	to	ADP
aijmsr-823	27	3	the	the	DET
aijmsr-823	27	4	data	datum	NOUN
aijmsr-823	27	5	provided	provide	VERB
aijmsr-823	27	6	by	by	ADP
aijmsr-823	27	7	the	the	DET
aijmsr-823	27	8	center	center	NOUN
aijmsr-823	27	9	for	for	ADP
aijmsr-823	27	10	the	the	DET
aijmsr-823	27	11	diseases	disease	NOUN
aijmsr-823	27	12	control	control	NOUN
aijmsr-823	27	13	and	and	CCONJ
aijmsr-823	27	14	prevention	prevention	NOUN
aijmsr-823	27	15	(	(	PUNCT
aijmsr-823	27	16	cdc	cdc	PROPN
aijmsr-823	27	17	)	)	PUNCT
aijmsr-823	27	18	,	,	PUNCT
aijmsr-823	27	19	p.	p.	NOUN
aijmsr-823	27	20	aeruginosa	aeruginosa	PROPN
aijmsr-823	27	21	can	can	AUX
aijmsr-823	27	22	cause	cause	VERB
aijmsr-823	27	23	a	a	DET
aijmsr-823	27	24	wide	wide	ADJ
aijmsr-823	27	25	variety	variety	NOUN
aijmsr-823	27	26	of	of	ADP
aijmsr-823	27	27	infections	infection	NOUN
aijmsr-823	27	28	and	and	CCONJ
aijmsr-823	27	29	is	be	AUX
aijmsr-823	27	30	also	also	ADV
aijmsr-823	27	31	one	one	NUM
aijmsr-823	27	32	of	of	ADP
aijmsr-823	27	33	the	the	DET
aijmsr-823	27	34	most	most	ADV
aijmsr-823	27	35	common	common	ADJ
aijmsr-823	27	36	infectious	infectious	ADJ
aijmsr-823	27	37	agents	agent	NOUN
aijmsr-823	27	38	for	for	ADP
aijmsr-823	27	39	nosocomial	nosocomial	ADJ
aijmsr-823	27	40	pneumonia	pneumonia	NOUN
aijmsr-823	27	41	(	(	PUNCT
aijmsr-823	27	42	cross	cross	VERB
aijmsr-823	27	43	et	et	PROPN
aijmsr-823	27	44	al	al	PROPN
aijmsr-823	27	45	.	.	PROPN
aijmsr-823	27	46	,	,	PUNCT
aijmsr-823	27	47	1983	1983	NUM
aijmsr-823	27	48	)	)	PUNCT
aijmsr-823	27	49	,	,	PUNCT
aijmsr-823	27	50	urinary	urinary	ADJ
aijmsr-823	27	51	tract	tract	NOUN
aijmsr-823	27	52	infections	infection	NOUN
aijmsr-823	27	53	,	,	PUNCT
aijmsr-823	27	54	ophthalmitis	ophthalmitis	PROPN
aijmsr-823	27	55	,	,	PUNCT
aijmsr-823	27	56	otitis	otitis	NOUN
aijmsr-823	27	57	,	,	PUNCT
aijmsr-823	27	58	surgical	surgical	ADJ
aijmsr-823	27	59	wound	wound	NOUN
aijmsr-823	27	60	infections	infection	NOUN
aijmsr-823	27	61	and	and	CCONJ
aijmsr-823	27	62	bacteremia	bacteremia	NOUN
aijmsr-823	27	63	(	(	PUNCT
aijmsr-823	27	64	trautmann	trautmann	NOUN
aijmsr-823	27	65	,	,	PUNCT
aijmsr-823	27	66	halder	halder	PROPN
aijmsr-823	27	67	,	,	PUNCT
aijmsr-823	27	68	hoegel	hoegel	NOUN
aijmsr-823	27	69	,	,	PUNCT
aijmsr-823	27	70	royer	royer	PROPN
aijmsr-823	27	71	,	,	PUNCT
aijmsr-823	27	72	&	&	CCONJ
aijmsr-823	27	73	haller	haller	PROPN
aijmsr-823	27	74	,	,	PUNCT
aijmsr-823	27	75	2008	2008	NUM
aijmsr-823	27	76	)	)	PUNCT
aijmsr-823	27	77	.	.	PUNCT
aijmsr-823	27	78	)	)	PUNCT
aijmsr-823	28	1	another	another	DET
aijmsr-823	28	2	study	study	NOUN
aijmsr-823	28	3	revealed	reveal	VERB
aijmsr-823	28	4	that	that	SCONJ
aijmsr-823	28	5	p.	p.	PROPN
aijmsr-823	28	6	aeruginosa	aeruginosa	PROPN
aijmsr-823	28	7	is	be	AUX
aijmsr-823	28	8	also	also	ADV
aijmsr-823	28	9	a	a	DET
aijmsr-823	28	10	leading	lead	VERB
aijmsr-823	28	11	cause	cause	NOUN
aijmsr-823	28	12	of	of	ADP
aijmsr-823	28	13	morbidity	morbidity	NOUN
aijmsr-823	28	14	and	and	CCONJ
aijmsr-823	28	15	mortality	mortality	NOUN
aijmsr-823	28	16	in	in	ADP
aijmsr-823	28	17	patients	patient	NOUN
aijmsr-823	28	18	of	of	ADP
aijmsr-823	28	19	cystic	cystic	ADJ
aijmsr-823	28	20	fibrosis	fibrosis	NOUN
aijmsr-823	28	21	(	(	PUNCT
aijmsr-823	28	22	kerem	kerem	PROPN
aijmsr-823	28	23	,	,	PUNCT
aijmsr-823	28	24	corey	corey	PROPN
aijmsr-823	28	25	,	,	PUNCT
aijmsr-823	28	26	gold	gold	NOUN
aijmsr-823	28	27	,	,	PUNCT
aijmsr-823	28	28	&	&	CCONJ
aijmsr-823	28	29	levison	levison	NOUN
aijmsr-823	28	30	,	,	PUNCT
aijmsr-823	28	31	1990	1990	NUM
aijmsr-823	28	32	)	)	PUNCT
aijmsr-823	28	33	.	.	PUNCT
aijmsr-823	29	1	colistin	colistin	PROPN
aijmsr-823	29	2	is	be	AUX
aijmsr-823	29	3	a	a	DET
aijmsr-823	29	4	polymyxin	polymyxin	ADJ
aijmsr-823	29	5	b	b	NOUN
aijmsr-823	29	6	antibiotic	antibiotic	NOUN
aijmsr-823	29	7	,	,	PUNCT
aijmsr-823	29	8	which	which	PRON
aijmsr-823	29	9	was	be	AUX
aijmsr-823	29	10	used	use	VERB
aijmsr-823	29	11	as	as	ADP
aijmsr-823	29	12	a	a	DET
aijmsr-823	29	13	therapeutic	therapeutic	ADJ
aijmsr-823	29	14	agent	agent	NOUN
aijmsr-823	29	15	for	for	ADP
aijmsr-823	29	16	gram	gram	NOUN
aijmsr-823	29	17	negative	negative	ADJ
aijmsr-823	29	18	organisms	organism	NOUN
aijmsr-823	29	19	.	.	PUNCT
aijmsr-823	30	1	(	(	PUNCT
aijmsr-823	30	2	evans	evans	PROPN
aijmsr-823	30	3	,	,	PUNCT
aijmsr-823	30	4	feola	feola	PROPN
aijmsr-823	30	5	,	,	PUNCT
aijmsr-823	30	6	&	&	CCONJ
aijmsr-823	30	7	rapp	rapp	PROPN
aijmsr-823	30	8	,	,	PUNCT
aijmsr-823	30	9	1999	1999	NUM
aijmsr-823	30	10	)	)	PUNCT
aijmsr-823	30	11	due	due	ADP
aijmsr-823	30	12	to	to	ADP
aijmsr-823	30	13	severe	severe	ADJ
aijmsr-823	30	14	nephrotoxicity	nephrotoxicity	NOUN
aijmsr-823	30	15	and	and	CCONJ
aijmsr-823	30	16	https://www.cribfb.com/journal/index.php/aijmsr	https://www.cribfb.com/journal/index.php/aijmsr	PROPN
aijmsr-823	30	17	american	american	PROPN
aijmsr-823	30	18	international	international	PROPN
aijmsr-823	30	19	journal	journal	PROPN
aijmsr-823	30	20	of	of	ADP
aijmsr-823	30	21	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	30	22	scientific	scientific	ADJ
aijmsr-823	30	23	research	research	NOUN
aijmsr-823	30	24	vol	vol	NOUN
aijmsr-823	30	25	.	.	PROPN
aijmsr-823	31	1	6	6	NUM
aijmsr-823	31	2	,	,	PUNCT
aijmsr-823	31	3	no	no	INTJ
aijmsr-823	31	4	.	.	NOUN
aijmsr-823	31	5	3	3	NUM
aijmsr-823	31	6	;	;	PUNCT
aijmsr-823	31	7	2020	2020	NUM
aijmsr-823	31	8	3	3	NUM
aijmsr-823	31	9	neurotoxicity	neurotoxicity	NOUN
aijmsr-823	31	10	after	after	ADP
aijmsr-823	31	11	the	the	DET
aijmsr-823	31	12	therapeutic	therapeutic	ADJ
aijmsr-823	31	13	use	use	NOUN
aijmsr-823	31	14	of	of	ADP
aijmsr-823	31	15	colistin	colistin	NOUN
aijmsr-823	31	16	,	,	PUNCT
aijmsr-823	31	17	its	its	PRON
aijmsr-823	31	18	use	use	NOUN
aijmsr-823	31	19	was	be	AUX
aijmsr-823	31	20	diminished	diminish	VERB
aijmsr-823	31	21	(	(	PUNCT
aijmsr-823	31	22	wolinsky	wolinsky	PROPN
aijmsr-823	31	23	&	&	CCONJ
aijmsr-823	31	24	hines	hine	NOUN
aijmsr-823	31	25	,	,	PUNCT
aijmsr-823	31	26	1962	1962	NUM
aijmsr-823	31	27	)	)	PUNCT
aijmsr-823	31	28	.	.	PUNCT
aijmsr-823	32	1	currently	currently	ADV
aijmsr-823	32	2	due	due	ADJ
aijmsr-823	32	3	to	to	ADP
aijmsr-823	32	4	severe	severe	ADJ
aijmsr-823	32	5	resistance	resistance	NOUN
aijmsr-823	32	6	shown	show	VERB
aijmsr-823	32	7	by	by	ADP
aijmsr-823	32	8	bacteria	bacteria	NOUN
aijmsr-823	32	9	,	,	PUNCT
aijmsr-823	32	10	colistin	colistin	NOUN
aijmsr-823	32	11	(	(	PUNCT
aijmsr-823	32	12	polymiyxin	polymiyxin	PROPN
aijmsr-823	32	13	b	b	X
aijmsr-823	32	14	)	)	PUNCT
aijmsr-823	32	15	has	have	AUX
aijmsr-823	32	16	reemerged	reemerge	VERB
aijmsr-823	32	17	as	as	ADP
aijmsr-823	32	18	a	a	DET
aijmsr-823	32	19	last	last	ADJ
aijmsr-823	32	20	line	line	NOUN
aijmsr-823	32	21	treatment	treatment	NOUN
aijmsr-823	32	22	modality	modality	NOUN
aijmsr-823	32	23	for	for	ADP
aijmsr-823	32	24	multi	multi	ADJ
aijmsr-823	32	25	drug	drug	NOUN
aijmsr-823	32	26	resistant	resistant	ADJ
aijmsr-823	32	27	isolates	isolate	NOUN
aijmsr-823	32	28	of	of	ADP
aijmsr-823	32	29	p.	p.	PROPN
aijmsr-823	32	30	aeruginosa	aeruginosa	PROPN
aijmsr-823	32	31	,	,	PUNCT
aijmsr-823	32	32	acinetobacter	acinetobacter	ADV
aijmsr-823	32	33	baumannii	baumannii	ADJ
aijmsr-823	32	34	and	and	CCONJ
aijmsr-823	32	35	klebseilla	klebseilla	NOUN
aijmsr-823	32	36	pneumonia	pneumonia	NOUN
aijmsr-823	32	37	.	.	PUNCT
aijmsr-823	33	1	according	accord	VERB
aijmsr-823	33	2	to	to	ADP
aijmsr-823	33	3	our	our	PRON
aijmsr-823	33	4	knowledge	knowledge	NOUN
aijmsr-823	33	5	,	,	PUNCT
aijmsr-823	33	6	in	in	ADP
aijmsr-823	33	7	pakistan	pakistan	PROPN
aijmsr-823	33	8	no	no	DET
aijmsr-823	33	9	current	current	ADJ
aijmsr-823	33	10	data	datum	NOUN
aijmsr-823	33	11	is	be	AUX
aijmsr-823	33	12	available	available	ADJ
aijmsr-823	33	13	for	for	ADP
aijmsr-823	33	14	usage	usage	NOUN
aijmsr-823	33	15	of	of	ADP
aijmsr-823	33	16	5th	5th	ADJ
aijmsr-823	33	17	generation	generation	NOUN
aijmsr-823	33	18	cephalosporin	cephalosporin	NOUN
aijmsr-823	33	19	comparison	comparison	NOUN
aijmsr-823	33	20	with	with	ADP
aijmsr-823	33	21	colistin	colistin	NOUN
aijmsr-823	33	22	.	.	PUNCT
aijmsr-823	34	1	antibiotic	antibiotic	ADJ
aijmsr-823	34	2	resistance	resistance	NOUN
aijmsr-823	34	3	,	,	PUNCT
aijmsr-823	34	4	an	an	DET
aijmsr-823	34	5	emerging	emerge	VERB
aijmsr-823	34	6	problem	problem	NOUN
aijmsr-823	34	7	and	and	CCONJ
aijmsr-823	34	8	a	a	DET
aijmsr-823	34	9	clinical	clinical	ADJ
aijmsr-823	34	10	concern	concern	NOUN
aijmsr-823	34	11	to	to	PART
aijmsr-823	34	12	treat	treat	VERB
aijmsr-823	34	13	uropathogenic	uropathogenic	ADJ
aijmsr-823	34	14	p.aeruginosa	p.aeruginosa	NOUN
aijmsr-823	34	15	,	,	PUNCT
aijmsr-823	34	16	it	it	PRON
aijmsr-823	34	17	is	be	AUX
aijmsr-823	34	18	now	now	ADV
aijmsr-823	34	19	a	a	DET
aijmsr-823	34	20	high	high	ADJ
aijmsr-823	34	21	time	time	NOUN
aijmsr-823	34	22	to	to	PART
aijmsr-823	34	23	look	look	VERB
aijmsr-823	34	24	for	for	ADP
aijmsr-823	34	25	more	more	ADV
aijmsr-823	34	26	specific	specific	ADJ
aijmsr-823	34	27	and	and	CCONJ
aijmsr-823	34	28	sensitive	sensitive	ADJ
aijmsr-823	34	29	antibacterial	antibacterial	ADJ
aijmsr-823	34	30	agents	agent	NOUN
aijmsr-823	34	31	to	to	PART
aijmsr-823	34	32	treat	treat	VERB
aijmsr-823	34	33	resistant	resistant	ADJ
aijmsr-823	34	34	infections	infection	NOUN
aijmsr-823	34	35	.	.	PUNCT
aijmsr-823	35	1	the	the	DET
aijmsr-823	35	2	aim	aim	NOUN
aijmsr-823	35	3	of	of	ADP
aijmsr-823	35	4	this	this	DET
aijmsr-823	35	5	study	study	NOUN
aijmsr-823	35	6	is	be	AUX
aijmsr-823	35	7	to	to	PART
aijmsr-823	35	8	ascertain	ascertain	VERB
aijmsr-823	35	9	the	the	DET
aijmsr-823	35	10	prevalence	prevalence	NOUN
aijmsr-823	35	11	of	of	ADP
aijmsr-823	35	12	p.	p.	PROPN
aijmsr-823	35	13	aeruginosa	aeruginosa	PROPN
aijmsr-823	35	14	,	,	PUNCT
aijmsr-823	35	15	in	in	ADP
aijmsr-823	35	16	the	the	DET
aijmsr-823	35	17	population	population	NOUN
aijmsr-823	35	18	of	of	ADP
aijmsr-823	35	19	karachi	karachi	PROPN
aijmsr-823	35	20	.	.	PUNCT
aijmsr-823	36	1	another	another	DET
aijmsr-823	36	2	aim	aim	NOUN
aijmsr-823	36	3	is	be	AUX
aijmsr-823	36	4	to	to	PART
aijmsr-823	36	5	determine	determine	VERB
aijmsr-823	36	6	and	and	CCONJ
aijmsr-823	36	7	compare	compare	VERB
aijmsr-823	36	8	the	the	DET
aijmsr-823	36	9	sensitivity	sensitivity	NOUN
aijmsr-823	36	10	of	of	ADP
aijmsr-823	36	11	ceftolozane	ceftolozane	NOUN
aijmsr-823	36	12	/	/	SYM
aijmsr-823	36	13	tazobactum	tazobactum	NOUN
aijmsr-823	36	14	,	,	PUNCT
aijmsr-823	36	15	a	a	DET
aijmsr-823	36	16	novel	novel	ADJ
aijmsr-823	36	17	5th	5th	ADJ
aijmsr-823	36	18	generation	generation	NOUN
aijmsr-823	36	19	cephalosporin	cephalosporin	NOUN
aijmsr-823	36	20	.	.	PUNCT
aijmsr-823	37	1	with	with	ADP
aijmsr-823	37	2	the	the	DET
aijmsr-823	37	3	sensitivity	sensitivity	NOUN
aijmsr-823	37	4	of	of	ADP
aijmsr-823	37	5	colistin	colistin	NOUN
aijmsr-823	37	6	–	–	PUNCT
aijmsr-823	37	7	as	as	SCONJ
aijmsr-823	37	8	it	it	PRON
aijmsr-823	37	9	is	be	AUX
aijmsr-823	37	10	the	the	DET
aijmsr-823	37	11	last	last	ADJ
aijmsr-823	37	12	line	line	NOUN
aijmsr-823	37	13	defense	defense	NOUN
aijmsr-823	37	14	option	option	NOUN
aijmsr-823	37	15	against	against	ADP
aijmsr-823	37	16	multi	multi	ADJ
aijmsr-823	37	17	drug	drug	NOUN
aijmsr-823	37	18	resistant	resistant	ADJ
aijmsr-823	37	19	(	(	PUNCT
aijmsr-823	37	20	mdr	mdr	NOUN
aijmsr-823	37	21	)	)	PUNCT
aijmsr-823	37	22	strains	strain	NOUN
aijmsr-823	37	23	of	of	ADP
aijmsr-823	37	24	p.	p.	NOUN
aijmsr-823	37	25	aeruginosa	aeruginosa	PROPN
aijmsr-823	37	26	.	.	PUNCT
aijmsr-823	38	1	materials	material	NOUN
aijmsr-823	38	2	and	and	CCONJ
aijmsr-823	38	3	methods	method	NOUN
aijmsr-823	38	4	this	this	PRON
aijmsr-823	38	5	was	be	AUX
aijmsr-823	38	6	a	a	DET
aijmsr-823	38	7	quasi	quasi	ADJ
aijmsr-823	38	8	experimental	experimental	ADJ
aijmsr-823	38	9	investigation	investigation	NOUN
aijmsr-823	38	10	and	and	CCONJ
aijmsr-823	38	11	samples	sample	NOUN
aijmsr-823	38	12	were	be	AUX
aijmsr-823	38	13	gathered	gather	VERB
aijmsr-823	38	14	utilizing	utilize	VERB
aijmsr-823	38	15	nonprobability	nonprobability	NOUN
aijmsr-823	38	16	strategy	strategy	NOUN
aijmsr-823	38	17	.	.	PUNCT
aijmsr-823	39	1	study	study	NOUN
aijmsr-823	39	2	was	be	AUX
aijmsr-823	39	3	directed	direct	VERB
aijmsr-823	39	4	from	from	ADP
aijmsr-823	39	5	october	october	PROPN
aijmsr-823	39	6	2017	2017	NUM
aijmsr-823	39	7	to	to	ADP
aijmsr-823	39	8	april	april	PROPN
aijmsr-823	39	9	2018	2018	NUM
aijmsr-823	39	10	at	at	ADP
aijmsr-823	39	11	ziauddin	ziauddin	VERB
aijmsr-823	39	12	university	university	NOUN
aijmsr-823	39	13	hospital	hospital	NOUN
aijmsr-823	39	14	,	,	PUNCT
aijmsr-823	39	15	karachi	karachi	PROPN
aijmsr-823	39	16	.	.	PUNCT
aijmsr-823	40	1	samples	sample	NOUN
aijmsr-823	40	2	were	be	AUX
aijmsr-823	40	3	gathered	gather	VERB
aijmsr-823	40	4	from	from	ADP
aijmsr-823	40	5	the	the	DET
aijmsr-823	40	6	inpatient	inpatient	NOUN
aijmsr-823	40	7	wards	ward	NOUN
aijmsr-823	40	8	and	and	CCONJ
aijmsr-823	40	9	outpatient	outpatient	NOUN
aijmsr-823	40	10	clinics	clinic	NOUN
aijmsr-823	40	11	,	,	PUNCT
aijmsr-823	40	12	subsequently	subsequently	ADV
aijmsr-823	40	13	submitted	submit	VERB
aijmsr-823	40	14	to	to	ADP
aijmsr-823	40	15	microbiology	microbiology	NOUN
aijmsr-823	40	16	lab	lab	NOUN
aijmsr-823	40	17	of	of	ADP
aijmsr-823	40	18	ziauddin	ziauddin	VERB
aijmsr-823	40	19	university	university	NOUN
aijmsr-823	40	20	hospital	hospital	NOUN
aijmsr-823	40	21	,	,	PUNCT
aijmsr-823	40	22	north	north	NOUN
aijmsr-823	40	23	nazimabad	nazimabad	PROPN
aijmsr-823	40	24	campus	campus	PROPN
aijmsr-823	40	25	,	,	PUNCT
aijmsr-823	40	26	karachi	karachi	PROPN
aijmsr-823	40	27	,	,	PUNCT
aijmsr-823	40	28	for	for	ADP
aijmsr-823	40	29	culture	culture	NOUN
aijmsr-823	40	30	and	and	CCONJ
aijmsr-823	40	31	sensitivity	sensitivity	NOUN
aijmsr-823	40	32	.	.	PUNCT
aijmsr-823	41	1	routine	routine	ADJ
aijmsr-823	41	2	samples	sample	NOUN
aijmsr-823	41	3	were	be	AUX
aijmsr-823	41	4	taken	take	VERB
aijmsr-823	41	5	including	include	VERB
aijmsr-823	41	6	pus	pus	NOUN
aijmsr-823	41	7	discharge	discharge	NOUN
aijmsr-823	41	8	,	,	PUNCT
aijmsr-823	41	9	wound	wound	NOUN
aijmsr-823	41	10	swabs	swab	NOUN
aijmsr-823	41	11	,	,	PUNCT
aijmsr-823	41	12	blood	blood	NOUN
aijmsr-823	41	13	,	,	PUNCT
aijmsr-823	41	14	tracheal	tracheal	NOUN
aijmsr-823	41	15	aspirates	aspirate	NOUN
aijmsr-823	41	16	and	and	CCONJ
aijmsr-823	41	17	urine	urine	NOUN
aijmsr-823	41	18	.	.	PUNCT
aijmsr-823	42	1	samples	sample	NOUN
aijmsr-823	42	2	were	be	AUX
aijmsr-823	42	3	treated	treat	VERB
aijmsr-823	42	4	as	as	ADP
aijmsr-823	42	5	per	per	ADP
aijmsr-823	42	6	microbiological	microbiological	ADJ
aijmsr-823	42	7	procedures	procedure	NOUN
aijmsr-823	42	8	clsi	clsi	NOUN
aijmsr-823	42	9	guidelines	guideline	NOUN
aijmsr-823	42	10	2018	2018	NUM
aijmsr-823	42	11	.	.	PUNCT
aijmsr-823	43	1	after	after	SCONJ
aijmsr-823	43	2	an	an	DET
aijmsr-823	43	3	informed	inform	VERB
aijmsr-823	43	4	and	and	CCONJ
aijmsr-823	43	5	written	write	VERB
aijmsr-823	43	6	consent	consent	VERB
aijmsr-823	43	7	detailed	detailed	ADJ
aijmsr-823	43	8	data	datum	NOUN
aijmsr-823	43	9	of	of	ADP
aijmsr-823	43	10	the	the	DET
aijmsr-823	43	11	patients	patient	NOUN
aijmsr-823	43	12	and	and	CCONJ
aijmsr-823	43	13	organisms	organism	NOUN
aijmsr-823	43	14	was	be	AUX
aijmsr-823	43	15	recorded	record	VERB
aijmsr-823	43	16	on	on	ADP
aijmsr-823	43	17	a	a	DET
aijmsr-823	43	18	different	different	ADJ
aijmsr-823	43	19	survey	survey	NOUN
aijmsr-823	43	20	form	form	NOUN
aijmsr-823	43	21	.	.	PUNCT
aijmsr-823	44	1	all	all	DET
aijmsr-823	44	2	non	non	ADJ
aijmsr-823	44	3	-	-	ADJ
aijmsr-823	44	4	lactose	lactose	ADJ
aijmsr-823	44	5	fermenting	fermenting	NOUN
aijmsr-823	44	6	growths	growth	NOUN
aijmsr-823	44	7	on	on	ADP
aijmsr-823	44	8	macconkey	macconkey	NOUN
aijmsr-823	44	9	's	's	PART
aijmsr-823	44	10	agar	agar	NOUN
aijmsr-823	44	11	were	be	AUX
aijmsr-823	44	12	collected	collect	VERB
aijmsr-823	44	13	and	and	CCONJ
aijmsr-823	44	14	stained	stain	VERB
aijmsr-823	44	15	with	with	ADP
aijmsr-823	44	16	gram	gram	NOUN
aijmsr-823	44	17	stain	stain	NOUN
aijmsr-823	44	18	and	and	CCONJ
aijmsr-823	44	19	biochemical	biochemical	ADJ
aijmsr-823	44	20	tests	test	NOUN
aijmsr-823	44	21	(	(	PUNCT
aijmsr-823	44	22	motility	motility	NOUN
aijmsr-823	44	23	,	,	PUNCT
aijmsr-823	44	24	pigment	pigment	NOUN
aijmsr-823	44	25	presentation	presentation	NOUN
aijmsr-823	44	26	,	,	PUNCT
aijmsr-823	44	27	citrate	citrate	NOUN
aijmsr-823	44	28	,	,	PUNCT
aijmsr-823	44	29	catalase	catalase	NOUN
aijmsr-823	44	30	and	and	CCONJ
aijmsr-823	44	31	oxidase	oxidase	NOUN
aijmsr-823	44	32	tests	test	NOUN
aijmsr-823	44	33	)	)	PUNCT
aijmsr-823	44	34	were	be	AUX
aijmsr-823	44	35	run	run	VERB
aijmsr-823	44	36	.	.	PUNCT
aijmsr-823	45	1	data	datum	NOUN
aijmsr-823	45	2	was	be	AUX
aijmsr-823	45	3	scrutinized	scrutinize	VERB
aijmsr-823	45	4	by	by	ADP
aijmsr-823	45	5	utilizing	utilize	VERB
aijmsr-823	45	6	statistical	statistical	ADJ
aijmsr-823	45	7	package	package	NOUN
aijmsr-823	45	8	for	for	ADP
aijmsr-823	45	9	social	social	ADJ
aijmsr-823	45	10	sciences	science	NOUN
aijmsr-823	45	11	(	(	PUNCT
aijmsr-823	45	12	spss	spss	PROPN
aijmsr-823	45	13	)	)	PUNCT
aijmsr-823	45	14	vesion	vesion	NOUN
aijmsr-823	45	15	21	21	NUM
aijmsr-823	45	16	.	.	PUNCT
aijmsr-823	46	1	descriptive	descriptive	ADJ
aijmsr-823	46	2	investigations	investigation	NOUN
aijmsr-823	46	3	for	for	ADP
aijmsr-823	46	4	numerical	numerical	ADJ
aijmsr-823	46	5	variables	variable	NOUN
aijmsr-823	46	6	have	have	AUX
aijmsr-823	46	7	been	be	AUX
aijmsr-823	46	8	referenced	reference	VERB
aijmsr-823	46	9	as	as	ADP
aijmsr-823	46	10	mean	mean	ADJ
aijmsr-823	46	11	with	with	ADP
aijmsr-823	46	12	standard	standard	ADJ
aijmsr-823	46	13	deviation	deviation	NOUN
aijmsr-823	46	14	.	.	PUNCT
aijmsr-823	47	1	frequencies	frequency	NOUN
aijmsr-823	47	2	and	and	CCONJ
aijmsr-823	47	3	percentages	percentage	NOUN
aijmsr-823	47	4	were	be	AUX
aijmsr-823	47	5	determined	determine	VERB
aijmsr-823	47	6	for	for	ADP
aijmsr-823	47	7	susceptibility	susceptibility	NOUN
aijmsr-823	47	8	of	of	ADP
aijmsr-823	47	9	antibacterial	antibacterial	ADJ
aijmsr-823	47	10	drugs	drug	NOUN
aijmsr-823	47	11	and	and	CCONJ
aijmsr-823	47	12	mdr	mdr	PROPN
aijmsr-823	47	13	strains	strain	NOUN
aijmsr-823	47	14	of	of	ADP
aijmsr-823	47	15	p.	p.	NOUN
aijmsr-823	47	16	aeruginosa	aeruginosa	NOUN
aijmsr-823	47	17	from	from	ADP
aijmsr-823	47	18	different	different	ADJ
aijmsr-823	47	19	clinical	clinical	ADJ
aijmsr-823	47	20	samples	sample	NOUN
aijmsr-823	47	21	.	.	PUNCT
aijmsr-823	48	1	zones	zone	NOUN
aijmsr-823	48	2	of	of	ADP
aijmsr-823	48	3	inhibition	inhibition	NOUN
aijmsr-823	48	4	were	be	AUX
aijmsr-823	48	5	deciphered	decipher	VERB
aijmsr-823	48	6	according	accord	VERB
aijmsr-823	48	7	to	to	ADP
aijmsr-823	48	8	clsi	clsi	ADJ
aijmsr-823	48	9	guidelines	guideline	NOUN
aijmsr-823	48	10	2018	2018	NUM
aijmsr-823	48	11	.	.	PUNCT
aijmsr-823	49	1	chi	chi	PROPN
aijmsr-823	49	2	square	square	PROPN
aijmsr-823	49	3	test	test	NOUN
aijmsr-823	49	4	was	be	AUX
aijmsr-823	49	5	applied	apply	VERB
aijmsr-823	49	6	to	to	PART
aijmsr-823	49	7	gauge	gauge	VERB
aijmsr-823	49	8	the	the	DET
aijmsr-823	49	9	relationship	relationship	NOUN
aijmsr-823	49	10	among	among	ADP
aijmsr-823	49	11	sensitivity	sensitivity	NOUN
aijmsr-823	49	12	and	and	CCONJ
aijmsr-823	49	13	resistance	resistance	NOUN
aijmsr-823	49	14	patterns	pattern	NOUN
aijmsr-823	49	15	of	of	ADP
aijmsr-823	49	16	antimicrobial	antimicrobial	ADJ
aijmsr-823	49	17	medications	medication	NOUN
aijmsr-823	49	18	.	.	PUNCT
aijmsr-823	50	1	a	a	DET
aijmsr-823	50	2	p	p	NOUN
aijmsr-823	50	3	-	-	PUNCT
aijmsr-823	50	4	value	value	NOUN
aijmsr-823	50	5	<	<	X
aijmsr-823	50	6	0.05	0.05	NUM
aijmsr-823	50	7	was	be	AUX
aijmsr-823	50	8	considered	consider	VERB
aijmsr-823	50	9	as	as	ADP
aijmsr-823	50	10	factually	factually	ADV
aijmsr-823	50	11	critical	critical	ADJ
aijmsr-823	50	12	.	.	PUNCT
aijmsr-823	51	1	results	result	VERB
aijmsr-823	51	2	a	a	DET
aijmsr-823	51	3	sum	sum	NOUN
aijmsr-823	51	4	of	of	ADP
aijmsr-823	51	5	176	176	NUM
aijmsr-823	51	6	strains	strain	NOUN
aijmsr-823	51	7	of	of	ADP
aijmsr-823	51	8	pseudomonas	pseudomona	NOUN
aijmsr-823	51	9	was	be	AUX
aijmsr-823	51	10	segregated	segregate	VERB
aijmsr-823	51	11	out	out	ADP
aijmsr-823	51	12	of	of	ADP
aijmsr-823	51	13	which	which	PRON
aijmsr-823	51	14	97	97	NUM
aijmsr-823	51	15	were	be	AUX
aijmsr-823	51	16	mdr	mdr	PROPN
aijmsr-823	51	17	p.	p.	PROPN
aijmsr-823	51	18	aeruginosa	aeruginosa	PROPN
aijmsr-823	51	19	.	.	PUNCT
aijmsr-823	52	1	the	the	DET
aijmsr-823	52	2	pre	pre	ADJ
aijmsr-823	52	3	-	-	ADJ
aijmsr-823	52	4	dominant	dominant	ADJ
aijmsr-823	52	5	bulk	bulk	NOUN
aijmsr-823	52	6	of	of	ADP
aijmsr-823	52	7	mdr	mdr	PROPN
aijmsr-823	52	8	p.	p.	PROPN
aijmsr-823	52	9	aeruginosa	aeruginosa	PROPN
aijmsr-823	52	10	segregates	segregate	NOUN
aijmsr-823	52	11	were	be	AUX
aijmsr-823	52	12	acquired	acquire	VERB
aijmsr-823	52	13	from	from	ADP
aijmsr-823	52	14	outpatient	outpatient	NOUN
aijmsr-823	52	15	division	division	NOUN
aijmsr-823	52	16	,	,	PUNCT
aijmsr-823	52	17	40	40	NUM
aijmsr-823	52	18	isolates	isolate	NOUN
aijmsr-823	52	19	(	(	PUNCT
aijmsr-823	52	20	41.2	41.2	NUM
aijmsr-823	52	21	%	%	NOUN
aijmsr-823	52	22	)	)	PUNCT
aijmsr-823	52	23	and	and	CCONJ
aijmsr-823	52	24	least	least	ADJ
aijmsr-823	52	25	were	be	AUX
aijmsr-823	52	26	gathered	gather	VERB
aijmsr-823	52	27	from	from	ADP
aijmsr-823	52	28	gynecology	gynecology	NOUN
aijmsr-823	52	29	ward	ward	NOUN
aijmsr-823	52	30	,	,	PUNCT
aijmsr-823	52	31	3	3	NUM
aijmsr-823	52	32	isolates	isolate	NOUN
aijmsr-823	52	33	(	(	PUNCT
aijmsr-823	52	34	4.1	4.1	NUM
aijmsr-823	52	35	%	%	NOUN
aijmsr-823	52	36	)	)	PUNCT
aijmsr-823	52	37	as	as	SCONJ
aijmsr-823	52	38	appeared	appear	VERB
aijmsr-823	52	39	in	in	ADP
aijmsr-823	52	40	table	table	NOUN
aijmsr-823	52	41	2	2	NUM
aijmsr-823	52	42	.	.	PUNCT
aijmsr-823	53	1	it	it	PRON
aijmsr-823	53	2	was	be	AUX
aijmsr-823	53	3	discovered	discover	VERB
aijmsr-823	53	4	that	that	SCONJ
aijmsr-823	53	5	60.0	60.0	NUM
aijmsr-823	53	6	%	%	NOUN
aijmsr-823	53	7	of	of	ADP
aijmsr-823	53	8	the	the	DET
aijmsr-823	53	9	mdr	mdr	PROPN
aijmsr-823	53	10	p.	p.	PROPN
aijmsr-823	53	11	aeruginosa	aeruginosa	PROPN
aijmsr-823	53	12	strains	strain	NOUN
aijmsr-823	53	13	were	be	AUX
aijmsr-823	53	14	found	find	VERB
aijmsr-823	53	15	susceptible	susceptible	ADJ
aijmsr-823	53	16	to	to	ADP
aijmsr-823	53	17	ceftolozane	ceftolozane	VERB
aijmsr-823	53	18	/	/	SYM
aijmsr-823	53	19	tazobactum	tazobactum	NOUN
aijmsr-823	53	20	but	but	CCONJ
aijmsr-823	53	21	when	when	SCONJ
aijmsr-823	53	22	contrasted	contrast	VERB
aijmsr-823	53	23	with	with	ADP
aijmsr-823	53	24	colistin	colistin	NOUN
aijmsr-823	53	25	the	the	DET
aijmsr-823	53	26	sensitivity	sensitivity	NOUN
aijmsr-823	53	27	came	come	VERB
aijmsr-823	53	28	out	out	ADP
aijmsr-823	53	29	to	to	PART
aijmsr-823	53	30	be	be	AUX
aijmsr-823	53	31	99	99	NUM
aijmsr-823	53	32	%	%	NOUN
aijmsr-823	53	33	.	.	PUNCT
aijmsr-823	54	1	p	p	NOUN
aijmsr-823	54	2	value	value	NOUN
aijmsr-823	54	3	was	be	AUX
aijmsr-823	54	4	discovered	discover	VERB
aijmsr-823	54	5	to	to	PART
aijmsr-823	54	6	be	be	AUX
aijmsr-823	54	7	statistically	statistically	ADV
aijmsr-823	54	8	significant	significant	ADJ
aijmsr-823	54	9	(	(	PUNCT
aijmsr-823	54	10	p	p	NOUN
aijmsr-823	54	11	value	value	NOUN
aijmsr-823	54	12	=	=	NOUN
aijmsr-823	54	13	0.0001	0.0001	NUM
aijmsr-823	54	14	)	)	PUNCT
aijmsr-823	54	15	as	as	SCONJ
aijmsr-823	54	16	appeared	appear	VERB
aijmsr-823	54	17	in	in	ADP
aijmsr-823	54	18	table	table	NOUN
aijmsr-823	54	19	3	3	NUM
aijmsr-823	54	20	.	.	PUNCT
aijmsr-823	55	1	https://www.cribfb.com/journal/index.php/aijmsr	https://www.cribfb.com/journal/index.php/aijmsr	PROPN
aijmsr-823	55	2	american	american	PROPN
aijmsr-823	55	3	international	international	PROPN
aijmsr-823	55	4	journal	journal	PROPN
aijmsr-823	55	5	of	of	ADP
aijmsr-823	55	6	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	55	7	scientific	scientific	ADJ
aijmsr-823	55	8	research	research	NOUN
aijmsr-823	55	9	vol	vol	NOUN
aijmsr-823	55	10	.	.	PROPN
aijmsr-823	56	1	6	6	NUM
aijmsr-823	56	2	,	,	PUNCT
aijmsr-823	56	3	no	no	INTJ
aijmsr-823	56	4	.	.	NOUN
aijmsr-823	56	5	3	3	NUM
aijmsr-823	56	6	;	;	PUNCT
aijmsr-823	56	7	2020	2020	NUM
aijmsr-823	56	8	4	4	NUM
aijmsr-823	56	9	table	table	NOUN
aijmsr-823	56	10	1	1	NUM
aijmsr-823	56	11	.	.	PUNCT
aijmsr-823	57	1	gender	gender	NOUN
aijmsr-823	57	2	wise	wise	ADJ
aijmsr-823	57	3	frequency	frequency	NOUN
aijmsr-823	57	4	of	of	ADP
aijmsr-823	57	5	mdr	mdr	PROPN
aijmsr-823	57	6	p.	p.	PROPN
aijmsr-823	57	7	aeruginosa	aeruginosa	PROPN
aijmsr-823	57	8	gender	gender	PROPN
aijmsr-823	57	9	mdr	mdr	PROPN
aijmsr-823	57	10	97(55	97(55	PROPN
aijmsr-823	58	1	%	%	NOUN
aijmsr-823	58	2	)	)	PUNCT
aijmsr-823	58	3	non	non	X
aijmsr-823	58	4	mdr	mdr	PROPN
aijmsr-823	58	5	79	79	NUM
aijmsr-823	58	6	(	(	PUNCT
aijmsr-823	58	7	45	45	NUM
aijmsr-823	58	8	%	%	NOUN
aijmsr-823	58	9	)	)	PUNCT
aijmsr-823	58	10	p	p	NOUN
aijmsr-823	58	11	value	value	NOUN
aijmsr-823	58	12	male	male	NOUN
aijmsr-823	58	13	45	45	NUM
aijmsr-823	58	14	(	(	PUNCT
aijmsr-823	58	15	46	46	NUM
aijmsr-823	58	16	%	%	NOUN
aijmsr-823	58	17	)	)	PUNCT
aijmsr-823	58	18	40	40	NUM
aijmsr-823	58	19	(	(	PUNCT
aijmsr-823	58	20	50.6	50.6	NUM
aijmsr-823	58	21	%	%	NOUN
aijmsr-823	58	22	)	)	PUNCT
aijmsr-823	58	23	0.59	0.59	NUM
aijmsr-823	58	24	female	female	NOUN
aijmsr-823	58	25	52	52	NUM
aijmsr-823	58	26	(	(	PUNCT
aijmsr-823	58	27	54	54	NUM
aijmsr-823	58	28	%	%	NOUN
aijmsr-823	58	29	)	)	PUNCT
aijmsr-823	58	30	37	37	NUM
aijmsr-823	58	31	(	(	PUNCT
aijmsr-823	58	32	46.8	46.8	NUM
aijmsr-823	58	33	%	%	NOUN
aijmsr-823	58	34	)	)	PUNCT
aijmsr-823	58	35	table	table	NOUN
aijmsr-823	58	36	2	2	NUM
aijmsr-823	58	37	.	.	PUNCT
aijmsr-823	58	38	percentage	percentage	NOUN
aijmsr-823	58	39	of	of	ADP
aijmsr-823	58	40	mdr	mdr	PROPN
aijmsr-823	58	41	isolates	isolate	NOUN
aijmsr-823	58	42	in	in	ADP
aijmsr-823	58	43	different	different	ADJ
aijmsr-823	58	44	departments	department	NOUN
aijmsr-823	58	45	department	department	PROPN
aijmsr-823	58	46	mdr	mdr	PROPN
aijmsr-823	58	47	non	non	PROPN
aijmsr-823	58	48	mdr	mdr	PROPN
aijmsr-823	58	49	p	p	PROPN
aijmsr-823	58	50	value	value	NOUN
aijmsr-823	58	51	gynecology	gynecology	NOUN
aijmsr-823	58	52	ward	ward	NOUN
aijmsr-823	58	53	3	3	NUM
aijmsr-823	58	54	(	(	PUNCT
aijmsr-823	58	55	4.1	4.1	NUM
aijmsr-823	58	56	)	)	PUNCT
aijmsr-823	58	57	0	0	NUM
aijmsr-823	59	1	(	(	PUNCT
aijmsr-823	59	2	0.0	0.0	NUM
aijmsr-823	59	3	)	)	PUNCT
aijmsr-823	59	4	0.29	0.29	NUM
aijmsr-823	59	5	intensive	intensive	ADJ
aijmsr-823	59	6	care	care	NOUN
aijmsr-823	59	7	unit	unit	NOUN
aijmsr-823	59	8	16	16	NUM
aijmsr-823	59	9	(	(	PUNCT
aijmsr-823	59	10	16.5	16.5	NUM
aijmsr-823	59	11	)	)	PUNCT
aijmsr-823	59	12	17	17	NUM
aijmsr-823	59	13	(	(	PUNCT
aijmsr-823	59	14	21.5	21.5	NUM
aijmsr-823	59	15	)	)	PUNCT
aijmsr-823	59	16	surgical	surgical	ADJ
aijmsr-823	59	17	ward	ward	NOUN
aijmsr-823	59	18	26(27.1	26(27.1	NOUN
aijmsr-823	59	19	)	)	PUNCT
aijmsr-823	59	20	30	30	NUM
aijmsr-823	59	21	(	(	PUNCT
aijmsr-823	59	22	38.0	38.0	NUM
aijmsr-823	59	23	)	)	PUNCT
aijmsr-823	59	24	outpatient	outpatient	NOUN
aijmsr-823	59	25	department	department	NOUN
aijmsr-823	59	26	40(41.2	40(41.2	NOUN
aijmsr-823	59	27	)	)	PUNCT
aijmsr-823	59	28	24(30.4	24(30.4	NUM
aijmsr-823	59	29	)	)	PUNCT
aijmsr-823	59	30	medicine	medicine	NOUN
aijmsr-823	59	31	ward	ward	NOUN
aijmsr-823	59	32	11(11.3	11(11.3	NUM
aijmsr-823	59	33	)	)	PUNCT
aijmsr-823	59	34	8(10.1	8(10.1	NUM
aijmsr-823	59	35	)	)	PUNCT
aijmsr-823	59	36	table	table	NOUN
aijmsr-823	59	37	3	3	NUM
aijmsr-823	59	38	.	.	PUNCT
aijmsr-823	59	39	comparison	comparison	NOUN
aijmsr-823	59	40	of	of	ADP
aijmsr-823	59	41	susceptibility	susceptibility	NOUN
aijmsr-823	59	42	results	result	NOUN
aijmsr-823	59	43	of	of	ADP
aijmsr-823	59	44	colistin	colistin	NOUN
aijmsr-823	59	45	and	and	CCONJ
aijmsr-823	59	46	c	c	X
aijmsr-823	59	47	/	/	SYM
aijmsr-823	59	48	t	t	NOUN
aijmsr-823	59	49	by	by	ADP
aijmsr-823	59	50	disc	disc	NOUN
aijmsr-823	59	51	diffusion	diffusion	NOUN
aijmsr-823	59	52	method	method	NOUN
aijmsr-823	59	53	antibiotics	antibiotic	NOUN
aijmsr-823	59	54	susceptible	susceptible	ADJ
aijmsr-823	59	55	n	n	CCONJ
aijmsr-823	59	56	(	(	PUNCT
aijmsr-823	59	57	%	%	INTJ
aijmsr-823	59	58	)	)	PUNCT
aijmsr-823	59	59	resistant	resistant	ADJ
aijmsr-823	59	60	n	n	CCONJ
aijmsr-823	59	61	(	(	PUNCT
aijmsr-823	59	62	%	%	NOUN
aijmsr-823	59	63	)	)	PUNCT
aijmsr-823	59	64	p	p	NOUN
aijmsr-823	59	65	value	value	NOUN
aijmsr-823	59	66	colistin	colistin	NOUN
aijmsr-823	59	67	ceftolozane	ceftolozane	NOUN
aijmsr-823	59	68	/	/	SYM
aijmsr-823	59	69	tazobactam	tazobactam	NOUN
aijmsr-823	59	70	99(99	99(99	NUM
aijmsr-823	59	71	%	%	NOUN
aijmsr-823	59	72	)	)	PUNCT
aijmsr-823	59	73	58	58	NUM
aijmsr-823	60	1	(	(	PUNCT
aijmsr-823	60	2	60.0	60.0	NUM
aijmsr-823	60	3	%	%	NOUN
aijmsr-823	60	4	)	)	PUNCT
aijmsr-823	60	5	1	1	NUM
aijmsr-823	60	6	(	(	PUNCT
aijmsr-823	60	7	1	1	NUM
aijmsr-823	60	8	%	%	NOUN
aijmsr-823	60	9	)	)	PUNCT
aijmsr-823	60	10	39	39	NUM
aijmsr-823	60	11	(	(	PUNCT
aijmsr-823	60	12	40	40	NUM
aijmsr-823	60	13	%	%	NOUN
aijmsr-823	60	14	)	)	PUNCT
aijmsr-823	60	15	0.0001	0.0001	NUM
aijmsr-823	60	16	discussion	discussion	NOUN
aijmsr-823	60	17	in	in	ADP
aijmsr-823	60	18	immune	immune	NOUN
aijmsr-823	60	19	-	-	PUNCT
aijmsr-823	60	20	compromised	compromise	VERB
aijmsr-823	60	21	patients	patient	NOUN
aijmsr-823	60	22	,	,	PUNCT
aijmsr-823	60	23	diseases	disease	NOUN
aijmsr-823	60	24	such	such	ADJ
aijmsr-823	60	25	as	as	ADP
aijmsr-823	60	26	pneumonia	pneumonia	NOUN
aijmsr-823	60	27	,	,	PUNCT
aijmsr-823	60	28	bacteremia	bacteremia	NOUN
aijmsr-823	60	29	,	,	PUNCT
aijmsr-823	60	30	urinary	urinary	ADJ
aijmsr-823	60	31	tract	tract	NOUN
aijmsr-823	60	32	infections	infection	NOUN
aijmsr-823	60	33	,	,	PUNCT
aijmsr-823	60	34	infections	infection	NOUN
aijmsr-823	60	35	of	of	ADP
aijmsr-823	60	36	skin	skin	NOUN
aijmsr-823	60	37	and	and	CCONJ
aijmsr-823	60	38	other	other	ADJ
aijmsr-823	60	39	soft	soft	ADJ
aijmsr-823	60	40	tissues	tissue	NOUN
aijmsr-823	60	41	are	be	AUX
aijmsr-823	60	42	usually	usually	ADV
aijmsr-823	60	43	linked	link	VERB
aijmsr-823	60	44	with	with	ADP
aijmsr-823	60	45	a	a	DET
aijmsr-823	60	46	notorious	notorious	ADJ
aijmsr-823	60	47	/	/	SYM
aijmsr-823	60	48	harmful	harmful	ADJ
aijmsr-823	60	49	gram	gram	NOUN
aijmsr-823	60	50	negative	negative	ADJ
aijmsr-823	60	51	,	,	PUNCT
aijmsr-823	60	52	aerobic	aerobic	ADJ
aijmsr-823	60	53	rod	rod	NOUN
aijmsr-823	60	54	-	-	PUNCT
aijmsr-823	60	55	shaped	shape	VERB
aijmsr-823	60	56	bacillus	bacillus	NOUN
aijmsr-823	60	57	called	call	VERB
aijmsr-823	60	58	pseudomonas	pseudomonas	PROPN
aijmsr-823	60	59	aeruginosa	aeruginosa	NOUN
aijmsr-823	60	60	(	(	PUNCT
aijmsr-823	60	61	el	el	PROPN
aijmsr-823	60	62	baze	baze	PROPN
aijmsr-823	60	63	et	et	PROPN
aijmsr-823	60	64	al	al	PROPN
aijmsr-823	60	65	.	.	PROPN
aijmsr-823	60	66	,	,	PUNCT
aijmsr-823	60	67	1991	1991	NUM
aijmsr-823	60	68	)	)	PUNCT
aijmsr-823	60	69	.	.	PUNCT
aijmsr-823	61	1	clinical	clinical	ADJ
aijmsr-823	61	2	isolates	isolate	NOUN
aijmsr-823	61	3	of	of	ADP
aijmsr-823	61	4	p.aeruginosa	p.aeruginosa	NOUN
aijmsr-823	61	5	show	show	VERB
aijmsr-823	61	6	resistance	resistance	NOUN
aijmsr-823	61	7	to	to	ADP
aijmsr-823	61	8	a	a	DET
aijmsr-823	61	9	lot	lot	NOUN
aijmsr-823	61	10	of	of	ADP
aijmsr-823	61	11	classes	class	NOUN
aijmsr-823	61	12	of	of	ADP
aijmsr-823	61	13	antibiotic	antibiotic	ADJ
aijmsr-823	61	14	drugs	drug	NOUN
aijmsr-823	61	15	and	and	CCONJ
aijmsr-823	61	16	have	have	AUX
aijmsr-823	61	17	left	leave	VERB
aijmsr-823	61	18	clinicians	clinician	NOUN
aijmsr-823	61	19	with	with	ADP
aijmsr-823	61	20	a	a	DET
aijmsr-823	61	21	few	few	ADJ
aijmsr-823	61	22	choices	choice	NOUN
aijmsr-823	61	23	of	of	ADP
aijmsr-823	61	24	course	course	NOUN
aijmsr-823	61	25	of	of	ADP
aijmsr-823	61	26	therapy	therapy	NOUN
aijmsr-823	61	27	for	for	ADP
aijmsr-823	61	28	infectious	infectious	ADJ
aijmsr-823	61	29	diseases	disease	NOUN
aijmsr-823	61	30	(	(	PUNCT
aijmsr-823	61	31	kalantar	kalantar	NOUN
aijmsr-823	61	32	,	,	PUNCT
aijmsr-823	61	33	2012	2012	NUM
aijmsr-823	61	34	;	;	PUNCT
aijmsr-823	61	35	rossolini	rossolini	PROPN
aijmsr-823	61	36	,	,	PUNCT
aijmsr-823	61	37	&	&	CCONJ
aijmsr-823	61	38	mantengoli	mantengoli	PROPN
aijmsr-823	61	39	,	,	PUNCT
aijmsr-823	61	40	2005	2005	NUM
aijmsr-823	61	41	)	)	PUNCT
aijmsr-823	61	42	research	research	NOUN
aijmsr-823	61	43	studies	study	NOUN
aijmsr-823	61	44	conducted	conduct	VERB
aijmsr-823	61	45	in	in	ADP
aijmsr-823	61	46	different	different	ADJ
aijmsr-823	61	47	areas	area	NOUN
aijmsr-823	61	48	/	/	SYM
aijmsr-823	61	49	countries	country	NOUN
aijmsr-823	61	50	of	of	ADP
aijmsr-823	61	51	the	the	DET
aijmsr-823	61	52	world	world	NOUN
aijmsr-823	61	53	also	also	ADV
aijmsr-823	61	54	support	support	VERB
aijmsr-823	61	55	/	/	SYM
aijmsr-823	61	56	exhibit	exhibit	NOUN
aijmsr-823	61	57	increased	increase	VERB
aijmsr-823	61	58	prevalence	prevalence	NOUN
aijmsr-823	61	59	rate	rate	NOUN
aijmsr-823	61	60	of	of	ADP
aijmsr-823	61	61	mdr	mdr	PROPN
aijmsr-823	61	62	p.aeruginosa	p.aeruginosa	PROPN
aijmsr-823	61	63	.	.	PUNCT
aijmsr-823	62	1	a	a	DET
aijmsr-823	62	2	research	research	NOUN
aijmsr-823	62	3	performed	perform	VERB
aijmsr-823	62	4	in	in	ADP
aijmsr-823	62	5	india	india	PROPN
aijmsr-823	62	6	in	in	ADP
aijmsr-823	62	7	2017	2017	NUM
aijmsr-823	62	8	,	,	PUNCT
aijmsr-823	62	9	at	at	ADP
aijmsr-823	62	10	a	a	DET
aijmsr-823	62	11	tertiary	tertiary	ADJ
aijmsr-823	62	12	care	care	NOUN
aijmsr-823	62	13	setup	setup	NOUN
aijmsr-823	62	14	demonstrated	demonstrate	VERB
aijmsr-823	62	15	85	85	NUM
aijmsr-823	62	16	%	%	NOUN
aijmsr-823	62	17	prevalence	prevalence	NOUN
aijmsr-823	62	18	rate	rate	NOUN
aijmsr-823	62	19	of	of	ADP
aijmsr-823	62	20	p.	p.	NOUN
aijmsr-823	62	21	aeruginosa	aeruginosa	PROPN
aijmsr-823	62	22	(	(	PUNCT
aijmsr-823	62	23	yuliandra	yuliandra	PROPN
aijmsr-823	62	24	,	,	PUNCT
aijmsr-823	62	25	2017	2017	NUM
aijmsr-823	62	26	)	)	PUNCT
aijmsr-823	62	27	.	.	PUNCT
aijmsr-823	63	1	another	another	DET
aijmsr-823	63	2	study	study	NOUN
aijmsr-823	63	3	conducted	conduct	VERB
aijmsr-823	63	4	in	in	ADP
aijmsr-823	63	5	egypt	egypt	PROPN
aijmsr-823	63	6	showed	show	VERB
aijmsr-823	63	7	highest	high	ADJ
aijmsr-823	63	8	incidence	incidence	NOUN
aijmsr-823	63	9	of	of	ADP
aijmsr-823	63	10	p.aeruginosa	p.aeruginosa	NOUN
aijmsr-823	63	11	at	at	ADP
aijmsr-823	63	12	the	the	DET
aijmsr-823	63	13	burns	burn	NOUN
aijmsr-823	63	14	unit	unit	NOUN
aijmsr-823	63	15	as	as	ADV
aijmsr-823	63	16	well	well	ADV
aijmsr-823	63	17	as	as	ADP
aijmsr-823	63	18	in	in	ADP
aijmsr-823	63	19	icu	icu	PROPN
aijmsr-823	63	20	(	(	PUNCT
aijmsr-823	63	21	mahmoud	mahmoud	PROPN
aijmsr-823	63	22	,	,	PUNCT
aijmsr-823	63	23	zahran	zahran	NOUN
aijmsr-823	63	24	,	,	PUNCT
aijmsr-823	63	25	hindawi	hindawi	ADJ
aijmsr-823	63	26	,	,	PUNCT
aijmsr-823	63	27	labib	labib	PROPN
aijmsr-823	63	28	,	,	PUNCT
aijmsr-823	63	29	&	&	CCONJ
aijmsr-823	63	30	galal	galal	PROPN
aijmsr-823	63	31	,	,	PUNCT
aijmsr-823	63	32	2013	2013	NUM
aijmsr-823	63	33	)	)	PUNCT
aijmsr-823	63	34	.	.	PUNCT
aijmsr-823	64	1	another	another	DET
aijmsr-823	64	2	high	high	ADJ
aijmsr-823	64	3	frequency	frequency	NOUN
aijmsr-823	64	4	was	be	AUX
aijmsr-823	64	5	also	also	ADV
aijmsr-823	64	6	noted	note	VERB
aijmsr-823	64	7	in	in	ADP
aijmsr-823	64	8	egypt	egypt	PROPN
aijmsr-823	64	9	(	(	PUNCT
aijmsr-823	64	10	56	56	NUM
aijmsr-823	64	11	%	%	NOUN
aijmsr-823	64	12	)	)	PUNCT
aijmsr-823	64	13	(	(	PUNCT
aijmsr-823	64	14	farooq	farooq	PROPN
aijmsr-823	64	15	,	,	PUNCT
aijmsr-823	64	16	memon	memon	PROPN
aijmsr-823	64	17	,	,	PUNCT
aijmsr-823	64	18	ismail	ismail	PROPN
aijmsr-823	64	19	,	,	PUNCT
aijmsr-823	64	20	&	&	CCONJ
aijmsr-823	64	21	sadiq	sadiq	PROPN
aijmsr-823	64	22	,	,	PUNCT
aijmsr-823	64	23	2019	2019	NUM
aijmsr-823	64	24	)	)	PUNCT
aijmsr-823	64	25	.	.	PUNCT
aijmsr-823	65	1	in	in	ADP
aijmsr-823	65	2	texas	texas	PROPN
aijmsr-823	65	3	a	a	DET
aijmsr-823	65	4	research	research	NOUN
aijmsr-823	65	5	was	be	AUX
aijmsr-823	65	6	conducted	conduct	VERB
aijmsr-823	65	7	in	in	ADP
aijmsr-823	65	8	2010	2010	NUM
aijmsr-823	65	9	,	,	PUNCT
aijmsr-823	65	10	that	that	PRON
aijmsr-823	65	11	revealed	reveal	VERB
aijmsr-823	65	12	a	a	DET
aijmsr-823	65	13	bulk	bulk	NOUN
aijmsr-823	65	14	of	of	ADP
aijmsr-823	65	15	involvement	involvement	NOUN
aijmsr-823	65	16	of	of	ADP
aijmsr-823	65	17	mdr	mdr	PROPN
aijmsr-823	65	18	p.	p.	PROPN
aijmsr-823	65	19	aeruginosa	aeruginosa	PROPN
aijmsr-823	65	20	from	from	ADP
aijmsr-823	65	21	gynecology	gynecology	NOUN
aijmsr-823	65	22	/	/	SYM
aijmsr-823	65	23	obstetrics	obstetric	NOUN
aijmsr-823	65	24	unit	unit	NOUN
aijmsr-823	65	25	(	(	PUNCT
aijmsr-823	65	26	4.1	4.1	NUM
aijmsr-823	65	27	%	%	NOUN
aijmsr-823	65	28	)	)	PUNCT
aijmsr-823	65	29	,	,	PUNCT
aijmsr-823	65	30	medicine	medicine	NOUN
aijmsr-823	65	31	ward	ward	NOUN
aijmsr-823	65	32	(	(	PUNCT
aijmsr-823	65	33	11.3	11.3	NUM
aijmsr-823	65	34	%	%	NOUN
aijmsr-823	65	35	)	)	PUNCT
aijmsr-823	65	36	,	,	PUNCT
aijmsr-823	65	37	icu	icu	PROPN
aijmsr-823	65	38	(	(	PUNCT
aijmsr-823	65	39	16.5	16.5	NUM
aijmsr-823	65	40	%	%	NOUN
aijmsr-823	65	41	)	)	PUNCT
aijmsr-823	65	42	and	and	CCONJ
aijmsr-823	65	43	from	from	ADP
aijmsr-823	65	44	surgical	surgical	ADJ
aijmsr-823	65	45	ward	ward	NOUN
aijmsr-823	65	46	(	(	PUNCT
aijmsr-823	65	47	26.8	26.8	NUM
aijmsr-823	65	48	%	%	NOUN
aijmsr-823	65	49	)	)	PUNCT
aijmsr-823	65	50	.	.	PUNCT
aijmsr-823	66	1	another	another	DET
aijmsr-823	66	2	study	study	NOUN
aijmsr-823	66	3	was	be	AUX
aijmsr-823	66	4	conducted	conduct	VERB
aijmsr-823	66	5	and	and	CCONJ
aijmsr-823	66	6	found	find	VERB
aijmsr-823	66	7	to	to	PART
aijmsr-823	66	8	support	support	VERB
aijmsr-823	66	9	the	the	DET
aijmsr-823	66	10	role	role	NOUN
aijmsr-823	66	11	of	of	ADP
aijmsr-823	66	12	p.	p.	NOUN
aijmsr-823	66	13	aeruginosa	aeruginosa	NOUN
aijmsr-823	66	14	in	in	ADP
aijmsr-823	66	15	10	10	NUM
aijmsr-823	66	16	icu	icu	PROPN
aijmsr-823	66	17	’s	’s	NOUN
aijmsr-823	66	18	in	in	ADP
aijmsr-823	66	19	france	france	PROPN
aijmsr-823	66	20	that	that	PRON
aijmsr-823	66	21	helped	help	VERB
aijmsr-823	66	22	in	in	ADP
aijmsr-823	66	23	identifying	identify	VERB
aijmsr-823	66	24	individual	individual	ADJ
aijmsr-823	66	25	and	and	CCONJ
aijmsr-823	66	26	environmental	environmental	ADJ
aijmsr-823	66	27	icu	icu	PROPN
aijmsr-823	66	28	risk	risk	NOUN
aijmsr-823	66	29	factors	factor	NOUN
aijmsr-823	66	30	that	that	PRON
aijmsr-823	66	31	aid	aid	VERB
aijmsr-823	66	32	in	in	ADP
aijmsr-823	66	33	acquiring	acquire	VERB
aijmsr-823	66	34	p.	p.	NOUN
aijmsr-823	66	35	aeruginosa	aeruginosa	NOUN
aijmsr-823	66	36	infections	infection	NOUN
aijmsr-823	66	37	(	(	PUNCT
aijmsr-823	66	38	venier	veni	ADJ
aijmsr-823	66	39	et	et	PROPN
aijmsr-823	66	40	al	al	PROPN
aijmsr-823	66	41	.	.	PROPN
aijmsr-823	66	42	,	,	PUNCT
aijmsr-823	66	43	2014	2014	NUM
aijmsr-823	66	44	)	)	PUNCT
aijmsr-823	67	1	https://www.cribfb.com/journal/index.php/aijmsr	https://www.cribfb.com/journal/index.php/aijmsr	PROPN
aijmsr-823	67	2	american	american	PROPN
aijmsr-823	67	3	international	international	PROPN
aijmsr-823	67	4	journal	journal	PROPN
aijmsr-823	67	5	of	of	ADP
aijmsr-823	67	6	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	67	7	scientific	scientific	ADJ
aijmsr-823	67	8	research	research	NOUN
aijmsr-823	67	9	vol	vol	NOUN
aijmsr-823	67	10	.	.	PROPN
aijmsr-823	68	1	6	6	NUM
aijmsr-823	68	2	,	,	PUNCT
aijmsr-823	68	3	no	no	INTJ
aijmsr-823	68	4	.	.	NOUN
aijmsr-823	68	5	3	3	NUM
aijmsr-823	68	6	;	;	PUNCT
aijmsr-823	68	7	2020	2020	NUM
aijmsr-823	68	8	5	5	NUM
aijmsr-823	68	9	in	in	ADP
aijmsr-823	68	10	this	this	DET
aijmsr-823	68	11	study	study	NOUN
aijmsr-823	68	12	multi	multi	ADJ
aijmsr-823	68	13	-	-	ADJ
aijmsr-823	68	14	drug	drug	ADJ
aijmsr-823	68	15	resistant	resistant	ADJ
aijmsr-823	68	16	strains	strain	NOUN
aijmsr-823	68	17	of	of	ADP
aijmsr-823	68	18	p.	p.	NOUN
aijmsr-823	68	19	aeruginosa	aeruginosa	NOUN
aijmsr-823	68	20	were	be	AUX
aijmsr-823	68	21	found	find	VERB
aijmsr-823	68	22	predominantly	predominantly	ADV
aijmsr-823	68	23	in	in	ADP
aijmsr-823	68	24	the	the	DET
aijmsr-823	68	25	female	female	ADJ
aijmsr-823	68	26	population	population	NOUN
aijmsr-823	68	27	and	and	CCONJ
aijmsr-823	68	28	the	the	DET
aijmsr-823	68	29	result	result	NOUN
aijmsr-823	68	30	was	be	AUX
aijmsr-823	68	31	64	64	NUM
aijmsr-823	68	32	%	%	NOUN
aijmsr-823	68	33	,	,	PUNCT
aijmsr-823	68	34	in	in	ADP
aijmsr-823	68	35	comparison	comparison	NOUN
aijmsr-823	68	36	to	to	ADP
aijmsr-823	68	37	the	the	DET
aijmsr-823	68	38	male	male	ADJ
aijmsr-823	68	39	population	population	NOUN
aijmsr-823	68	40	in	in	ADP
aijmsr-823	68	41	which	which	PRON
aijmsr-823	68	42	the	the	DET
aijmsr-823	68	43	result	result	NOUN
aijmsr-823	68	44	was	be	AUX
aijmsr-823	68	45	46	46	NUM
aijmsr-823	68	46	%	%	NOUN
aijmsr-823	68	47	.	.	PUNCT
aijmsr-823	69	1	the	the	DET
aijmsr-823	69	2	results	result	NOUN
aijmsr-823	69	3	are	be	AUX
aijmsr-823	69	4	similar	similar	ADJ
aijmsr-823	69	5	to	to	ADP
aijmsr-823	69	6	a	a	DET
aijmsr-823	69	7	research	research	NOUN
aijmsr-823	69	8	conducted	conduct	VERB
aijmsr-823	69	9	in	in	ADP
aijmsr-823	69	10	nepal	nepal	NOUN
aijmsr-823	69	11	,	,	PUNCT
aijmsr-823	69	12	which	which	PRON
aijmsr-823	69	13	revealed	reveal	VERB
aijmsr-823	69	14	mdr	mdr	PROPN
aijmsr-823	69	15	p.	p.	PROPN
aijmsr-823	69	16	aeruginosa	aeruginosa	PROPN
aijmsr-823	69	17	strains	strain	NOUN
aijmsr-823	69	18	were	be	AUX
aijmsr-823	69	19	(	(	PUNCT
aijmsr-823	69	20	64	64	NUM
aijmsr-823	69	21	%	%	NOUN
aijmsr-823	69	22	)	)	PUNCT
aijmsr-823	69	23	higher	high	ADJ
aijmsr-823	69	24	in	in	ADP
aijmsr-823	69	25	females	female	NOUN
aijmsr-823	69	26	while	while	SCONJ
aijmsr-823	69	27	(	(	PUNCT
aijmsr-823	69	28	31	31	NUM
aijmsr-823	69	29	%	%	NOUN
aijmsr-823	69	30	)	)	PUNCT
aijmsr-823	69	31	lower	low	ADJ
aijmsr-823	69	32	in	in	ADP
aijmsr-823	69	33	males	male	NOUN
aijmsr-823	69	34	(	(	PUNCT
aijmsr-823	69	35	kattel	kattel	NOUN
aijmsr-823	69	36	,	,	PUNCT
aijmsr-823	69	37	2012	2012	NUM
aijmsr-823	69	38	)	)	PUNCT
aijmsr-823	69	39	.	.	PUNCT
aijmsr-823	70	1	another	another	DET
aijmsr-823	70	2	study	study	NOUN
aijmsr-823	70	3	on	on	ADP
aijmsr-823	70	4	uti	uti	PROPN
aijmsr-823	70	5	also	also	ADV
aijmsr-823	70	6	supported	support	VERB
aijmsr-823	70	7	higher	high	ADJ
aijmsr-823	70	8	incidence	incidence	NOUN
aijmsr-823	70	9	of	of	ADP
aijmsr-823	70	10	infection	infection	NOUN
aijmsr-823	70	11	by	by	ADP
aijmsr-823	70	12	p.	p.	NOUN
aijmsr-823	70	13	aeruginosa	aeruginosa	PROPN
aijmsr-823	70	14	in	in	ADP
aijmsr-823	70	15	female	female	ADJ
aijmsr-823	70	16	population	population	NOUN
aijmsr-823	70	17	as	as	SCONJ
aijmsr-823	70	18	compared	compare	VERB
aijmsr-823	70	19	to	to	ADP
aijmsr-823	70	20	male	male	ADJ
aijmsr-823	70	21	population	population	NOUN
aijmsr-823	70	22	.	.	PUNCT
aijmsr-823	71	1	women	woman	NOUN
aijmsr-823	71	2	aged	age	VERB
aijmsr-823	71	3	between	between	ADP
aijmsr-823	71	4	20	20	NUM
aijmsr-823	71	5	-	-	SYM
aijmsr-823	71	6	40	40	NUM
aijmsr-823	71	7	years	year	NOUN
aijmsr-823	71	8	show	show	VERB
aijmsr-823	71	9	incidence	incidence	NOUN
aijmsr-823	71	10	ranging	range	VERB
aijmsr-823	71	11	from	from	ADP
aijmsr-823	71	12	25	25	NUM
aijmsr-823	71	13	30	30	NUM
aijmsr-823	71	14	%	%	NOUN
aijmsr-823	71	15	in	in	ADP
aijmsr-823	71	16	contrast	contrast	NOUN
aijmsr-823	71	17	to	to	ADP
aijmsr-823	71	18	older	old	ADJ
aijmsr-823	71	19	women	woman	NOUN
aijmsr-823	71	20	aged	age	VERB
aijmsr-823	71	21	60	60	NUM
aijmsr-823	71	22	years	year	NOUN
aijmsr-823	71	23	or	or	CCONJ
aijmsr-823	71	24	more	more	ADJ
aijmsr-823	71	25	who	who	PRON
aijmsr-823	71	26	showed	show	VERB
aijmsr-823	71	27	an	an	DET
aijmsr-823	71	28	incidence	incidence	NOUN
aijmsr-823	71	29	ranging	range	VERB
aijmsr-823	71	30	from	from	ADP
aijmsr-823	71	31	4	4	NUM
aijmsr-823	71	32	43	43	NUM
aijmsr-823	71	33	%	%	NOUN
aijmsr-823	71	34	(	(	PUNCT
aijmsr-823	71	35	mittal	mittal	ADJ
aijmsr-823	71	36	,	,	PUNCT
aijmsr-823	71	37	aggarwal	aggarwal	NOUN
aijmsr-823	71	38	,	,	PUNCT
aijmsr-823	71	39	sharma	sharma	PROPN
aijmsr-823	71	40	,	,	PUNCT
aijmsr-823	71	41	chhibber	chhibber	NOUN
aijmsr-823	71	42	,	,	PUNCT
aijmsr-823	71	43	&	&	CCONJ
aijmsr-823	71	44	harjai	harjai	PROPN
aijmsr-823	71	45	,	,	PUNCT
aijmsr-823	71	46	2009	2009	NUM
aijmsr-823	71	47	)	)	PUNCT
aijmsr-823	71	48	.	.	PUNCT
aijmsr-823	72	1	in	in	ADP
aijmsr-823	72	2	2013	2013	NUM
aijmsr-823	72	3	,	,	PUNCT
aijmsr-823	72	4	a	a	DET
aijmsr-823	72	5	cross	cross	ADJ
aijmsr-823	72	6	sectional	sectional	ADJ
aijmsr-823	72	7	study	study	NOUN
aijmsr-823	72	8	was	be	AUX
aijmsr-823	72	9	done	do	VERB
aijmsr-823	72	10	in	in	ADP
aijmsr-823	72	11	a	a	DET
aijmsr-823	72	12	teaching	teaching	NOUN
aijmsr-823	72	13	hospital	hospital	NOUN
aijmsr-823	72	14	of	of	ADP
aijmsr-823	72	15	ethiopia	ethiopia	PROPN
aijmsr-823	72	16	from	from	ADP
aijmsr-823	72	17	january	january	PROPN
aijmsr-823	72	18	to	to	ADP
aijmsr-823	72	19	may	may	AUX
aijmsr-823	72	20	and	and	CCONJ
aijmsr-823	72	21	urine	urine	NOUN
aijmsr-823	72	22	samples	sample	NOUN
aijmsr-823	72	23	were	be	AUX
aijmsr-823	72	24	collected	collect	VERB
aijmsr-823	72	25	from	from	ADP
aijmsr-823	72	26	73	73	NUM
aijmsr-823	72	27	patients	patient	NOUN
aijmsr-823	72	28	who	who	PRON
aijmsr-823	72	29	were	be	AUX
aijmsr-823	72	30	catheterized	catheterize	VERB
aijmsr-823	72	31	and	and	CCONJ
aijmsr-823	72	32	developed	develop	VERB
aijmsr-823	72	33	urinary	urinary	ADJ
aijmsr-823	72	34	tract	tract	NOUN
aijmsr-823	72	35	infections	infection	NOUN
aijmsr-823	72	36	.	.	PUNCT
aijmsr-823	73	1	out	out	ADP
aijmsr-823	73	2	of	of	ADP
aijmsr-823	73	3	those	those	DET
aijmsr-823	73	4	73	73	NUM
aijmsr-823	73	5	patients	patient	NOUN
aijmsr-823	73	6	,	,	PUNCT
aijmsr-823	73	7	p.	p.	NOUN
aijmsr-823	73	8	aeruginosa	aeruginosa	PROPN
aijmsr-823	73	9	was	be	AUX
aijmsr-823	73	10	found	find	VERB
aijmsr-823	73	11	in	in	ADP
aijmsr-823	73	12	urine	urine	NOUN
aijmsr-823	73	13	samples	sample	NOUN
aijmsr-823	73	14	of	of	ADP
aijmsr-823	73	15	36	36	NUM
aijmsr-823	73	16	patients	patient	NOUN
aijmsr-823	73	17	(	(	PUNCT
aijmsr-823	73	18	49.32	49.32	NUM
aijmsr-823	73	19	%	%	NOUN
aijmsr-823	73	20	)	)	PUNCT
aijmsr-823	73	21	who	who	PRON
aijmsr-823	73	22	were	be	AUX
aijmsr-823	73	23	catheterized	catheterize	VERB
aijmsr-823	73	24	,	,	PUNCT
aijmsr-823	73	25	out	out	ADP
aijmsr-823	73	26	of	of	ADP
aijmsr-823	73	27	which	which	PRON
aijmsr-823	73	28	17	17	NUM
aijmsr-823	73	29	were	be	AUX
aijmsr-823	73	30	males	male	NOUN
aijmsr-823	73	31	(	(	PUNCT
aijmsr-823	73	32	23.29	23.29	NUM
aijmsr-823	73	33	%	%	NOUN
aijmsr-823	73	34	)	)	PUNCT
aijmsr-823	73	35	and	and	CCONJ
aijmsr-823	73	36	19	19	NUM
aijmsr-823	73	37	were	be	AUX
aijmsr-823	73	38	females	female	NOUN
aijmsr-823	73	39	(	(	PUNCT
aijmsr-823	73	40	26.03	26.03	NUM
aijmsr-823	73	41	%	%	NOUN
aijmsr-823	73	42	)	)	PUNCT
aijmsr-823	73	43	.	.	PUNCT
aijmsr-823	74	1	after	after	ADP
aijmsr-823	74	2	antibiotic	antibiotic	ADJ
aijmsr-823	74	3	sensitivity	sensitivity	NOUN
aijmsr-823	74	4	testing	testing	NOUN
aijmsr-823	74	5	,	,	PUNCT
aijmsr-823	74	6	all	all	DET
aijmsr-823	74	7	clinical	clinical	ADJ
aijmsr-823	74	8	isolates	isolate	NOUN
aijmsr-823	74	9	of	of	ADP
aijmsr-823	74	10	p.	p.	NOUN
aijmsr-823	74	11	aeruginosa	aeruginosa	PROPN
aijmsr-823	74	12	were	be	AUX
aijmsr-823	74	13	susceptible	susceptible	ADJ
aijmsr-823	74	14	to	to	ADP
aijmsr-823	74	15	norfloxacin	norfloxacin	PROPN
aijmsr-823	74	16	and	and	CCONJ
aijmsr-823	74	17	ciprofloxacin	ciprofloxacin	PROPN
aijmsr-823	74	18	.	.	PUNCT
aijmsr-823	75	1	susceptibility	susceptibility	NOUN
aijmsr-823	75	2	to	to	ADP
aijmsr-823	75	3	gentamicin	gentamicin	PROPN
aijmsr-823	75	4	was	be	AUX
aijmsr-823	75	5	also	also	ADV
aijmsr-823	75	6	noted	note	VERB
aijmsr-823	75	7	and	and	CCONJ
aijmsr-823	75	8	was	be	AUX
aijmsr-823	75	9	found	find	VERB
aijmsr-823	75	10	to	to	PART
aijmsr-823	75	11	be	be	AUX
aijmsr-823	75	12	86.12	86.12	NUM
aijmsr-823	75	13	%	%	NOUN
aijmsr-823	75	14	(	(	PUNCT
aijmsr-823	75	15	bekele	bekele	PROPN
aijmsr-823	75	16	,	,	PUNCT
aijmsr-823	75	17	tesfaye	tesfaye	PROPN
aijmsr-823	75	18	,	,	PUNCT
aijmsr-823	75	19	sewunet	sewunet	NOUN
aijmsr-823	75	20	,	,	PUNCT
aijmsr-823	75	21	&	&	CCONJ
aijmsr-823	75	22	waktola	waktola	PROPN
aijmsr-823	75	23	,	,	PUNCT
aijmsr-823	75	24	2015	2015	NUM
aijmsr-823	75	25	)	)	PUNCT
aijmsr-823	75	26	.	.	PUNCT
aijmsr-823	76	1	geographical	geographical	ADJ
aijmsr-823	76	2	variation	variation	NOUN
aijmsr-823	76	3	and	and	CCONJ
aijmsr-823	76	4	duration	duration	NOUN
aijmsr-823	76	5	of	of	ADP
aijmsr-823	76	6	study	study	NOUN
aijmsr-823	76	7	may	may	AUX
aijmsr-823	76	8	also	also	ADV
aijmsr-823	76	9	act	act	VERB
aijmsr-823	76	10	as	as	ADP
aijmsr-823	76	11	an	an	DET
aijmsr-823	76	12	influencing	influence	VERB
aijmsr-823	76	13	factor	factor	NOUN
aijmsr-823	76	14	that	that	PRON
aijmsr-823	76	15	is	be	AUX
aijmsr-823	76	16	associated	associate	VERB
aijmsr-823	76	17	with	with	ADP
aijmsr-823	76	18	the	the	DET
aijmsr-823	76	19	difference	difference	NOUN
aijmsr-823	76	20	in	in	ADP
aijmsr-823	76	21	gender	gender	NOUN
aijmsr-823	76	22	prevalence	prevalence	NOUN
aijmsr-823	76	23	.	.	PUNCT
aijmsr-823	77	1	in	in	ADP
aijmsr-823	77	2	our	our	PRON
aijmsr-823	77	3	study	study	NOUN
aijmsr-823	77	4	,	,	PUNCT
aijmsr-823	77	5	it	it	PRON
aijmsr-823	77	6	was	be	AUX
aijmsr-823	77	7	found	find	VERB
aijmsr-823	77	8	that	that	SCONJ
aijmsr-823	77	9	mdr	mdr	PROPN
aijmsr-823	77	10	strains	strain	VERB
aijmsr-823	77	11	of	of	ADP
aijmsr-823	77	12	p.	p.	NOUN
aijmsr-823	77	13	aeruginosa	aeruginosa	NOUN
aijmsr-823	77	14	are	be	AUX
aijmsr-823	77	15	99%susceptible	99%susceptible	ADJ
aijmsr-823	77	16	to	to	PART
aijmsr-823	77	17	colistin	colistin	VERB
aijmsr-823	77	18	(	(	PUNCT
aijmsr-823	77	19	polymyxin	polymyxin	PROPN
aijmsr-823	77	20	b	b	NOUN
aijmsr-823	77	21	)	)	PUNCT
aijmsr-823	77	22	.	.	PUNCT
aijmsr-823	78	1	another	another	DET
aijmsr-823	78	2	research	research	NOUN
aijmsr-823	78	3	conducted	conduct	VERB
aijmsr-823	78	4	in	in	ADP
aijmsr-823	78	5	pakistan	pakistan	PROPN
aijmsr-823	78	6	also	also	ADV
aijmsr-823	78	7	supported	support	VERB
aijmsr-823	78	8	our	our	PRON
aijmsr-823	78	9	study	study	NOUN
aijmsr-823	78	10	and	and	CCONJ
aijmsr-823	78	11	demonstrated	demonstrate	VERB
aijmsr-823	78	12	that	that	PRON
aijmsr-823	78	13	colistin	colistin	NOUN
aijmsr-823	78	14	(	(	PUNCT
aijmsr-823	78	15	polymyxin	polymyxin	PROPN
aijmsr-823	78	16	b	b	NOUN
aijmsr-823	78	17	)	)	PUNCT
aijmsr-823	78	18	is	be	AUX
aijmsr-823	78	19	the	the	DET
aijmsr-823	78	20	most	most	ADV
aijmsr-823	78	21	sensitive	sensitive	ADJ
aijmsr-823	78	22	antibacterial	antibacterial	ADJ
aijmsr-823	78	23	option	option	NOUN
aijmsr-823	78	24	among	among	ADP
aijmsr-823	78	25	the	the	DET
aijmsr-823	78	26	antibiotic	antibiotic	ADJ
aijmsr-823	78	27	regimen	regimen	NOUN
aijmsr-823	78	28	options	option	NOUN
aijmsr-823	78	29	(	(	PUNCT
aijmsr-823	78	30	gill	gill	NOUN
aijmsr-823	78	31	,	,	PUNCT
aijmsr-823	78	32	2011	2011	NUM
aijmsr-823	78	33	)	)	PUNCT
aijmsr-823	78	34	.	.	PUNCT
aijmsr-823	79	1	polymyxin	polymyxin	PROPN
aijmsr-823	79	2	b	b	NUM
aijmsr-823	79	3	antibacterial	antibacterial	ADJ
aijmsr-823	79	4	drug	drug	NOUN
aijmsr-823	79	5	,	,	PUNCT
aijmsr-823	79	6	also	also	ADV
aijmsr-823	79	7	called	call	VERB
aijmsr-823	79	8	colistin	colistin	PROPN
aijmsr-823	79	9	is	be	AUX
aijmsr-823	79	10	used	use	VERB
aijmsr-823	79	11	as	as	ADP
aijmsr-823	79	12	a	a	DET
aijmsr-823	79	13	therapeutic	therapeutic	ADJ
aijmsr-823	79	14	agent	agent	NOUN
aijmsr-823	79	15	against	against	ADP
aijmsr-823	79	16	gram	gram	NOUN
aijmsr-823	79	17	negative	negative	ADJ
aijmsr-823	79	18	bacilli	bacilli	NOUN
aijmsr-823	79	19	.	.	PUNCT
aijmsr-823	80	1	all	all	ADV
aijmsr-823	80	2	over	over	ADP
aijmsr-823	80	3	the	the	DET
aijmsr-823	80	4	world	world	NOUN
aijmsr-823	80	5	and	and	CCONJ
aijmsr-823	80	6	in	in	ADP
aijmsr-823	80	7	our	our	PRON
aijmsr-823	80	8	country	country	NOUN
aijmsr-823	80	9	polymyxin	polymyxin	PROPN
aijmsr-823	80	10	b	b	PROPN
aijmsr-823	80	11	,	,	PUNCT
aijmsr-823	80	12	is	be	AUX
aijmsr-823	80	13	a	a	DET
aijmsr-823	80	14	sensitive	sensitive	ADJ
aijmsr-823	80	15	antibacterial	antibacterial	ADJ
aijmsr-823	80	16	therapeutic	therapeutic	ADJ
aijmsr-823	80	17	agent	agent	NOUN
aijmsr-823	80	18	but	but	CCONJ
aijmsr-823	80	19	due	due	ADP
aijmsr-823	80	20	to	to	ADP
aijmsr-823	80	21	its	its	PRON
aijmsr-823	80	22	narrow	narrow	ADJ
aijmsr-823	80	23	therapeutic	therapeutic	ADJ
aijmsr-823	80	24	index	index	NOUN
aijmsr-823	80	25	and	and	CCONJ
aijmsr-823	80	26	noteworthy	noteworthy	ADJ
aijmsr-823	80	27	side	side	NOUN
aijmsr-823	80	28	effects	effect	NOUN
aijmsr-823	80	29	,	,	PUNCT
aijmsr-823	80	30	the	the	DET
aijmsr-823	80	31	empirical	empirical	ADJ
aijmsr-823	80	32	use	use	NOUN
aijmsr-823	80	33	of	of	ADP
aijmsr-823	80	34	this	this	DET
aijmsr-823	80	35	medicine	medicine	NOUN
aijmsr-823	80	36	is	be	AUX
aijmsr-823	80	37	very	very	ADV
aijmsr-823	80	38	finite	finite	ADJ
aijmsr-823	80	39	(	(	PUNCT
aijmsr-823	80	40	landersdorfer	landersdorfer	NOUN
aijmsr-823	80	41	,	,	PUNCT
aijmsr-823	80	42	&	&	CCONJ
aijmsr-823	80	43	nation	nation	NOUN
aijmsr-823	80	44	,	,	PUNCT
aijmsr-823	80	45	2015	2015	NUM
aijmsr-823	80	46	)	)	PUNCT
aijmsr-823	80	47	.	.	PUNCT
aijmsr-823	81	1	colistin	colistin	PROPN
aijmsr-823	81	2	was	be	AUX
aijmsr-823	81	3	found	find	VERB
aijmsr-823	81	4	to	to	PART
aijmsr-823	81	5	have	have	VERB
aijmsr-823	81	6	a	a	DET
aijmsr-823	81	7	better	well	ADJ
aijmsr-823	81	8	in	in	ADP
aijmsr-823	81	9	vitro	vitro	X
aijmsr-823	81	10	function	function	NOUN
aijmsr-823	81	11	(	(	PUNCT
aijmsr-823	81	12	98	98	NUM
aijmsr-823	81	13	%	%	NOUN
aijmsr-823	81	14	)	)	PUNCT
aijmsr-823	81	15	which	which	PRON
aijmsr-823	81	16	is	be	AUX
aijmsr-823	81	17	significantly	significantly	ADV
aijmsr-823	81	18	comparable	comparable	ADJ
aijmsr-823	81	19	to	to	ADP
aijmsr-823	81	20	tazobactum	tazobactum	NOUN
aijmsr-823	81	21	/	/	SYM
aijmsr-823	81	22	ceftalozane	ceftalozane	NOUN
aijmsr-823	81	23	(	(	PUNCT
aijmsr-823	81	24	60	60	NUM
aijmsr-823	81	25	%	%	NOUN
aijmsr-823	81	26	)	)	PUNCT
aijmsr-823	81	27	when	when	SCONJ
aijmsr-823	81	28	diffuse	diffuse	NOUN
aijmsr-823	81	29	disc	disc	NOUN
aijmsr-823	81	30	method	method	NOUN
aijmsr-823	81	31	of	of	ADP
aijmsr-823	81	32	antibiotic	antibiotic	ADJ
aijmsr-823	81	33	sensitivity	sensitivity	NOUN
aijmsr-823	81	34	was	be	AUX
aijmsr-823	81	35	applied	apply	VERB
aijmsr-823	81	36	.	.	PUNCT
aijmsr-823	82	1	increased	increase	VERB
aijmsr-823	82	2	resistance	resistance	NOUN
aijmsr-823	82	3	of	of	ADP
aijmsr-823	82	4	bacterial	bacterial	ADJ
aijmsr-823	82	5	to	to	ADP
aijmsr-823	82	6	antibiotic	antibiotic	ADJ
aijmsr-823	82	7	drugs	drug	NOUN
aijmsr-823	82	8	,	,	PUNCT
aijmsr-823	82	9	side	side	NOUN
aijmsr-823	82	10	effects	effect	NOUN
aijmsr-823	82	11	and	and	CCONJ
aijmsr-823	82	12	toxicities	toxicity	NOUN
aijmsr-823	82	13	,	,	PUNCT
aijmsr-823	82	14	pharmacokinetics	pharmacokinetic	NOUN
aijmsr-823	82	15	,	,	PUNCT
aijmsr-823	82	16	therapeutic	therapeutic	ADJ
aijmsr-823	82	17	uses	use	NOUN
aijmsr-823	82	18	,	,	PUNCT
aijmsr-823	82	19	clinical	clinical	ADJ
aijmsr-823	82	20	findings	finding	NOUN
aijmsr-823	82	21	and	and	CCONJ
aijmsr-823	82	22	combination	combination	NOUN
aijmsr-823	82	23	therapy	therapy	NOUN
aijmsr-823	82	24	in	in	ADP
aijmsr-823	82	25	relation	relation	NOUN
aijmsr-823	82	26	to	to	PART
aijmsr-823	82	27	colistin	colistin	VERB
aijmsr-823	82	28	(	(	PUNCT
aijmsr-823	82	29	polymyxin	polymyxin	PROPN
aijmsr-823	82	30	b	b	NOUN
aijmsr-823	82	31	)	)	PUNCT
aijmsr-823	82	32	has	have	AUX
aijmsr-823	82	33	been	be	AUX
aijmsr-823	82	34	reviewed	review	VERB
aijmsr-823	82	35	(	(	PUNCT
aijmsr-823	82	36	pfaller	pfaller	NOUN
aijmsr-823	82	37	,	,	PUNCT
aijmsr-823	82	38	shortridge	shortridge	NOUN
aijmsr-823	82	39	,	,	PUNCT
aijmsr-823	82	40	sader	sader	NOUN
aijmsr-823	82	41	,	,	PUNCT
aijmsr-823	82	42	flamm	flamm	PROPN
aijmsr-823	82	43	,	,	PUNCT
aijmsr-823	82	44	&	&	CCONJ
aijmsr-823	82	45	castanheira	castanheira	PROPN
aijmsr-823	82	46	,	,	PUNCT
aijmsr-823	82	47	2017	2017	NUM
aijmsr-823	82	48	)	)	PUNCT
aijmsr-823	82	49	.	.	PUNCT
aijmsr-823	83	1	current	current	ADJ
aijmsr-823	83	2	methods	method	NOUN
aijmsr-823	83	3	to	to	PART
aijmsr-823	83	4	utilize	utilize	VERB
aijmsr-823	83	5	colistin	colistin	NOUN
aijmsr-823	83	6	with	with	ADP
aijmsr-823	83	7	other	other	ADJ
aijmsr-823	83	8	antibacterial	antibacterial	ADJ
aijmsr-823	83	9	drugs	drug	NOUN
aijmsr-823	83	10	can	can	AUX
aijmsr-823	83	11	be	be	AUX
aijmsr-823	83	12	fruitful	fruitful	ADJ
aijmsr-823	83	13	for	for	ADP
aijmsr-823	83	14	increased	increase	VERB
aijmsr-823	83	15	antibacterial	antibacterial	ADJ
aijmsr-823	83	16	/	/	SYM
aijmsr-823	83	17	antibiotic	antibiotic	ADJ
aijmsr-823	83	18	efficacy	efficacy	NOUN
aijmsr-823	83	19	.	.	PUNCT
aijmsr-823	84	1	in	in	ADP
aijmsr-823	84	2	21st	21st	ADJ
aijmsr-823	84	3	century	century	NOUN
aijmsr-823	84	4	,	,	PUNCT
aijmsr-823	84	5	it	it	PRON
aijmsr-823	84	6	can	can	AUX
aijmsr-823	84	7	be	be	AUX
aijmsr-823	84	8	predicted	predict	VERB
aijmsr-823	84	9	that	that	SCONJ
aijmsr-823	84	10	against	against	ADP
aijmsr-823	84	11	multidrug	multidrug	VERB
aijmsr-823	84	12	resistant	resistant	ADJ
aijmsr-823	84	13	gram	gram	NOUN
aijmsr-823	84	14	-	-	PUNCT
aijmsr-823	84	15	negative	negative	ADJ
aijmsr-823	84	16	bacillus	bacillus	NOUN
aijmsr-823	84	17	colistin	colistin	NOUN
aijmsr-823	84	18	will	will	AUX
aijmsr-823	84	19	be	be	AUX
aijmsr-823	84	20	the	the	DET
aijmsr-823	84	21	last	last	ADJ
aijmsr-823	84	22	line	line	NOUN
aijmsr-823	84	23	of	of	ADP
aijmsr-823	84	24	defense	defense	NOUN
aijmsr-823	84	25	among	among	ADP
aijmsr-823	84	26	all	all	DET
aijmsr-823	84	27	antibacterial	antibacterial	ADJ
aijmsr-823	84	28	therapeutic	therapeutic	ADJ
aijmsr-823	84	29	agents	agent	NOUN
aijmsr-823	84	30	(	(	PUNCT
aijmsr-823	84	31	biswas	biswas	PROPN
aijmsr-823	84	32	,	,	PUNCT
aijmsr-823	84	33	brunel	brunel	PROPN
aijmsr-823	84	34	,	,	PUNCT
aijmsr-823	84	35	dubus	dubus	NOUN
aijmsr-823	84	36	,	,	PUNCT
aijmsr-823	84	37	reynaud	reynaud	NOUN
aijmsr-823	84	38	-	-	PUNCT
aijmsr-823	84	39	gaubert	gaubert	NOUN
aijmsr-823	84	40	,	,	PUNCT
aijmsr-823	84	41	&	&	CCONJ
aijmsr-823	84	42	rolain	rolain	PROPN
aijmsr-823	84	43	,	,	PUNCT
aijmsr-823	84	44	2012	2012	NUM
aijmsr-823	84	45	)	)	PUNCT
aijmsr-823	84	46	.	.	PUNCT
aijmsr-823	85	1	as	as	SCONJ
aijmsr-823	85	2	ceftolazane	ceftolazane	NOUN
aijmsr-823	85	3	/	/	PUNCT
aijmsr-823	85	4	tazobactum	tazobactum	NOUN
aijmsr-823	85	5	is	be	AUX
aijmsr-823	85	6	not	not	PART
aijmsr-823	85	7	a	a	DET
aijmsr-823	85	8	drug	drug	NOUN
aijmsr-823	85	9	a	a	DET
aijmsr-823	85	10	choice	choice	NOUN
aijmsr-823	85	11	in	in	ADP
aijmsr-823	85	12	our	our	PRON
aijmsr-823	85	13	set	set	NOUN
aijmsr-823	85	14	up	up	ADP
aijmsr-823	85	15	,	,	PUNCT
aijmsr-823	85	16	still	still	ADV
aijmsr-823	85	17	40	40	NUM
aijmsr-823	85	18	%	%	NOUN
aijmsr-823	85	19	resistance	resistance	NOUN
aijmsr-823	85	20	was	be	AUX
aijmsr-823	85	21	demonstrated	demonstrate	VERB
aijmsr-823	85	22	in	in	ADP
aijmsr-823	85	23	the	the	DET
aijmsr-823	85	24	results	result	NOUN
aijmsr-823	85	25	.	.	PUNCT
aijmsr-823	86	1	this	this	PRON
aijmsr-823	86	2	can	can	AUX
aijmsr-823	86	3	be	be	AUX
aijmsr-823	86	4	due	due	ADJ
aijmsr-823	86	5	to	to	PART
aijmsr-823	86	6	cross	cross	VERB
aijmsr-823	86	7	resistance	resistance	NOUN
aijmsr-823	86	8	that	that	PRON
aijmsr-823	86	9	is	be	AUX
aijmsr-823	86	10	if	if	SCONJ
aijmsr-823	86	11	the	the	DET
aijmsr-823	86	12	patient	patient	NOUN
aijmsr-823	86	13	is	be	AUX
aijmsr-823	86	14	resistant	resistant	ADJ
aijmsr-823	86	15	to	to	ADP
aijmsr-823	86	16	one	one	NUM
aijmsr-823	86	17	group	group	NOUN
aijmsr-823	86	18	of	of	ADP
aijmsr-823	86	19	cephalosporin	cephalosporin	NOUN
aijmsr-823	86	20	then	then	ADV
aijmsr-823	86	21	cross	cross	VERB
aijmsr-823	86	22	resistance	resistance	NOUN
aijmsr-823	86	23	may	may	AUX
aijmsr-823	86	24	develop	develop	VERB
aijmsr-823	86	25	to	to	ADP
aijmsr-823	86	26	newer	new	ADJ
aijmsr-823	86	27	agents	agent	NOUN
aijmsr-823	86	28	of	of	ADP
aijmsr-823	86	29	cephalosporins	cephalosporin	NOUN
aijmsr-823	86	30	.	.	PUNCT
aijmsr-823	87	1	conclusion	conclusion	NOUN
aijmsr-823	87	2	resistance	resistance	NOUN
aijmsr-823	87	3	of	of	ADP
aijmsr-823	87	4	pseudomonas	pseudomona	NOUN
aijmsr-823	87	5	aeruginosa	aeruginosa	NOUN
aijmsr-823	87	6	against	against	ADP
aijmsr-823	87	7	antibiotic	antibiotic	ADJ
aijmsr-823	87	8	agents	agent	NOUN
aijmsr-823	87	9	is	be	AUX
aijmsr-823	87	10	amplified	amplify	VERB
aijmsr-823	87	11	over	over	ADP
aijmsr-823	87	12	a	a	DET
aijmsr-823	87	13	past	past	ADJ
aijmsr-823	87	14	few	few	ADJ
aijmsr-823	87	15	years	year	NOUN
aijmsr-823	87	16	.	.	PUNCT
aijmsr-823	88	1	previously	previously	ADV
aijmsr-823	88	2	colistin	colistin	PROPN
aijmsr-823	88	3	was	be	AUX
aijmsr-823	88	4	considered	consider	VERB
aijmsr-823	88	5	a	a	DET
aijmsr-823	88	6	last	last	ADJ
aijmsr-823	88	7	resort	resort	NOUN
aijmsr-823	88	8	therapy	therapy	NOUN
aijmsr-823	88	9	for	for	ADP
aijmsr-823	88	10	various	various	ADJ
aijmsr-823	88	11	multi	multi	ADJ
aijmsr-823	88	12	drug	drug	NOUN
aijmsr-823	88	13	resistant	resistant	ADJ
aijmsr-823	88	14	bacteria	bacteria	NOUN
aijmsr-823	88	15	in	in	ADP
aijmsr-823	88	16	clinical	clinical	ADJ
aijmsr-823	88	17	set	set	VERB
aijmsr-823	88	18	up	up	ADP
aijmsr-823	88	19	.	.	PUNCT
aijmsr-823	89	1	fortunately	fortunately	ADV
aijmsr-823	89	2	,	,	PUNCT
aijmsr-823	89	3	ceftolozane	ceftolozane	ADJ
aijmsr-823	89	4	/	/	PUNCT
aijmsr-823	89	5	tazobactum	tazobactum	NOUN
aijmsr-823	89	6	a	a	DET
aijmsr-823	89	7	comparatively	comparatively	ADV
aijmsr-823	89	8	newer	new	ADJ
aijmsr-823	89	9	antibiotic	antibiotic	ADJ
aijmsr-823	89	10	,	,	PUNCT
aijmsr-823	89	11	the	the	DET
aijmsr-823	89	12	therapeutic	therapeutic	ADJ
aijmsr-823	89	13	use	use	NOUN
aijmsr-823	89	14	of	of	ADP
aijmsr-823	89	15	ceftolozane	ceftolozane	NOUN
aijmsr-823	89	16	/	/	SYM
aijmsr-823	89	17	tazobactum	tazobactum	NOUN
aijmsr-823	89	18	should	should	AUX
aijmsr-823	89	19	be	be	AUX
aijmsr-823	89	20	reserved	reserve	VERB
aijmsr-823	89	21	only	only	ADV
aijmsr-823	89	22	for	for	ADP
aijmsr-823	89	23	severe	severe	ADJ
aijmsr-823	89	24	https://www.cribfb.com/journal/index.php/aijmsr	https://www.cribfb.com/journal/index.php/aijmsr	PROPN
aijmsr-823	89	25	american	american	PROPN
aijmsr-823	89	26	international	international	PROPN
aijmsr-823	89	27	journal	journal	PROPN
aijmsr-823	89	28	of	of	ADP
aijmsr-823	89	29	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	89	30	scientific	scientific	ADJ
aijmsr-823	89	31	research	research	NOUN
aijmsr-823	89	32	vol	vol	NOUN
aijmsr-823	89	33	.	.	PROPN
aijmsr-823	90	1	6	6	NUM
aijmsr-823	90	2	,	,	PUNCT
aijmsr-823	90	3	no	no	INTJ
aijmsr-823	90	4	.	.	NOUN
aijmsr-823	90	5	3	3	NUM
aijmsr-823	90	6	;	;	PUNCT
aijmsr-823	90	7	2020	2020	NUM
aijmsr-823	90	8	6	6	NUM
aijmsr-823	90	9	and	and	CCONJ
aijmsr-823	90	10	life	life	NOUN
aijmsr-823	90	11	-	-	PUNCT
aijmsr-823	90	12	threatening	threaten	VERB
aijmsr-823	90	13	infections	infection	NOUN
aijmsr-823	90	14	.	.	PUNCT
aijmsr-823	91	1	this	this	PRON
aijmsr-823	91	2	is	be	AUX
aijmsr-823	91	3	particularly	particularly	ADV
aijmsr-823	91	4	true	true	ADJ
aijmsr-823	91	5	where	where	SCONJ
aijmsr-823	91	6	the	the	DET
aijmsr-823	91	7	infection	infection	NOUN
aijmsr-823	91	8	is	be	AUX
aijmsr-823	91	9	polymicrobial	polymicrobial	ADJ
aijmsr-823	91	10	,	,	PUNCT
aijmsr-823	91	11	anaerobic	anaerobic	NOUN
aijmsr-823	91	12	or	or	CCONJ
aijmsr-823	91	13	pseudomonas	pseudomona	NOUN
aijmsr-823	91	14	resistant	resistant	ADJ
aijmsr-823	91	15	to	to	ADP
aijmsr-823	91	16	other	other	ADJ
aijmsr-823	91	17	antimicrobial	antimicrobial	ADJ
aijmsr-823	91	18	drugs	drug	NOUN
aijmsr-823	91	19	.	.	PUNCT
aijmsr-823	92	1	references	reference	NOUN
aijmsr-823	92	2	biswas	biswas	PROPN
aijmsr-823	92	3	,	,	PUNCT
aijmsr-823	92	4	s.	s.	PROPN
aijmsr-823	92	5	,	,	PUNCT
aijmsr-823	92	6	brunel	brunel	PROPN
aijmsr-823	92	7	,	,	PUNCT
aijmsr-823	92	8	j.	j.	PROPN
aijmsr-823	92	9	m.	m.	PROPN
aijmsr-823	92	10	,	,	PUNCT
aijmsr-823	92	11	dubus	dubus	PROPN
aijmsr-823	92	12	,	,	PUNCT
aijmsr-823	92	13	j.	j.	PROPN
aijmsr-823	92	14	c.	c.	PROPN
aijmsr-823	92	15	,	,	PUNCT
aijmsr-823	92	16	reynaud	reynaud	NOUN
aijmsr-823	92	17	-	-	PUNCT
aijmsr-823	92	18	gaubert	gaubert	NOUN
aijmsr-823	92	19	,	,	PUNCT
aijmsr-823	92	20	m.	m.	NOUN
aijmsr-823	92	21	,	,	PUNCT
aijmsr-823	92	22	&	&	CCONJ
aijmsr-823	92	23	rolain	rolain	PROPN
aijmsr-823	92	24	,	,	PUNCT
aijmsr-823	92	25	j.	j.	PROPN
aijmsr-823	92	26	m.	m.	PROPN
aijmsr-823	92	27	(	(	PUNCT
aijmsr-823	92	28	2012	2012	NUM
aijmsr-823	92	29	)	)	PUNCT
aijmsr-823	92	30	.	.	PUNCT
aijmsr-823	93	1	colistin	colistin	PROPN
aijmsr-823	93	2	:	:	PUNCT
aijmsr-823	93	3	an	an	DET
aijmsr-823	93	4	update	update	NOUN
aijmsr-823	93	5	on	on	ADP
aijmsr-823	93	6	the	the	DET
aijmsr-823	93	7	antibiotic	antibiotic	NOUN
aijmsr-823	93	8	of	of	ADP
aijmsr-823	93	9	the	the	DET
aijmsr-823	93	10	21st	21st	ADJ
aijmsr-823	93	11	century	century	NOUN
aijmsr-823	93	12	.	.	PUNCT
aijmsr-823	94	1	expert	expert	NOUN
aijmsr-823	94	2	review	review	NOUN
aijmsr-823	94	3	of	of	ADP
aijmsr-823	94	4	anti	anti	ADJ
aijmsr-823	94	5	-	-	ADJ
aijmsr-823	94	6	infective	infective	ADJ
aijmsr-823	94	7	therapy	therapy	NOUN
aijmsr-823	94	8	,	,	PUNCT
aijmsr-823	94	9	10(8	10(8	NOUN
aijmsr-823	94	10	)	)	PUNCT
aijmsr-823	94	11	,	,	PUNCT
aijmsr-823	94	12	917	917	NUM
aijmsr-823	94	13	-	-	SYM
aijmsr-823	94	14	934	934	NUM
aijmsr-823	94	15	.	.	PUNCT
aijmsr-823	95	1	bekele	bekele	PROPN
aijmsr-823	95	2	,	,	PUNCT
aijmsr-823	95	3	t.	t.	PROPN
aijmsr-823	95	4	,	,	PUNCT
aijmsr-823	95	5	tesfaye	tesfaye	PROPN
aijmsr-823	95	6	,	,	PUNCT
aijmsr-823	95	7	a.	a.	NOUN
aijmsr-823	95	8	,	,	PUNCT
aijmsr-823	95	9	sewunet	sewunet	NOUN
aijmsr-823	95	10	,	,	PUNCT
aijmsr-823	95	11	t.	t.	PROPN
aijmsr-823	95	12	,	,	PUNCT
aijmsr-823	95	13	&	&	CCONJ
aijmsr-823	95	14	waktola	waktola	PROPN
aijmsr-823	95	15	,	,	PUNCT
aijmsr-823	95	16	h.	h.	PROPN
aijmsr-823	95	17	d.	d.	PROPN
aijmsr-823	95	18	(	(	PUNCT
aijmsr-823	95	19	2015	2015	NUM
aijmsr-823	95	20	)	)	PUNCT
aijmsr-823	95	21	.	.	PUNCT
aijmsr-823	96	1	pseudomonas	pseudomona	VERB
aijmsr-823	96	2	aeruginosa	aeruginosa	NOUN
aijmsr-823	96	3	isolates	isolate	NOUN
aijmsr-823	96	4	and	and	CCONJ
aijmsr-823	96	5	their	their	PRON
aijmsr-823	96	6	antimicrobial	antimicrobial	ADJ
aijmsr-823	96	7	susceptibility	susceptibility	NOUN
aijmsr-823	96	8	pattern	pattern	NOUN
aijmsr-823	96	9	among	among	ADP
aijmsr-823	96	10	catheterized	catheterize	VERB
aijmsr-823	96	11	patients	patient	NOUN
aijmsr-823	96	12	at	at	ADP
aijmsr-823	96	13	jimma	jimma	PROPN
aijmsr-823	96	14	university	university	PROPN
aijmsr-823	96	15	teaching	teaching	NOUN
aijmsr-823	96	16	hospital	hospital	NOUN
aijmsr-823	96	17	,	,	PUNCT
aijmsr-823	96	18	jimma	jimma	PROPN
aijmsr-823	96	19	,	,	PUNCT
aijmsr-823	96	20	ethiopia	ethiopia	PROPN
aijmsr-823	96	21	.	.	PUNCT
aijmsr-823	97	1	bmc	bmc	PROPN
aijmsr-823	97	2	research	research	NOUN
aijmsr-823	97	3	notes	note	NOUN
aijmsr-823	97	4	,	,	PUNCT
aijmsr-823	97	5	8(1	8(1	NOUN
aijmsr-823	97	6	)	)	PUNCT
aijmsr-823	97	7	,	,	PUNCT
aijmsr-823	97	8	488	488	X
aijmsr-823	97	9	.	.	PUNCT
aijmsr-823	98	1	buke	buke	PROPN
aijmsr-823	98	2	,	,	PUNCT
aijmsr-823	98	3	c.	c.	PROPN
aijmsr-823	98	4	,	,	PUNCT
aijmsr-823	98	5	hosgor	hosgor	ADV
aijmsr-823	98	6	-	-	PUNCT
aijmsr-823	98	7	limoncu	limoncu	ADJ
aijmsr-823	98	8	,	,	PUNCT
aijmsr-823	98	9	m.	m.	NOUN
aijmsr-823	98	10	,	,	PUNCT
aijmsr-823	98	11	ermertcan	ermertcan	PROPN
aijmsr-823	98	12	,	,	PUNCT
aijmsr-823	98	13	s.	s.	PROPN
aijmsr-823	98	14	,	,	PUNCT
aijmsr-823	98	15	ciceklioglu	ciceklioglu	NOUN
aijmsr-823	98	16	,	,	PUNCT
aijmsr-823	98	17	m.	m.	NOUN
aijmsr-823	98	18	,	,	PUNCT
aijmsr-823	98	19	tuncel	tuncel	NOUN
aijmsr-823	98	20	,	,	PUNCT
aijmsr-823	98	21	m.	m.	NOUN
aijmsr-823	98	22	,	,	PUNCT
aijmsr-823	98	23	köse	köse	PROPN
aijmsr-823	98	24	,	,	PUNCT
aijmsr-823	98	25	t.	t.	PROPN
aijmsr-823	98	26	,	,	PUNCT
aijmsr-823	98	27	eren	eren	PROPN
aijmsr-823	98	28	,	,	PUNCT
aijmsr-823	98	29	s.	s.	PROPN
aijmsr-823	98	30	(	(	PUNCT
aijmsr-823	98	31	2005	2005	NUM
aijmsr-823	98	32	)	)	PUNCT
aijmsr-823	98	33	.	.	PUNCT
aijmsr-823	99	1	irrational	irrational	ADJ
aijmsr-823	99	2	use	use	NOUN
aijmsr-823	99	3	of	of	ADP
aijmsr-823	99	4	antibiotics	antibiotic	NOUN
aijmsr-823	99	5	among	among	ADP
aijmsr-823	99	6	university	university	NOUN
aijmsr-823	99	7	students	student	NOUN
aijmsr-823	99	8	.	.	PUNCT
aijmsr-823	100	1	journal	journal	NOUN
aijmsr-823	100	2	of	of	ADP
aijmsr-823	100	3	infection	infection	NOUN
aijmsr-823	100	4	.	.	PUNCT
aijmsr-823	101	1	51(2	51(2	X
aijmsr-823	101	2	)	)	PUNCT
aijmsr-823	101	3	,	,	PUNCT
aijmsr-823	101	4	135	135	NUM
aijmsr-823	101	5	-	-	SYM
aijmsr-823	101	6	9	9	NUM
aijmsr-823	101	7	.	.	PUNCT
aijmsr-823	101	8	cox	cox	PROPN
aijmsr-823	101	9	,	,	PUNCT
aijmsr-823	101	10	c.	c.	PROPN
aijmsr-823	101	11	d.	d.	PROPN
aijmsr-823	101	12	,	,	PUNCT
aijmsr-823	101	13	&	&	CCONJ
aijmsr-823	101	14	parker	parker	PROPN
aijmsr-823	101	15	,	,	PUNCT
aijmsr-823	101	16	j.	j.	PROPN
aijmsr-823	101	17	(	(	PUNCT
aijmsr-823	101	18	1979	1979	NUM
aijmsr-823	101	19	)	)	PUNCT
aijmsr-823	101	20	.	.	PUNCT
aijmsr-823	102	1	use	use	NOUN
aijmsr-823	102	2	of	of	ADP
aijmsr-823	102	3	2	2	NUM
aijmsr-823	102	4	-	-	PUNCT
aijmsr-823	102	5	aminoacetophenone	aminoacetophenone	NOUN
aijmsr-823	102	6	production	production	NOUN
aijmsr-823	102	7	in	in	ADP
aijmsr-823	102	8	identification	identification	NOUN
aijmsr-823	102	9	of	of	ADP
aijmsr-823	102	10	pseudomonas	pseudomona	NOUN
aijmsr-823	102	11	aeruginosa	aeruginosa	NOUN
aijmsr-823	102	12	.	.	PUNCT
aijmsr-823	103	1	journal	journal	NOUN
aijmsr-823	103	2	of	of	ADP
aijmsr-823	103	3	clinical	clinical	ADJ
aijmsr-823	103	4	microbiology	microbiology	NOUN
aijmsr-823	103	5	,	,	PUNCT
aijmsr-823	103	6	9(4	9(4	NUM
aijmsr-823	103	7	)	)	PUNCT
aijmsr-823	103	8	,	,	PUNCT
aijmsr-823	103	9	479	479	NUM
aijmsr-823	103	10	-	-	SYM
aijmsr-823	103	11	484	484	NUM
aijmsr-823	103	12	.	.	PUNCT
aijmsr-823	104	1	cross	cross	PROPN
aijmsr-823	104	2	,	,	PUNCT
aijmsr-823	104	3	a.	a.	PROPN
aijmsr-823	104	4	,	,	PUNCT
aijmsr-823	104	5	allen	allen	PROPN
aijmsr-823	104	6	,	,	PUNCT
aijmsr-823	104	7	j.	j.	PROPN
aijmsr-823	104	8	r.	r.	PROPN
aijmsr-823	104	9	,	,	PUNCT
aijmsr-823	104	10	burke	burke	PROPN
aijmsr-823	104	11	,	,	PUNCT
aijmsr-823	104	12	j.	j.	PROPN
aijmsr-823	104	13	,	,	PUNCT
aijmsr-823	104	14	ducel	ducel	PROPN
aijmsr-823	104	15	,	,	PUNCT
aijmsr-823	104	16	g.	g.	PROPN
aijmsr-823	104	17	,	,	PUNCT
aijmsr-823	104	18	harris	harris	PROPN
aijmsr-823	104	19	,	,	PUNCT
aijmsr-823	104	20	a.	a.	PROPN
aijmsr-823	104	21	,	,	PUNCT
aijmsr-823	104	22	john	john	PROPN
aijmsr-823	104	23	,	,	PUNCT
aijmsr-823	104	24	j.	j.	PROPN
aijmsr-823	104	25	,	,	PUNCT
aijmsr-823	104	26	...	...	PUNCT
aijmsr-823	104	27	&	&	CCONJ
aijmsr-823	104	28	skalova	skalova	PROPN
aijmsr-823	104	29	,	,	PUNCT
aijmsr-823	104	30	r.	r.	PROPN
aijmsr-823	104	31	(	(	PUNCT
aijmsr-823	104	32	1983	1983	NUM
aijmsr-823	104	33	)	)	PUNCT
aijmsr-823	104	34	.	.	PUNCT
aijmsr-823	105	1	nosocomial	nosocomial	ADJ
aijmsr-823	105	2	infections	infection	NOUN
aijmsr-823	105	3	due	due	ADP
aijmsr-823	105	4	to	to	ADP
aijmsr-823	105	5	pseudomonas	pseudomona	NOUN
aijmsr-823	105	6	aeruginosa	aeruginosa	NOUN
aijmsr-823	105	7	:	:	PUNCT
aijmsr-823	105	8	review	review	NOUN
aijmsr-823	105	9	of	of	ADP
aijmsr-823	105	10	recent	recent	ADJ
aijmsr-823	105	11	trends	trend	NOUN
aijmsr-823	105	12	.	.	PUNCT
aijmsr-823	106	1	reviews	review	NOUN
aijmsr-823	106	2	of	of	ADP
aijmsr-823	106	3	infectious	infectious	ADJ
aijmsr-823	106	4	diseases	disease	NOUN
aijmsr-823	106	5	,	,	PUNCT
aijmsr-823	106	6	5(supplement_5	5(supplement_5	NUM
aijmsr-823	106	7	)	)	PUNCT
aijmsr-823	106	8	,	,	PUNCT
aijmsr-823	106	9	s837	s837	PROPN
aijmsr-823	106	10	-	-	PUNCT
aijmsr-823	106	11	s845	s845	PROPN
aijmsr-823	106	12	.	.	PUNCT
aijmsr-823	106	13	evans	evans	PROPN
aijmsr-823	106	14	,	,	PUNCT
aijmsr-823	106	15	m.	m.	PROPN
aijmsr-823	106	16	e.	e.	PROPN
aijmsr-823	106	17	,	,	PUNCT
aijmsr-823	106	18	feola	feola	PROPN
aijmsr-823	106	19	,	,	PUNCT
aijmsr-823	106	20	d.	d.	PROPN
aijmsr-823	106	21	j.	j.	PROPN
aijmsr-823	106	22	,	,	PUNCT
aijmsr-823	106	23	&	&	CCONJ
aijmsr-823	106	24	rapp	rapp	PROPN
aijmsr-823	106	25	,	,	PUNCT
aijmsr-823	106	26	r.	r.	PROPN
aijmsr-823	106	27	p.	p.	PROPN
aijmsr-823	106	28	(	(	PUNCT
aijmsr-823	106	29	1999	1999	NUM
aijmsr-823	106	30	)	)	PUNCT
aijmsr-823	106	31	.	.	PUNCT
aijmsr-823	107	1	polymyxin	polymyxin	PROPN
aijmsr-823	107	2	b	b	PROPN
aijmsr-823	107	3	sulfate	sulfate	NOUN
aijmsr-823	107	4	and	and	CCONJ
aijmsr-823	107	5	colistin	colistin	PROPN
aijmsr-823	107	6	:	:	PUNCT
aijmsr-823	107	7	old	old	ADJ
aijmsr-823	107	8	antibiotics	antibiotic	NOUN
aijmsr-823	107	9	for	for	ADP
aijmsr-823	107	10	emerging	emerge	VERB
aijmsr-823	107	11	multiresistant	multiresistant	ADJ
aijmsr-823	107	12	gram	gram	NOUN
aijmsr-823	107	13	-	-	PUNCT
aijmsr-823	107	14	negative	negative	ADJ
aijmsr-823	107	15	bacteria	bacteria	NOUN
aijmsr-823	107	16	.	.	PUNCT
aijmsr-823	108	1	annals	annal	NOUN
aijmsr-823	108	2	of	of	ADP
aijmsr-823	108	3	pharmacotherapy	pharmacotherapy	NOUN
aijmsr-823	108	4	,	,	PUNCT
aijmsr-823	108	5	33(9	33(9	NUM
aijmsr-823	108	6	)	)	PUNCT
aijmsr-823	108	7	,	,	PUNCT
aijmsr-823	108	8	960	960	NUM
aijmsr-823	108	9	-	-	SYM
aijmsr-823	108	10	967	967	NUM
aijmsr-823	108	11	.	.	PUNCT
aijmsr-823	109	1	el	el	PROPN
aijmsr-823	109	2	baze	baze	PROPN
aijmsr-823	109	3	,	,	PUNCT
aijmsr-823	109	4	p.	p.	NOUN
aijmsr-823	109	5	,	,	PUNCT
aijmsr-823	109	6	thyss	thyss	NOUN
aijmsr-823	109	7	,	,	PUNCT
aijmsr-823	109	8	a.	a.	NOUN
aijmsr-823	109	9	,	,	PUNCT
aijmsr-823	109	10	vinti	vinti	PROPN
aijmsr-823	109	11	,	,	PUNCT
aijmsr-823	109	12	h.	h.	PROPN
aijmsr-823	109	13	,	,	PUNCT
aijmsr-823	109	14	deville	deville	PROPN
aijmsr-823	109	15	,	,	PUNCT
aijmsr-823	109	16	a.	a.	NOUN
aijmsr-823	109	17	,	,	PUNCT
aijmsr-823	109	18	dellamonica	dellamonica	PROPN
aijmsr-823	109	19	,	,	PUNCT
aijmsr-823	109	20	p.	p.	PROPN
aijmsr-823	109	21	,	,	PUNCT
aijmsr-823	109	22	&	&	CCONJ
aijmsr-823	109	23	ortonne	ortonne	PROPN
aijmsr-823	109	24	,	,	PUNCT
aijmsr-823	109	25	j.	j.	PROPN
aijmsr-823	109	26	p.	p.	PROPN
aijmsr-823	109	27	(	(	PUNCT
aijmsr-823	109	28	1991	1991	NUM
aijmsr-823	109	29	)	)	PUNCT
aijmsr-823	109	30	.	.	PUNCT
aijmsr-823	110	1	a	a	DET
aijmsr-823	110	2	study	study	NOUN
aijmsr-823	110	3	of	of	ADP
aijmsr-823	110	4	nineteen	nineteen	NUM
aijmsr-823	110	5	immunocompromised	immunocompromise	VERB
aijmsr-823	110	6	patients	patient	NOUN
aijmsr-823	110	7	with	with	ADP
aijmsr-823	110	8	extensive	extensive	ADJ
aijmsr-823	110	9	skin	skin	NOUN
aijmsr-823	110	10	lesions	lesion	NOUN
aijmsr-823	110	11	caused	cause	VERB
aijmsr-823	110	12	by	by	ADP
aijmsr-823	110	13	pseudomonas	pseudomona	NOUN
aijmsr-823	110	14	aeruginosa	aeruginosa	NOUN
aijmsr-823	110	15	with	with	ADP
aijmsr-823	110	16	and	and	CCONJ
aijmsr-823	110	17	without	without	ADP
aijmsr-823	110	18	bacteremia	bacteremia	NOUN
aijmsr-823	110	19	.	.	PUNCT
aijmsr-823	111	1	acta	acta	PROPN
aijmsr-823	111	2	dermato	dermato	PROPN
aijmsr-823	111	3	-	-	PUNCT
aijmsr-823	111	4	venereologica	venereologica	PROPN
aijmsr-823	111	5	,	,	PUNCT
aijmsr-823	111	6	71(5	71(5	NUM
aijmsr-823	111	7	)	)	PUNCT
aijmsr-823	111	8	,	,	PUNCT
aijmsr-823	111	9	411	411	NUM
aijmsr-823	111	10	.	.	PUNCT
aijmsr-823	112	1	farooq	farooq	PROPN
aijmsr-823	112	2	,	,	PUNCT
aijmsr-823	112	3	l.	l.	PROPN
aijmsr-823	112	4	,	,	PUNCT
aijmsr-823	112	5	memon	memon	PROPN
aijmsr-823	112	6	,	,	PUNCT
aijmsr-823	112	7	z.	z.	PROPN
aijmsr-823	112	8	,	,	PUNCT
aijmsr-823	112	9	ismail	ismail	PROPN
aijmsr-823	112	10	,	,	PUNCT
aijmsr-823	112	11	m.	m.	NOUN
aijmsr-823	112	12	o.	o.	PROPN
aijmsr-823	112	13	,	,	PUNCT
aijmsr-823	112	14	&	&	CCONJ
aijmsr-823	112	15	sadiq	sadiq	PROPN
aijmsr-823	112	16	,	,	PUNCT
aijmsr-823	112	17	s.	s.	PROPN
aijmsr-823	112	18	(	(	PUNCT
aijmsr-823	112	19	2019	2019	NUM
aijmsr-823	112	20	)	)	PUNCT
aijmsr-823	112	21	.	.	PUNCT
aijmsr-823	113	1	frequency	frequency	NOUN
aijmsr-823	113	2	and	and	CCONJ
aijmsr-823	113	3	antibiogram	antibiogram	PROPN
aijmsr-823	113	4	of	of	ADP
aijmsr-823	113	5	multidrug	multidrug	NOUN
aijmsr-823	113	6	resistant	resistant	ADJ
aijmsr-823	113	7	pseudomonas	pseudomona	NOUN
aijmsr-823	113	8	aeruginosa	aeruginosa	NOUN
aijmsr-823	113	9	in	in	ADP
aijmsr-823	113	10	a	a	DET
aijmsr-823	113	11	tertiary	tertiary	ADJ
aijmsr-823	113	12	care	care	NOUN
aijmsr-823	113	13	hospital	hospital	NOUN
aijmsr-823	113	14	of	of	ADP
aijmsr-823	113	15	pakistan	pakistan	PROPN
aijmsr-823	113	16	.	.	PUNCT
aijmsr-823	114	1	pakistan	pakistan	PROPN
aijmsr-823	114	2	journal	journal	PROPN
aijmsr-823	114	3	of	of	ADP
aijmsr-823	114	4	medical	medical	ADJ
aijmsr-823	114	5	sciences	science	NOUN
aijmsr-823	114	6	,	,	PUNCT
aijmsr-823	114	7	35(6	35(6	NUM
aijmsr-823	114	8	)	)	PUNCT
aijmsr-823	114	9	,	,	PUNCT
aijmsr-823	114	10	1622	1622	NUM
aijmsr-823	114	11	.	.	PUNCT
aijmsr-823	115	1	gill	gill	NOUN
aijmsr-823	115	2	,	,	PUNCT
aijmsr-823	115	3	m.	m.	NOUN
aijmsr-823	115	4	m.	m.	NOUN
aijmsr-823	115	5	,	,	PUNCT
aijmsr-823	115	6	usman	usman	PROPN
aijmsr-823	115	7	,	,	PUNCT
aijmsr-823	115	8	j.	j.	PROPN
aijmsr-823	115	9	,	,	PUNCT
aijmsr-823	115	10	kaleem	kaleem	PROPN
aijmsr-823	115	11	,	,	PUNCT
aijmsr-823	115	12	f.	f.	PROPN
aijmsr-823	115	13	,	,	PUNCT
aijmsr-823	115	14	hassan	hassan	PROPN
aijmsr-823	115	15	,	,	PUNCT
aijmsr-823	115	16	a.	a.	PROPN
aijmsr-823	115	17	,	,	PUNCT
aijmsr-823	115	18	khalid	khalid	PROPN
aijmsr-823	115	19	,	,	PUNCT
aijmsr-823	115	20	a.	a.	PROPN
aijmsr-823	115	21	,	,	PUNCT
aijmsr-823	115	22	anjum	anjum	PROPN
aijmsr-823	115	23	,	,	PUNCT
aijmsr-823	115	24	r.	r.	PROPN
aijmsr-823	115	25	,	,	PUNCT
aijmsr-823	115	26	&	&	CCONJ
aijmsr-823	115	27	fahim	fahim	PROPN
aijmsr-823	115	28	,	,	PUNCT
aijmsr-823	115	29	q.	q.	PROPN
aijmsr-823	115	30	(	(	PUNCT
aijmsr-823	115	31	2011	2011	NUM
aijmsr-823	115	32	)	)	PUNCT
aijmsr-823	115	33	.	.	PUNCT
aijmsr-823	116	1	frequency	frequency	NOUN
aijmsr-823	116	2	and	and	CCONJ
aijmsr-823	116	3	antibiogram	antibiogram	PROPN
aijmsr-823	116	4	of	of	ADP
aijmsr-823	116	5	multi	multi	ADJ
aijmsr-823	116	6	-	-	ADJ
aijmsr-823	116	7	drug	drug	ADJ
aijmsr-823	116	8	resistant	resistant	ADJ
aijmsr-823	116	9	pseudomonas	pseudomona	NOUN
aijmsr-823	116	10	aeruginosa	aeruginosa	NOUN
aijmsr-823	116	11	.	.	PUNCT
aijmsr-823	117	1	j	j	PROPN
aijmsr-823	117	2	coll	coll	PROPN
aijmsr-823	117	3	physicians	physicians	PROPN
aijmsr-823	117	4	surg	surg	PROPN
aijmsr-823	117	5	pak	pak	PROPN
aijmsr-823	117	6	,	,	PUNCT
aijmsr-823	117	7	21(9	21(9	PROPN
aijmsr-823	117	8	)	)	PUNCT
aijmsr-823	117	9	,	,	PUNCT
aijmsr-823	117	10	531	531	NUM
aijmsr-823	117	11	-	-	SYM
aijmsr-823	117	12	534	534	NUM
aijmsr-823	117	13	.	.	PUNCT
aijmsr-823	117	14	haley	haley	NOUN
aijmsr-823	117	15	,	,	PUNCT
aijmsr-823	117	16	c.	c.	PROPN
aijmsr-823	117	17	l.	l.	PROPN
aijmsr-823	117	18	,	,	PUNCT
aijmsr-823	117	19	colmer	colmer	NOUN
aijmsr-823	117	20	-	-	PUNCT
aijmsr-823	117	21	hamood	hamood	PROPN
aijmsr-823	117	22	,	,	PUNCT
aijmsr-823	117	23	j.	j.	PROPN
aijmsr-823	117	24	a.	a.	PROPN
aijmsr-823	117	25	,	,	PUNCT
aijmsr-823	117	26	&	&	CCONJ
aijmsr-823	117	27	hamood	hamood	PROPN
aijmsr-823	117	28	,	,	PUNCT
aijmsr-823	117	29	a.	a.	NOUN
aijmsr-823	117	30	n.	n.	PROPN
aijmsr-823	117	31	(	(	PUNCT
aijmsr-823	117	32	2012	2012	NUM
aijmsr-823	117	33	)	)	PUNCT
aijmsr-823	117	34	.	.	PUNCT
aijmsr-823	118	1	characterization	characterization	NOUN
aijmsr-823	118	2	of	of	ADP
aijmsr-823	118	3	biofilm	biofilm	NOUN
aijmsr-823	118	4	-	-	PUNCT
aijmsr-823	118	5	like	like	ADJ
aijmsr-823	118	6	structures	structure	NOUN
aijmsr-823	118	7	formed	form	VERB
aijmsr-823	118	8	by	by	ADP
aijmsr-823	118	9	pseudomonas	pseudomona	NOUN
aijmsr-823	118	10	aeruginosa	aeruginosa	NOUN
aijmsr-823	118	11	in	in	ADP
aijmsr-823	118	12	a	a	DET
aijmsr-823	118	13	synthetic	synthetic	ADJ
aijmsr-823	118	14	mucus	mucus	NOUN
aijmsr-823	118	15	medium	medium	NOUN
aijmsr-823	118	16	.	.	PUNCT
aijmsr-823	119	1	bmc	bmc	PROPN
aijmsr-823	119	2	microbiology	microbiology	NOUN
aijmsr-823	119	3	,	,	PUNCT
aijmsr-823	119	4	12(1	12(1	NUM
aijmsr-823	119	5	)	)	PUNCT
aijmsr-823	119	6	,	,	PUNCT
aijmsr-823	119	7	181	181	NUM
aijmsr-823	119	8	.	.	PUNCT
aijmsr-823	120	1	kielhofner	kielhofner	NOUN
aijmsr-823	120	2	,	,	PUNCT
aijmsr-823	120	3	m.	m.	NOUN
aijmsr-823	120	4	,	,	PUNCT
aijmsr-823	120	5	atmar	atmar	PROPN
aijmsr-823	120	6	,	,	PUNCT
aijmsr-823	120	7	r.	r.	PROPN
aijmsr-823	120	8	l.	l.	PROPN
aijmsr-823	120	9	,	,	PUNCT
aijmsr-823	120	10	hamill	hamill	PROPN
aijmsr-823	120	11	,	,	PUNCT
aijmsr-823	120	12	r.	r.	PROPN
aijmsr-823	120	13	j.	j.	PROPN
aijmsr-823	120	14	,	,	PUNCT
aijmsr-823	120	15	&	&	CCONJ
aijmsr-823	120	16	musher	musher	PROPN
aijmsr-823	120	17	,	,	PUNCT
aijmsr-823	120	18	d.	d.	PROPN
aijmsr-823	120	19	m.	m.	PROPN
aijmsr-823	120	20	(	(	PUNCT
aijmsr-823	120	21	1992	1992	NUM
aijmsr-823	120	22	)	)	PUNCT
aijmsr-823	120	23	.	.	PUNCT
aijmsr-823	121	1	life	life	NOUN
aijmsr-823	121	2	-	-	PUNCT
aijmsr-823	121	3	threatening	threaten	VERB
aijmsr-823	121	4	pseudomonas	pseudomona	NOUN
aijmsr-823	121	5	aeruginosa	aeruginosa	NOUN
aijmsr-823	121	6	infections	infection	NOUN
aijmsr-823	121	7	in	in	ADP
aijmsr-823	121	8	patients	patient	NOUN
aijmsr-823	121	9	with	with	ADP
aijmsr-823	121	10	human	human	ADJ
aijmsr-823	121	11	immunodeficiency	immunodeficiency	NOUN
aijmsr-823	121	12	virus	virus	NOUN
aijmsr-823	121	13	infection	infection	NOUN
aijmsr-823	121	14	.	.	PUNCT
aijmsr-823	122	1	clinical	clinical	ADJ
aijmsr-823	122	2	infectious	infectious	ADJ
aijmsr-823	122	3	diseases	disease	NOUN
aijmsr-823	122	4	,	,	PUNCT
aijmsr-823	122	5	14(2	14(2	NUM
aijmsr-823	122	6	)	)	PUNCT
aijmsr-823	122	7	,	,	PUNCT
aijmsr-823	122	8	403	403	NUM
aijmsr-823	122	9	-	-	SYM
aijmsr-823	122	10	411	411	NUM
aijmsr-823	122	11	.	.	PUNCT
aijmsr-823	122	12	kerem	kerem	PROPN
aijmsr-823	122	13	,	,	PUNCT
aijmsr-823	122	14	e.	e.	PROPN
aijmsr-823	122	15	,	,	PUNCT
aijmsr-823	122	16	corey	corey	PROPN
aijmsr-823	122	17	,	,	PUNCT
aijmsr-823	122	18	m.	m.	NOUN
aijmsr-823	122	19	,	,	PUNCT
aijmsr-823	122	20	gold	gold	NOUN
aijmsr-823	122	21	,	,	PUNCT
aijmsr-823	122	22	r.	r.	PROPN
aijmsr-823	122	23	t.	t.	PROPN
aijmsr-823	122	24	,	,	PUNCT
aijmsr-823	122	25	&	&	CCONJ
aijmsr-823	122	26	levison	levison	PROPN
aijmsr-823	122	27	,	,	PUNCT
aijmsr-823	122	28	h.	h.	PROPN
aijmsr-823	122	29	(	(	PUNCT
aijmsr-823	122	30	1990	1990	NUM
aijmsr-823	122	31	)	)	PUNCT
aijmsr-823	122	32	.	.	PUNCT
aijmsr-823	123	1	pulmonary	pulmonary	ADJ
aijmsr-823	123	2	function	function	NOUN
aijmsr-823	123	3	and	and	CCONJ
aijmsr-823	123	4	clinical	clinical	ADJ
aijmsr-823	123	5	course	course	NOUN
aijmsr-823	123	6	in	in	ADP
aijmsr-823	123	7	patients	patient	NOUN
aijmsr-823	123	8	with	with	ADP
aijmsr-823	123	9	cystic	cystic	ADJ
aijmsr-823	123	10	fibrosis	fibrosis	NOUN
aijmsr-823	123	11	after	after	ADP
aijmsr-823	123	12	pulmonary	pulmonary	ADJ
aijmsr-823	123	13	colonization	colonization	NOUN
aijmsr-823	123	14	with	with	ADP
aijmsr-823	123	15	pseudomonas	pseudomona	NOUN
aijmsr-823	123	16	aeruginosa	aeruginosa	NOUN
aijmsr-823	123	17	.	.	PUNCT
aijmsr-823	124	1	the	the	DET
aijmsr-823	124	2	journal	journal	NOUN
aijmsr-823	124	3	of	of	ADP
aijmsr-823	124	4	pediatrics	pediatric	NOUN
aijmsr-823	124	5	,	,	PUNCT
aijmsr-823	124	6	116(5	116(5	NUM
aijmsr-823	124	7	)	)	PUNCT
aijmsr-823	124	8	,	,	PUNCT
aijmsr-823	124	9	714	714	NUM
aijmsr-823	124	10	-	-	SYM
aijmsr-823	124	11	719	719	NUM
aijmsr-823	124	12	.	.	PUNCT
aijmsr-823	124	13	kalantar	kalantar	PROPN
aijmsr-823	124	14	,	,	PUNCT
aijmsr-823	124	15	e.	e.	PROPN
aijmsr-823	124	16	,	,	PUNCT
aijmsr-823	124	17	torabi	torabi	PROPN
aijmsr-823	124	18	,	,	PUNCT
aijmsr-823	124	19	v.	v.	ADV
aijmsr-823	124	20	,	,	PUNCT
aijmsr-823	124	21	salimizand	salimizand	NOUN
aijmsr-823	124	22	,	,	PUNCT
aijmsr-823	124	23	h.	h.	PROPN
aijmsr-823	124	24	,	,	PUNCT
aijmsr-823	124	25	soheili	soheili	NOUN
aijmsr-823	124	26	,	,	PUNCT
aijmsr-823	124	27	f.	f.	PROPN
aijmsr-823	124	28	,	,	PUNCT
aijmsr-823	124	29	beiranvand	beiranvand	PROPN
aijmsr-823	124	30	,	,	PUNCT
aijmsr-823	124	31	s.	s.	PROPN
aijmsr-823	124	32	,	,	PUNCT
aijmsr-823	124	33	&	&	CCONJ
aijmsr-823	124	34	dallal	dallal	PROPN
aijmsr-823	124	35	,	,	PUNCT
aijmsr-823	124	36	m.	m.	NOUN
aijmsr-823	124	37	m.	m.	PROPN
aijmsr-823	124	38	s.	s.	PROPN
aijmsr-823	124	39	(	(	PUNCT
aijmsr-823	124	40	2012	2012	NUM
aijmsr-823	124	41	)	)	PUNCT
aijmsr-823	124	42	.	.	PUNCT
aijmsr-823	125	1	first	first	ADJ
aijmsr-823	125	2	survey	survey	NOUN
aijmsr-823	125	3	of	of	ADP
aijmsr-823	125	4	metallo	metallo	PROPN
aijmsr-823	125	5	-	-	PUNCT
aijmsr-823	125	6	β	β	NOUN
aijmsr-823	125	7	–	–	PUNCT
aijmsr-823	125	8	lactamase	lactamase	ADJ
aijmsr-823	125	9	producers	producer	NOUN
aijmsr-823	125	10	in	in	ADP
aijmsr-823	125	11	clinical	clinical	ADJ
aijmsr-823	125	12	isolates	isolate	NOUN
aijmsr-823	125	13	of	of	ADP
aijmsr-823	125	14	pseudomonas	pseudomona	NOUN
aijmsr-823	125	15	aeruginosa	aeruginosa	NOUN
aijmsr-823	125	16	from	from	ADP
aijmsr-823	125	17	a	a	DET
aijmsr-823	125	18	referral	referral	ADJ
aijmsr-823	125	19	burn	burn	NOUN
aijmsr-823	125	20	center	center	NOUN
aijmsr-823	125	21	in	in	ADP
aijmsr-823	125	22	kurdistan	kurdistan	PROPN
aijmsr-823	125	23	province	province	PROPN
aijmsr-823	125	24	.	.	PUNCT
aijmsr-823	126	1	jundishapur	jundishapur	PROPN
aijmsr-823	126	2	journal	journal	PROPN
aijmsr-823	126	3	of	of	ADP
aijmsr-823	126	4	natural	natural	ADJ
aijmsr-823	126	5	pharmaceutical	pharmaceutical	ADJ
aijmsr-823	126	6	products	product	NOUN
aijmsr-823	126	7	,	,	PUNCT
aijmsr-823	126	8	7(1	7(1	NUM
aijmsr-823	126	9	)	)	PUNCT
aijmsr-823	126	10	,	,	PUNCT
aijmsr-823	126	11	23	23	NUM
aijmsr-823	126	12	.	.	PUNCT
aijmsr-823	127	1	https://www.cribfb.com/journal/index.php/aijmsr	https://www.cribfb.com/journal/index.php/aijmsr	PROPN
aijmsr-823	127	2	american	american	PROPN
aijmsr-823	127	3	international	international	PROPN
aijmsr-823	127	4	journal	journal	PROPN
aijmsr-823	127	5	of	of	ADP
aijmsr-823	127	6	multidisciplinary	multidisciplinary	ADJ
aijmsr-823	127	7	scientific	scientific	ADJ
aijmsr-823	127	8	research	research	NOUN
aijmsr-823	127	9	vol	vol	NOUN
aijmsr-823	127	10	.	.	PROPN
aijmsr-823	128	1	6	6	NUM
aijmsr-823	128	2	,	,	PUNCT
aijmsr-823	128	3	no	no	INTJ
aijmsr-823	128	4	.	.	NOUN
aijmsr-823	128	5	3	3	NUM
aijmsr-823	128	6	;	;	PUNCT
aijmsr-823	128	7	2020	2020	NUM
aijmsr-823	128	8	7	7	NUM
aijmsr-823	128	9	kattel	kattel	NOUN
aijmsr-823	128	10	,	,	PUNCT
aijmsr-823	128	11	h.	h.	PROPN
aijmsr-823	128	12	p.	p.	PROPN
aijmsr-823	128	13	,	,	PUNCT
aijmsr-823	128	14	mishra	mishra	PROPN
aijmsr-823	128	15	,	,	PUNCT
aijmsr-823	128	16	s.	s.	PROPN
aijmsr-823	128	17	k.	k.	PROPN
aijmsr-823	128	18	,	,	PUNCT
aijmsr-823	128	19	acharya	acharya	PROPN
aijmsr-823	128	20	,	,	PUNCT
aijmsr-823	128	21	j.	j.	PROPN
aijmsr-823	128	22	,	,	PUNCT
aijmsr-823	128	23	sigdel	sigdel	PROPN
aijmsr-823	128	24	,	,	PUNCT
aijmsr-823	128	25	m.	m.	PROPN
aijmsr-823	128	26	r.	r.	PROPN
aijmsr-823	128	27	,	,	PUNCT
aijmsr-823	128	28	prasad	prasad	PROPN
aijmsr-823	128	29	,	,	PUNCT
aijmsr-823	128	30	n.	n.	NOUN
aijmsr-823	128	31	,	,	PUNCT
aijmsr-823	128	32	shah	shah	NOUN
aijmsr-823	128	33	,	,	PUNCT
aijmsr-823	128	34	a.	a.	PROPN
aijmsr-823	128	35	s.	s.	PROPN
aijmsr-823	128	36	s.	s.	PROPN
aijmsr-823	128	37	,	,	PUNCT
aijmsr-823	128	38	...	...	PUNCT
aijmsr-823	128	39	&	&	CCONJ
aijmsr-823	128	40	pokhrel	pokhrel	PROPN
aijmsr-823	128	41	,	,	PUNCT
aijmsr-823	128	42	b.	b.	PROPN
aijmsr-823	128	43	m.	m.	PROPN
aijmsr-823	128	44	(	(	PUNCT
aijmsr-823	128	45	2012	2012	NUM
aijmsr-823	128	46	)	)	PUNCT
aijmsr-823	128	47	.	.	PUNCT
aijmsr-823	129	1	antibiotic	antibiotic	ADJ
aijmsr-823	129	2	sensitivity	sensitivity	NOUN
aijmsr-823	129	3	profile	profile	NOUN
aijmsr-823	129	4	of	of	ADP
aijmsr-823	129	5	different	different	ADJ
aijmsr-823	129	6	uropathogens	uropathogen	NOUN
aijmsr-823	129	7	in	in	ADP
aijmsr-823	129	8	a	a	DET
aijmsr-823	129	9	tertiary	tertiary	ADJ
aijmsr-823	129	10	care	care	NOUN
aijmsr-823	129	11	center	center	NOUN
aijmsr-823	129	12	in	in	ADP
aijmsr-823	129	13	nepal	nepal	PROPN
aijmsr-823	129	14	.	.	PUNCT
aijmsr-823	130	1	journal	journal	PROPN
aijmsr-823	130	2	of	of	ADP
aijmsr-823	130	3	nepal	nepal	PROPN
aijmsr-823	130	4	association	association	PROPN
aijmsr-823	130	5	of	of	ADP
aijmsr-823	130	6	medical	medical	ADJ
aijmsr-823	130	7	laboratory	laboratory	NOUN
aijmsr-823	130	8	science	science	NOUN
aijmsr-823	130	9	,	,	PUNCT
aijmsr-823	130	10	11(1	11(1	NUM
aijmsr-823	130	11	)	)	PUNCT
aijmsr-823	130	12	,	,	PUNCT
aijmsr-823	130	13	1933	1933	NUM
aijmsr-823	130	14	.	.	PUNCT
aijmsr-823	131	1	levy	levy	NOUN
aijmsr-823	131	2	,	,	PUNCT
aijmsr-823	131	3	s.	s.	PROPN
aijmsr-823	131	4	b.	b.	PROPN
aijmsr-823	131	5	(	(	PUNCT
aijmsr-823	131	6	2002	2002	NUM
aijmsr-823	131	7	)	)	PUNCT
aijmsr-823	131	8	.	.	PUNCT
aijmsr-823	132	1	factors	factor	NOUN
aijmsr-823	132	2	impacting	impact	VERB
aijmsr-823	132	3	on	on	ADP
aijmsr-823	132	4	the	the	DET
aijmsr-823	132	5	problem	problem	NOUN
aijmsr-823	132	6	of	of	ADP
aijmsr-823	132	7	antibiotic	antibiotic	ADJ
aijmsr-823	132	8	resistance	resistance	NOUN
aijmsr-823	132	9	.	.	PUNCT
aijmsr-823	133	1	journal	journal	NOUN
aijmsr-823	133	2	of	of	ADP
aijmsr-823	133	3	antimicrobial	antimicrobial	ADJ
aijmsr-823	133	4	chemotherapy	chemotherapy	NOUN
aijmsr-823	133	5	,	,	PUNCT
aijmsr-823	133	6	49(1	49(1	NOUN
aijmsr-823	133	7	)	)	PUNCT
aijmsr-823	133	8	,	,	PUNCT
aijmsr-823	133	9	25	25	NUM
aijmsr-823	133	10	-	-	SYM
aijmsr-823	133	11	30	30	NUM
aijmsr-823	133	12	.	.	PUNCT
aijmsr-823	134	1	landersdorfer	landersdorfer	PROPN
aijmsr-823	134	2	,	,	PUNCT
aijmsr-823	134	3	c.	c.	PROPN
aijmsr-823	134	4	b.	b.	PROPN
aijmsr-823	134	5	,	,	PUNCT
aijmsr-823	134	6	&	&	CCONJ
aijmsr-823	134	7	nation	nation	PROPN
aijmsr-823	134	8	,	,	PUNCT
aijmsr-823	134	9	r.	r.	PROPN
aijmsr-823	134	10	l.	l.	PROPN
aijmsr-823	134	11	(	(	PUNCT
aijmsr-823	134	12	2015	2015	NUM
aijmsr-823	134	13	,	,	PUNCT
aijmsr-823	134	14	february	february	PROPN
aijmsr-823	134	15	)	)	PUNCT
aijmsr-823	134	16	.	.	PUNCT
aijmsr-823	135	1	colistin	colistin	PROPN
aijmsr-823	135	2	:	:	PUNCT
aijmsr-823	135	3	how	how	SCONJ
aijmsr-823	135	4	should	should	AUX
aijmsr-823	135	5	it	it	PRON
aijmsr-823	135	6	be	be	AUX
aijmsr-823	135	7	dosed	dose	VERB
aijmsr-823	135	8	for	for	ADP
aijmsr-823	135	9	the	the	DET
aijmsr-823	135	10	critically	critically	ADV
aijmsr-823	135	11	ill	ill	ADJ
aijmsr-823	135	12	?	?	PUNCT
aijmsr-823	135	13	.	.	PUNCT
aijmsr-823	136	1	in	in	ADP
aijmsr-823	136	2	seminars	seminar	NOUN
aijmsr-823	136	3	in	in	ADP
aijmsr-823	136	4	respiratory	respiratory	ADJ
aijmsr-823	136	5	and	and	CCONJ
aijmsr-823	136	6	critical	critical	ADJ
aijmsr-823	136	7	care	care	NOUN
aijmsr-823	136	8	medicine	medicine	NOUN
aijmsr-823	136	9	(	(	PUNCT
aijmsr-823	136	10	vol	vol	NOUN
aijmsr-823	136	11	.	.	PROPN
aijmsr-823	136	12	36	36	NUM
aijmsr-823	136	13	,	,	PUNCT
aijmsr-823	136	14	no	no	INTJ
aijmsr-823	136	15	.	.	NOUN
aijmsr-823	136	16	01	01	NUM
aijmsr-823	136	17	,	,	PUNCT
aijmsr-823	136	18	pp	pp	ADJ
aijmsr-823	136	19	.	.	PUNCT
aijmsr-823	136	20	126	126	NUM
aijmsr-823	136	21	-	-	SYM
aijmsr-823	136	22	135	135	NUM
aijmsr-823	136	23	)	)	PUNCT
aijmsr-823	136	24	.	.	PUNCT
aijmsr-823	137	1	thieme	thieme	NOUN
aijmsr-823	137	2	medical	medical	ADJ
aijmsr-823	137	3	publishers	publisher	NOUN
aijmsr-823	137	4	.	.	PUNCT
aijmsr-823	138	1	mahmoud	mahmoud	PROPN
aijmsr-823	138	2	,	,	PUNCT
aijmsr-823	138	3	a.	a.	PROPN
aijmsr-823	138	4	b.	b.	PROPN
aijmsr-823	138	5	,	,	PUNCT
aijmsr-823	138	6	zahran	zahran	PROPN
aijmsr-823	138	7	,	,	PUNCT
aijmsr-823	138	8	w.	w.	PROPN
aijmsr-823	138	9	a.	a.	PROPN
aijmsr-823	138	10	,	,	PUNCT
aijmsr-823	138	11	hindawi	hindawi	ADJ
aijmsr-823	138	12	,	,	PUNCT
aijmsr-823	138	13	g.	g.	PROPN
aijmsr-823	138	14	r.	r.	PROPN
aijmsr-823	138	15	,	,	PUNCT
aijmsr-823	138	16	labib	labib	PROPN
aijmsr-823	138	17	,	,	PUNCT
aijmsr-823	138	18	a.	a.	PROPN
aijmsr-823	138	19	z.	z.	PROPN
aijmsr-823	138	20	,	,	PUNCT
aijmsr-823	138	21	&	&	CCONJ
aijmsr-823	138	22	galal	galal	PROPN
aijmsr-823	138	23	,	,	PUNCT
aijmsr-823	138	24	r.	r.	PROPN
aijmsr-823	138	25	(	(	PUNCT
aijmsr-823	138	26	2013	2013	NUM
aijmsr-823	138	27	)	)	PUNCT
aijmsr-823	138	28	.	.	PUNCT
aijmsr-823	139	1	prevalence	prevalence	NOUN
aijmsr-823	139	2	of	of	ADP
aijmsr-823	139	3	multidrug	multidrug	NOUN
aijmsr-823	139	4	-	-	PUNCT
aijmsr-823	139	5	resistant	resistant	ADJ
aijmsr-823	139	6	pseudomonas	pseudomona	NOUN
aijmsr-823	139	7	aeruginosa	aeruginosa	NOUN
aijmsr-823	139	8	in	in	ADP
aijmsr-823	139	9	patients	patient	NOUN
aijmsr-823	139	10	with	with	ADP
aijmsr-823	139	11	nosocomial	nosocomial	ADJ
aijmsr-823	139	12	infections	infection	NOUN
aijmsr-823	139	13	at	at	ADP
aijmsr-823	139	14	a	a	DET
aijmsr-823	139	15	university	university	NOUN
aijmsr-823	139	16	hospital	hospital	NOUN
aijmsr-823	139	17	in	in	ADP
aijmsr-823	139	18	egypt	egypt	PROPN
aijmsr-823	139	19	,	,	PUNCT
aijmsr-823	139	20	with	with	ADP
aijmsr-823	139	21	special	special	ADJ
aijmsr-823	139	22	reference	reference	NOUN
aijmsr-823	139	23	to	to	ADP
aijmsr-823	139	24	typing	type	VERB
aijmsr-823	139	25	methods	method	NOUN
aijmsr-823	139	26	.	.	PUNCT
aijmsr-823	140	1	j	j	PROPN
aijmsr-823	140	2	virol	virol	PROPN
aijmsr-823	140	3	microbiol	microbiol	PROPN
aijmsr-823	140	4	,	,	PUNCT
aijmsr-823	140	5	13	13	NUM
aijmsr-823	140	6	,	,	PUNCT
aijmsr-823	140	7	165	165	NUM
aijmsr-823	140	8	-	-	SYM
aijmsr-823	140	9	59	59	NUM
aijmsr-823	140	10	.	.	PUNCT
aijmsr-823	140	11	mittal	mittal	PROPN
aijmsr-823	140	12	,	,	PUNCT
aijmsr-823	140	13	r.	r.	PROPN
aijmsr-823	140	14	,	,	PUNCT
aijmsr-823	140	15	aggarwal	aggarwal	PROPN
aijmsr-823	140	16	,	,	PUNCT
aijmsr-823	140	17	s.	s.	PROPN
aijmsr-823	140	18	,	,	PUNCT
aijmsr-823	140	19	sharma	sharma	PROPN
aijmsr-823	140	20	,	,	PUNCT
aijmsr-823	140	21	s.	s.	PROPN
aijmsr-823	140	22	,	,	PUNCT
aijmsr-823	140	23	chhibber	chhibber	PROPN
aijmsr-823	140	24	,	,	PUNCT
aijmsr-823	140	25	s.	s.	PROPN
aijmsr-823	140	26	,	,	PUNCT
aijmsr-823	140	27	&	&	CCONJ
aijmsr-823	140	28	harjai	harjai	PROPN
aijmsr-823	140	29	,	,	PUNCT
aijmsr-823	140	30	k.	k.	PROPN
aijmsr-823	140	31	(	(	PUNCT
aijmsr-823	140	32	2009	2009	NUM
aijmsr-823	140	33	)	)	PUNCT
aijmsr-823	140	34	.	.	PUNCT
aijmsr-823	141	1	urinary	urinary	ADJ
aijmsr-823	141	2	tract	tract	NOUN
aijmsr-823	141	3	infections	infection	NOUN
aijmsr-823	141	4	caused	cause	VERB
aijmsr-823	141	5	by	by	ADP
aijmsr-823	141	6	pseudomonas	pseudomona	NOUN
aijmsr-823	141	7	aeruginosa	aeruginosa	NOUN
aijmsr-823	141	8	:	:	PUNCT
aijmsr-823	141	9	a	a	DET
aijmsr-823	141	10	minireview	minireview	NOUN
aijmsr-823	141	11	.	.	PUNCT
aijmsr-823	142	1	journal	journal	NOUN
aijmsr-823	142	2	of	of	ADP
aijmsr-823	142	3	infection	infection	NOUN
aijmsr-823	142	4	and	and	CCONJ
aijmsr-823	142	5	public	public	ADJ
aijmsr-823	142	6	health	health	NOUN
aijmsr-823	142	7	,	,	PUNCT
aijmsr-823	142	8	2(3	2(3	NUM
aijmsr-823	142	9	)	)	PUNCT
aijmsr-823	142	10	,	,	PUNCT
aijmsr-823	142	11	101	101	NUM
aijmsr-823	142	12	-	-	SYM
aijmsr-823	142	13	111	111	NUM
aijmsr-823	142	14	.	.	PUNCT
aijmsr-823	143	1	pfaller	pfaller	NOUN
aijmsr-823	143	2	,	,	PUNCT
aijmsr-823	143	3	m.	m.	NOUN
aijmsr-823	143	4	a.	a.	PROPN
aijmsr-823	143	5	,	,	PUNCT
aijmsr-823	143	6	shortridge	shortridge	PROPN
aijmsr-823	143	7	,	,	PUNCT
aijmsr-823	143	8	d.	d.	PROPN
aijmsr-823	143	9	,	,	PUNCT
aijmsr-823	143	10	sader	sader	PROPN
aijmsr-823	143	11	,	,	PUNCT
aijmsr-823	143	12	h.	h.	PROPN
aijmsr-823	143	13	s.	s.	PROPN
aijmsr-823	143	14	,	,	PUNCT
aijmsr-823	143	15	flamm	flamm	PROPN
aijmsr-823	143	16	,	,	PUNCT
aijmsr-823	143	17	r.	r.	PROPN
aijmsr-823	143	18	k.	k.	PROPN
aijmsr-823	143	19	,	,	PUNCT
aijmsr-823	143	20	&	&	CCONJ
aijmsr-823	143	21	castanheira	castanheira	PROPN
aijmsr-823	143	22	,	,	PUNCT
aijmsr-823	143	23	m.	m.	NOUN
aijmsr-823	143	24	(	(	PUNCT
aijmsr-823	143	25	2017	2017	NUM
aijmsr-823	143	26	)	)	PUNCT
aijmsr-823	143	27	.	.	PUNCT
aijmsr-823	144	1	ceftolozane	ceftolozane	ADJ
aijmsr-823	144	2	–	–	PUNCT
aijmsr-823	144	3	tazobactam	tazobactam	NOUN
aijmsr-823	144	4	activity	activity	NOUN
aijmsr-823	144	5	against	against	ADP
aijmsr-823	144	6	drug	drug	NOUN
aijmsr-823	144	7	-	-	PUNCT
aijmsr-823	144	8	resistant	resistant	ADJ
aijmsr-823	144	9	enterobacteriaceae	enterobacteriaceae	NOUN
aijmsr-823	144	10	and	and	CCONJ
aijmsr-823	144	11	pseudomonas	pseudomona	VERB
aijmsr-823	144	12	aeruginosa	aeruginosa	NOUN
aijmsr-823	144	13	causing	cause	VERB
aijmsr-823	144	14	healthcare	healthcare	NOUN
aijmsr-823	144	15	-	-	PUNCT
aijmsr-823	144	16	associated	associate	VERB
aijmsr-823	144	17	infections	infection	NOUN
aijmsr-823	144	18	in	in	ADP
aijmsr-823	144	19	australia	australia	PROPN
aijmsr-823	144	20	and	and	CCONJ
aijmsr-823	144	21	new	new	PROPN
aijmsr-823	144	22	zealand	zealand	PROPN
aijmsr-823	144	23	:	:	PUNCT
aijmsr-823	144	24	report	report	NOUN
aijmsr-823	144	25	from	from	ADP
aijmsr-823	144	26	an	an	DET
aijmsr-823	144	27	antimicrobial	antimicrobial	ADJ
aijmsr-823	144	28	surveillance	surveillance	NOUN
aijmsr-823	144	29	program	program	NOUN
aijmsr-823	144	30	(	(	PUNCT
aijmsr-823	144	31	2013–2015	2013–2015	NUM
aijmsr-823	144	32	)	)	PUNCT
aijmsr-823	144	33	.	.	PUNCT
aijmsr-823	145	1	journal	journal	PROPN
aijmsr-823	145	2	of	of	ADP
aijmsr-823	145	3	global	global	ADJ
aijmsr-823	145	4	antimicrobial	antimicrobial	ADJ
aijmsr-823	145	5	resistance	resistance	NOUN
aijmsr-823	145	6	,	,	PUNCT
aijmsr-823	145	7	10	10	NUM
aijmsr-823	145	8	,	,	PUNCT
aijmsr-823	145	9	186	186	NUM
aijmsr-823	145	10	-	-	SYM
aijmsr-823	145	11	194	194	NUM
aijmsr-823	145	12	.	.	PUNCT
aijmsr-823	146	1	rossolini	rossolini	PROPN
aijmsr-823	146	2	,	,	PUNCT
aijmsr-823	146	3	g.	g.	PROPN
aijmsr-823	146	4	m.	m.	PROPN
aijmsr-823	146	5	,	,	PUNCT
aijmsr-823	146	6	&	&	CCONJ
aijmsr-823	146	7	mantengoli	mantengoli	PROPN
aijmsr-823	146	8	,	,	PUNCT
aijmsr-823	146	9	e.	e.	PROPN
aijmsr-823	146	10	(	(	PUNCT
aijmsr-823	146	11	2005	2005	NUM
aijmsr-823	146	12	)	)	PUNCT
aijmsr-823	146	13	.	.	PUNCT
aijmsr-823	147	1	treatment	treatment	NOUN
aijmsr-823	147	2	and	and	CCONJ
aijmsr-823	147	3	control	control	NOUN
aijmsr-823	147	4	of	of	ADP
aijmsr-823	147	5	severe	severe	ADJ
aijmsr-823	147	6	infections	infection	NOUN
aijmsr-823	147	7	caused	cause	VERB
aijmsr-823	147	8	by	by	ADP
aijmsr-823	147	9	multiresistant	multiresistant	ADJ
aijmsr-823	147	10	pseudomonas	pseudomona	NOUN
aijmsr-823	147	11	aeruginosa	aeruginosa	NOUN
aijmsr-823	147	12	.	.	PUNCT
aijmsr-823	148	1	clinical	clinical	ADJ
aijmsr-823	148	2	microbiology	microbiology	NOUN
aijmsr-823	148	3	and	and	CCONJ
aijmsr-823	148	4	infection	infection	NOUN
aijmsr-823	148	5	,	,	PUNCT
aijmsr-823	148	6	11	11	NUM
aijmsr-823	148	7	,	,	PUNCT
aijmsr-823	148	8	1732	1732	NUM
aijmsr-823	148	9	.	.	PUNCT
aijmsr-823	149	1	trautmann	trautmann	PROPN
aijmsr-823	149	2	,	,	PUNCT
aijmsr-823	149	3	m.	m.	NOUN
aijmsr-823	149	4	,	,	PUNCT
aijmsr-823	149	5	halder	halder	PROPN
aijmsr-823	149	6	,	,	PUNCT
aijmsr-823	149	7	s.	s.	PROPN
aijmsr-823	149	8	,	,	PUNCT
aijmsr-823	149	9	hoegel	hoegel	PROPN
aijmsr-823	149	10	,	,	PUNCT
aijmsr-823	149	11	j.	j.	PROPN
aijmsr-823	149	12	,	,	PUNCT
aijmsr-823	149	13	royer	royer	PROPN
aijmsr-823	149	14	,	,	PUNCT
aijmsr-823	149	15	h.	h.	PROPN
aijmsr-823	149	16	,	,	PUNCT
aijmsr-823	149	17	&	&	CCONJ
aijmsr-823	149	18	haller	haller	PROPN
aijmsr-823	149	19	,	,	PUNCT
aijmsr-823	149	20	m.	m.	NOUN
aijmsr-823	149	21	(	(	PUNCT
aijmsr-823	149	22	2008	2008	NUM
aijmsr-823	149	23	)	)	PUNCT
aijmsr-823	149	24	.	.	PUNCT
aijmsr-823	150	1	point	point	NOUN
aijmsr-823	150	2	-	-	PUNCT
aijmsr-823	150	3	of	of	ADP
aijmsr-823	150	4	-	-	PUNCT
aijmsr-823	150	5	use	use	NOUN
aijmsr-823	150	6	water	water	NOUN
aijmsr-823	150	7	filtration	filtration	NOUN
aijmsr-823	150	8	reduces	reduce	VERB
aijmsr-823	150	9	endemic	endemic	ADJ
aijmsr-823	150	10	pseudomonas	pseudomona	NOUN
aijmsr-823	150	11	aeruginosa	aeruginosa	NOUN
aijmsr-823	150	12	infections	infection	NOUN
aijmsr-823	150	13	on	on	ADP
aijmsr-823	150	14	a	a	DET
aijmsr-823	150	15	surgical	surgical	ADJ
aijmsr-823	150	16	intensive	intensive	ADJ
aijmsr-823	150	17	care	care	NOUN
aijmsr-823	150	18	unit	unit	NOUN
aijmsr-823	150	19	.	.	PUNCT
aijmsr-823	151	1	american	american	PROPN
aijmsr-823	151	2	journal	journal	PROPN
aijmsr-823	151	3	of	of	ADP
aijmsr-823	151	4	infection	infection	NOUN
aijmsr-823	151	5	control	control	NOUN
aijmsr-823	151	6	,	,	PUNCT
aijmsr-823	151	7	36(6	36(6	NUM
aijmsr-823	151	8	)	)	PUNCT
aijmsr-823	151	9	,	,	PUNCT
aijmsr-823	151	10	421	421	NUM
aijmsr-823	151	11	-	-	SYM
aijmsr-823	151	12	429	429	NUM
aijmsr-823	151	13	.	.	PUNCT
aijmsr-823	152	1	venier	veni	ADJ
aijmsr-823	152	2	,	,	PUNCT
aijmsr-823	152	3	a.	a.	NOUN
aijmsr-823	152	4	g.	g.	PROPN
aijmsr-823	152	5	,	,	PUNCT
aijmsr-823	152	6	leroyer	leroyer	PROPN
aijmsr-823	152	7	,	,	PUNCT
aijmsr-823	152	8	c.	c.	PROPN
aijmsr-823	152	9	,	,	PUNCT
aijmsr-823	152	10	slekovec	slekovec	PROPN
aijmsr-823	152	11	,	,	PUNCT
aijmsr-823	152	12	c.	c.	PROPN
aijmsr-823	152	13	,	,	PUNCT
aijmsr-823	152	14	talon	talon	PROPN
aijmsr-823	152	15	,	,	PUNCT
aijmsr-823	152	16	d.	d.	PROPN
aijmsr-823	152	17	,	,	PUNCT
aijmsr-823	152	18	bertrand	bertrand	PROPN
aijmsr-823	152	19	,	,	PUNCT
aijmsr-823	152	20	x.	x.	PROPN
aijmsr-823	152	21	,	,	PUNCT
aijmsr-823	152	22	parer	parer	PROPN
aijmsr-823	152	23	,	,	PUNCT
aijmsr-823	152	24	s.	s.	PROPN
aijmsr-823	152	25	,	,	PUNCT
aijmsr-823	152	26	...	...	PUNCT
aijmsr-823	152	27	&	&	CCONJ
aijmsr-823	152	28	clair	clair	PROPN
aijmsr-823	152	29	,	,	PUNCT
aijmsr-823	152	30	b.	b.	PROPN
aijmsr-823	152	31	(	(	PUNCT
aijmsr-823	152	32	2014	2014	NUM
aijmsr-823	152	33	)	)	PUNCT
aijmsr-823	152	34	.	.	PUNCT
aijmsr-823	153	1	risk	risk	NOUN
aijmsr-823	153	2	factors	factor	NOUN
aijmsr-823	153	3	for	for	ADP
aijmsr-823	153	4	pseudomonas	pseudomona	NOUN
aijmsr-823	153	5	aeruginosa	aeruginosa	NOUN
aijmsr-823	153	6	acquisition	acquisition	NOUN
aijmsr-823	153	7	in	in	ADP
aijmsr-823	153	8	intensive	intensive	ADJ
aijmsr-823	153	9	care	care	NOUN
aijmsr-823	153	10	units	unit	NOUN
aijmsr-823	153	11	:	:	PUNCT
aijmsr-823	153	12	a	a	DET
aijmsr-823	153	13	prospective	prospective	ADJ
aijmsr-823	153	14	multicentre	multicentre	NOUN
aijmsr-823	153	15	study	study	NOUN
aijmsr-823	153	16	.	.	PUNCT
aijmsr-823	154	1	journal	journal	PROPN
aijmsr-823	154	2	of	of	ADP
aijmsr-823	154	3	hospital	hospital	NOUN
aijmsr-823	154	4	infection	infection	NOUN
aijmsr-823	154	5	,	,	PUNCT
aijmsr-823	154	6	88(2	88(2	NUM
aijmsr-823	154	7	)	)	PUNCT
aijmsr-823	154	8	,	,	PUNCT
aijmsr-823	154	9	103	103	NUM
aijmsr-823	154	10	-	-	SYM
aijmsr-823	154	11	108	108	NUM
aijmsr-823	154	12	.	.	PUNCT
aijmsr-823	155	1	ventola	ventola	PROPN
aijmsr-823	155	2	,	,	PUNCT
aijmsr-823	155	3	c.	c.	PROPN
aijmsr-823	155	4	l.	l.	PROPN
aijmsr-823	155	5	(	(	PUNCT
aijmsr-823	155	6	2015	2015	NUM
aijmsr-823	155	7	)	)	PUNCT
aijmsr-823	155	8	.	.	PUNCT
aijmsr-823	156	1	the	the	DET
aijmsr-823	156	2	antibiotic	antibiotic	ADJ
aijmsr-823	156	3	resistance	resistance	NOUN
aijmsr-823	156	4	crisis	crisis	NOUN
aijmsr-823	156	5	:	:	PUNCT
aijmsr-823	156	6	part	part	NOUN
aijmsr-823	156	7	1	1	NUM
aijmsr-823	156	8	:	:	PUNCT
aijmsr-823	156	9	causes	cause	NOUN
aijmsr-823	156	10	and	and	CCONJ
aijmsr-823	156	11	threats	threat	NOUN
aijmsr-823	156	12	.	.	PUNCT
aijmsr-823	157	1	pharmacy	pharmacy	NOUN
aijmsr-823	157	2	and	and	CCONJ
aijmsr-823	157	3	therapeutics	therapeutic	NOUN
aijmsr-823	157	4	,	,	PUNCT
aijmsr-823	157	5	40(4	40(4	NUM
aijmsr-823	157	6	)	)	PUNCT
aijmsr-823	157	7	,	,	PUNCT
aijmsr-823	157	8	277	277	NUM
aijmsr-823	157	9	.	.	PUNCT
aijmsr-823	158	1	wolinsky	wolinsky	ADV
aijmsr-823	158	2	,	,	PUNCT
aijmsr-823	158	3	e.	e.	PROPN
aijmsr-823	158	4	,	,	PUNCT
aijmsr-823	158	5	&	&	CCONJ
aijmsr-823	158	6	hines	hines	PROPN
aijmsr-823	158	7	,	,	PUNCT
aijmsr-823	158	8	j.	j.	PROPN
aijmsr-823	158	9	d.	d.	PROPN
aijmsr-823	158	10	(	(	PUNCT
aijmsr-823	158	11	1962	1962	NUM
aijmsr-823	158	12	)	)	PUNCT
aijmsr-823	158	13	.	.	PUNCT
aijmsr-823	159	1	neurotoxic	neurotoxic	ADJ
aijmsr-823	159	2	and	and	CCONJ
aijmsr-823	159	3	nephrotoxic	nephrotoxic	ADJ
aijmsr-823	159	4	effects	effect	NOUN
aijmsr-823	159	5	of	of	ADP
aijmsr-823	159	6	colistin	colistin	NOUN
aijmsr-823	159	7	in	in	ADP
aijmsr-823	159	8	patients	patient	NOUN
aijmsr-823	159	9	with	with	ADP
aijmsr-823	159	10	renal	renal	ADJ
aijmsr-823	159	11	disease	disease	NOUN
aijmsr-823	159	12	.	.	PUNCT
aijmsr-823	160	1	new	new	PROPN
aijmsr-823	160	2	england	england	PROPN
aijmsr-823	160	3	journal	journal	PROPN
aijmsr-823	160	4	of	of	ADP
aijmsr-823	160	5	medicine	medicine	NOUN
aijmsr-823	160	6	,	,	PUNCT
aijmsr-823	160	7	266(15	266(15	NUM
aijmsr-823	160	8	)	)	PUNCT
aijmsr-823	160	9	,	,	PUNCT
aijmsr-823	160	10	759	759	NUM
aijmsr-823	160	11	-	-	SYM
aijmsr-823	160	12	762	762	NUM
aijmsr-823	160	13	.	.	PUNCT
aijmsr-823	161	1	yuliandra	yuliandra	NOUN
aijmsr-823	161	2	,	,	PUNCT
aijmsr-823	161	3	y.	y.	PROPN
aijmsr-823	161	4	(	(	PUNCT
aijmsr-823	161	5	2017	2017	NUM
aijmsr-823	161	6	)	)	PUNCT
aijmsr-823	161	7	.	.	PUNCT
aijmsr-823	162	1	antibacterial	antibacterial	ADJ
aijmsr-823	162	2	resistance	resistance	NOUN
aijmsr-823	162	3	pattern	pattern	NOUN
aijmsr-823	162	4	of	of	ADP
aijmsr-823	162	5	pseudomonas	pseudomona	NOUN
aijmsr-823	162	6	aeruginosa	aeruginosa	NOUN
aijmsr-823	162	7	isolated	isolate	VERB
aijmsr-823	162	8	from	from	ADP
aijmsr-823	162	9	clinical	clinical	ADJ
aijmsr-823	162	10	samples	sample	NOUN
aijmsr-823	162	11	at	at	ADP
aijmsr-823	162	12	a	a	DET
aijmsr-823	162	13	general	general	ADJ
aijmsr-823	162	14	hospital	hospital	NOUN
aijmsr-823	162	15	in	in	ADP
aijmsr-823	162	16	...	...	PUNCT
aijmsr-823	162	17	copyrights	copyright	VERB
aijmsr-823	162	18	copyright	copyright	NOUN
aijmsr-823	162	19	for	for	ADP
aijmsr-823	162	20	this	this	DET
aijmsr-823	162	21	article	article	NOUN
aijmsr-823	162	22	is	be	AUX
aijmsr-823	162	23	retained	retain	VERB
aijmsr-823	162	24	by	by	ADP
aijmsr-823	162	25	the	the	DET
aijmsr-823	162	26	author(s	author(s	PROPN
aijmsr-823	162	27	)	)	PUNCT
aijmsr-823	162	28	,	,	PUNCT
aijmsr-823	162	29	with	with	ADP
aijmsr-823	162	30	first	first	ADJ
aijmsr-823	162	31	publication	publication	NOUN
aijmsr-823	162	32	rights	right	NOUN
aijmsr-823	162	33	granted	grant	VERB
aijmsr-823	162	34	to	to	ADP
aijmsr-823	162	35	the	the	DET
aijmsr-823	162	36	journal	journal	NOUN
aijmsr-823	162	37	.	.	PUNCT
aijmsr-823	163	1	this	this	PRON
aijmsr-823	163	2	is	be	AUX
aijmsr-823	163	3	an	an	DET
aijmsr-823	163	4	open	open	ADJ
aijmsr-823	163	5	-	-	PUNCT
aijmsr-823	163	6	access	access	NOUN
aijmsr-823	163	7	article	article	NOUN
aijmsr-823	163	8	distributed	distribute	VERB
aijmsr-823	163	9	under	under	ADP
aijmsr-823	163	10	the	the	DET
aijmsr-823	163	11	terms	term	NOUN
aijmsr-823	163	12	and	and	CCONJ
aijmsr-823	163	13	conditions	condition	NOUN
aijmsr-823	163	14	of	of	ADP
aijmsr-823	163	15	the	the	DET
aijmsr-823	163	16	creative	creative	ADJ
aijmsr-823	163	17	commons	common	NOUN
aijmsr-823	163	18	attribution	attribution	NOUN
aijmsr-823	163	19	license	license	NOUN
aijmsr-823	163	20	(	(	PUNCT
aijmsr-823	163	21	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
aijmsr-823	163	22	)	)	PUNCT